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ABSTRACT
The neuropeptide vasoactive intestinal polypeptide (VIP) is expressed in
dorsal root ganglion (DRG) neurons of the rat in response to peripheral
axotomy (Nielsch and Keen, 1989, Shehab et al., 1986), where it may
influence neuronal survival (Brenneman and Eiden, 1986), or modulate
nociceptive input into the spinal cord (Wiesenfeld-Hallin et al., 1990). As this
increase is paralleled by an increase in mRNA (Noguchi et al., 1989), it is
likely that regulation occurs at the level of transcription. The aim of the
present study was to identify regions of DNA within the VIP gene that may
be responsible for the spontaneous expression of VIP. The expression of a
number of neuropeptides, including VIP, in cultured DRG neurons from adult
rats parallels that seen in axotomised DRG neurons in vivo (Mulderry and
Lindsay, 1990). Cultured DRG neurons were therefore used as a model
system with which to study mechanisms involved in the spontaneous
expression of VIP. Previous experiments have shown that expression of the
oncogene c-jun is required for spontaneous expression of VIP in cultured
adult rat DRG neurons (Mulderry and Dobson, 1995, submitted). Since c-
Jun is capable of forming a complex that can bind DNA to activate
transcription (Curran and Franzen, 1988, Nakabeppu et al., 1988) it is likely
that c-Jun containing complexes bind to sequences in the promoter region of
the rat VIP gene to direct spontaneous expression. One such sequence is a
putative cAMP responsive element (CRE) found between -94bp and -67bp
relative to the start of transcription (Giladi et al., 1990), that shows homology
to a sequence from the human VIP gene known to bind c-Jun containing
complexes (Fink et al., 1991). Using an electrophoretic mobility shift assay
the present study has shown that the rat VIP CRE is capable of binding c-
Jun in a heterodimer with c-Fos. To determine the importance of these
proteins in binding to the VIP CRE, an attempt was made to compete them
off the endogenous rat VIP CRE. DRG neurons were transfected with
constructs containing copies of the CRE ligated into the plasmid pUC18.
Quantitative analysis of the effects of transfection on endogenous VIP
immunoreactivity, showed that the CRE containing construct caused a
selective reduction in VIP expression. Proteins binding to the CRE are
therefore important for spontaneous VIP expression.
To determine whether the rat VIP CRE is all that is necessary for
spontaneous VIP expression it was analysed, using reporter constructs, for
its ability to mediate patterns of gene expression analogous to those seen
for endogenous VIP. The present study showed that the CRE is capable of
increasing gene transcription from a heterologous c-fos promoter in neonatal
but not adult rat DRG neurons in response to stimuli that raise cAMP and
intracellular calcium. Therefore the VIP CRE may be responsible for the
synergistic increase in VIP expression that occurs in neonatal rat DRG
neurons in response to these same stimuli (Mulderry, 1993). Since the CRE
was shown to be incapable of increasing expression from the c-fos promoter
in the absence of stimuli other sequences together with the CRE must be
involved in spontaneous VIP expression. The present study has shown that
reporter constructs containing up to 1697bp of the endogenous rat VIP gene,
5' from the transcription start site (including the CRE), together with the first
exon (151 bp) and approximately 950bp of the first intron, do not contain
enough sequence to direct spontaneous expression of VIP.
The present study suggests that the spontaneous expression of rat VIP is
dependent on protein complexes binding to the CRE, and that these
complexes probably contain c-Jun. Although the CRE alone is capable of
mediating the response of VIP to cAMP and calcium and may mediate
developmental differences in VIP expression, sequences are required in
combination with the CRE for spontaneous VIP expression. At least some of
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Primary afferent neurons with perikarya in the dorsal root ganglia (DRG)
mediate the transmission of sensory information from the periphery and
viscera to the spinal cord. Depending on the type of stimulus to which they
respond, sensory nerve fibres have been categorised into three groups:
large myelinated (A-beta), small myelinated (A-delta) and unmyelinated
(C-fibres). A-beta fibres respond to light pressure whereas A-de!ta and
C-fibres can respond to pressure, thermal and chemical stimuli. Each fibre
in these groups may respond to only one or to several of these stimuli.
Sensory neurons that respond with increasing frequency to stimuli that
have the potential to cause tissue damage (painful stimuli) are termed
primary afferent nociceptors and belong to the A-delta or C-fibre groups.
Sensory neurons synthesise a number of neuropeptides, of which four
or more may coexist in the same neuron (Cameron, et al., 1988). These
neuropeptides can be released by action potentials, from both the
peripheral and central terminals and exert effects on post synaptic and
presynaptic-receptors (Levine, et al., 1993). The released peptides also
affect neutrophils and macrophages and play a role in the inflammatory
response (Hartung, et al., 1986, Payan, et al., 1984). Some, for example
neurokinin A, a tachykinin related to substance P, are relatively stable and
are thought to be able to act on cells some distance away from their point of
release (Levine, et al., 1993). The same peptides are also
neurotransmitters. Substance P, for example released at central terminals
has a predominantly excitatory effect on dorsal horn neurons (Henry, 1978,
Sastry, 1979, Fleetwood-Walker, et a!., 1990) although it is also capable of
indirectly inhibiting a subpopulation of neurons (Fleetwood-Walker, et al.,
1990). The DRG peptides also have neuromodulatory actions. For
example, calcitonin gene related peptide (CGRP) exerts only limited effects
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on its own, yet potentiates the effects of substance P on dorsal horn
neurons (Wiesenfeld-Hallin, et al., 1984, Woolf and Wiesenfeld-Hallin,
1986).
Plasticity of peptide expression may be an important aspect of primary
afferent function since peptide concentrations change in response to nerve
damage or tissue injury. Injection of formalin into the hind limb results in a
short-lived pain syndrome associated with increased expression of
substance P in DRG neurons (Noguchi, et al., 1988). Adjuvant induced
arthritis increases the concentrations of substance P and CGRP, but not
somatostatin, in DRG neurons that innervate the affected joints (Smith, et
al., 1992). In contrast, sciatic nerve section (axotomy) is associated with
decreases in the levels of substance P, CGRP and somatostatin (Inaishi, et
al., 1992, Nielsch and Keen, 1989, Noguchi, et al., 1990, Villar, et al.,
1989). At the same time sciatic nerve section results in increases in the
peptides galanin, vasoactive intestinal polypeptide (VIP) and neuropeptide
tyrosine (NPY) which are not normally found in DRG neurons (Nielsch and
Keen, 1989, Villar, etal., 1989, Wakisaka, et al., 1991, Doughty, etal.,
1991, Frisen, et al., 1992, Hokfelt, etal., 1987, Kashiba, et al., 1992,
Noguchi, et al., 1989, Shehab and Atkinson, 1986, Shehab, et al., 1986).
Peripheral fibre transection has been proposed as a model for chronic
neuropathic pain as it can lead to animals biting and removing their toes
(autotomy), a process not merely due to numbing of the limb (Devor, 1991).
1.2 VIP and its functions
VIP is a 28 amino acid peptide, originally isolated from the porcine
gastrointestinal tract by Said and Mutt (1970) due to its vasodilatory
properties. It shows structural similarities with a number of other
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gastrointestinal hormones such as secretin, glucagon and gastric inhibitory
peptide (Mutt, 1988).
cDNA cloning studies demonstrated that VIP is derived from a precursor
that generates, in addition to VIP, 27 amino acid peptides designated PHM
(peptide histidine methionine) in man and PHI (peptide histidine
isoleucine) in the rat (Itoh, et al., 1983, Bloom, et al., 1983). The VIP gene
is composed of seven exons each coding for a distinct functional domain of
the VIP precursor (Fig. 4.2). In the human VIP gene, exon 1 (165bp) codes
for the 5' untranslated region of the mRNA, exon 2 (117bp) codes for the
signal peptide, exon 3 (123bp) codes for an N-terminal peptide, exon 4
(105bp) codes for PHM, exon 5 (132bp) codes for VIP, exon 6 (89bp) codes
for the C-terminal peptide and exon 7 (723bp) codes for the 3' untranslated
region of the mRNA. The rat VIP gene (Fig. 4.2) has a very similar structure
to the human gene. The human VIP gene promoter region contains three
TATA boxes (the consensus sequence capable of binding RNA polymerase
II), one at -28bp from exon 1 (the start of transcription) and one each at
position -145bp and -155bp (Itoh, et al., 1983). TATA boxes have been
located at corresponding positions in the rat VIP gene suggesting they play
an important role in gene regulation and have thus been conserved in
evolution. Similarly a putative cAMP response element (CRE) at position
-80 is found in an identical position in both the human and rat genes
(Giladi, et al., 1990).
VIP is widely distributed in the peripheral and central nervous system
and in endocrine cells where it exerts a wide variety of biological actions
including vasodilation, increased cardiac output, bronchodilation,
hyperglycemia (Said and Mutt, 1970, Said and Mutt, 1988) smooth muscle
relaxation (Piper, et al., 1970), secretory processes in the gastrointestinal
tract (Reid, et al., 1988) and glycogenolysis in the liver (Karins and Said,
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1973) and cerebral cortex (Magistretti, et al., 1981). The VIP content in
various brain areas changes during development (Nobou, et al., 1985,
Said, 1984) reaching a peak concomitantly with synapse formation in the
rat brain (Gozes, et al., 1987) and decreasing as the brain ages (Gozes, et
al., 1988). Administration of VIP antagonists in vivo has been reported to
result in neurological deficits and to impairment of neuronal development,
acquisition of reflexes and learning and memory mechanisms (Gozes, et
al., 1990, Hill, et al., 1991, Hill, et al., 1994, Panlilio, et al., 1990, Glowa, et
al., 1992). In the suprachiasmatic nucleus (SCN), rhythmical alteration in
the levels of VIP mRNA occur in response to day-night changes (Okamoto,
et al., 1991) suggesting a role for VIP in changes associated with the
circadian clock. VIP appears to have proliferative, growth factor and
neurotrophic actions, some of which appear to be mediated through
indirect cellular interactions. Electrical blockade of spinal cord neurons in
culture has been shown to accelerate neuronal death, a process that can
be prevented by the addition of VIP (Brenneman and Eiden, 1986). This
action of VIP is dependent on the presence in the culture of non-neuronal
cells and it is thought that VIP interacts with high affinity receptors on glial
cells to induce the secretion of neuronal survival factors (Brenneman, et al.,
1987). One of the factors released is an interleukin-1 -like substance that
has been shown to increase glial proliferation and may play an important
developmental role (Brenneman, et al., 1992). VIP produces a small but
significant increase in the number of glial fibrillary acidic protein positive
cells in spinal cord cultures (Brenneman, et al., 1990); it also exerts
mitogenic effects on embryonic neurons in the superior cervical ganglion
(Pincus, et al., 1990), on kertinocytes and on lung cancer cells
(Haegerstrand, et al., 1989, Moody, et al., 1992), where it may act as an
autocrine regulator.
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This thesis is focused on the investigation of mechanisms regulating VIP
expression in cultured DRG neurons. These mechanisms may be relevant
to the expression of VIP as part of the axotomy response and may play a
role in the regulation of other genes induced following axotomy. It is also
possible that similar mechanisms regulate VIP expression in a number of
the systems described above and may, therefore, have far reaching
implications.
1.3 The response of peripheral neurons to axotomy
Following damage to a peripheral nerve a number of physical changes
occur both at the site of damage and within the cell bodies and axons of the
relevant neurons (for a review see Pleasure, 1994). The cut ends of both
parts of the axon immediately lose axoplasm until becoming sealed off by
membrane fusion. They then retract from one another and begin to swell,
largely due to materials carried to the site by axonal transport and
axoplasmic flow. Degeneration proceeds for a short distance in the
proximal segment, usually only as far as the point of origin of the first axon
collateral. However if the cell body dies then degeneration spreads down
the remainder of the proximal segment. Conversely degeneration is
widespread within the distal segment following a process termed Wallerian
degeneration (after the 19th century physician Augustus Waller). The axon
swells, becomes beaded and fragments are absorbed by local phagocytes
derived from Schwann cells that have undergone a transient phase of
intense proliferation. In many cases however the connective tissue sheath
surrounding the nerve may remain intact. The proximal segment is then
capable of regenerating and reconnecting to its previous sites as long as its
cell body remains alive. Regenerating axons can run along the connective
tissue sheath, which acts as a conduit leading the growing axons back to
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the peripheral target. A growth promoting environment composed of
proliferating Schwann cells and Schwann cell derived matrix (including
collagen, fibronectin and laminin) aids the regeneration process.
Axotomy involves dramatic changes in the expression of a number of
genes (Lasek and Hoffman, 1976, Wong and Oblinger, 1990, Koo, et al.,
1988, Hokfelt, et al., 1994, Troy, et al., 1990, Wong and Oblinger, 1990,
Woolf, et al., 1990). Some of these changes are assumed to act to
minimise damage to the organism as a whole and to promote survival and
regeneration of the injured neuron. Thus axons regenerating from DRG
neurons in culture do so faster if the DRG neuron is axotomised in vivo up
to two weeks previously (a conditioning lesion). It would appear that the
neuron responds to the conditioning lesion with a program of events that
aid its regeneration (Forman, et al., 1981, Oblinger and Lasek, 1984). It
has also been proposed that neuronal injury results in decreased
expression of substances required for chemical transmission and an
increase in those required for cell survival (Kreutzberg, 1982, Lieberman,
1971). However, the functional importance of many of the changes in gene
expression are poorly understood.
Consistent with an increased requirement of structural proteins for
axonal replacement, axotomised peripheral neurons show increased
expression of cytoskeletal proteins. For example, increased tubulin
expression occurs in rat motor neurons, sympathetic neurons and dorsal
root ganglion (DRG) neurons following injury (Lasek and Hoffman, 1976,
Wong and Oblinger, 1990, Koo, et al., 1988). Similarly, expression of the
intermediate-filament protein peripherin is upregulated in rat motor neurons
and dorsal root ganglion (DRG) neurons following injury (Troy, et al., 1990,
Wong and Oblinger, 1990). The cytoskeletal polymers formed provide
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structure, motility and stability to the axon. They may also promote axon
elongation and facilitate regeneration (Obiinger, et al., 1989).
The expression of a number of genes involved in chemical transmission
across synapses is reduced following nerve injury. For example,
expression of tyrosine hydroxylase, the rate limiting enzyme in the
synthesis of catecholamines, is reduced in sympathetic ganglia following
axotomy resulting in a decrease in the amount of available neurotransmitter
(Chean and Geffen, 1973). Similarly, axotomy of DRG neurons results in
decreased expression of substance P and calcitonin gene related peptide
(CGRP) (inaishi, et ai., 1992, Nieisch and Keen, 1989, Noguchi, et ai.,
1990, Villar, etal., 1989).
In contrast, axotomy of DRG neurons results in an increase in the
neuropeptides galanin, vasoactive intestinal polypeptide (VIP) and
neuropeptide tyrosine (NPY) (Nieisch and Keen, 1989, Villar, et ai., 1989,
Wakisaka, etal., 1991, Doughty, et al., 1991, Frisen, etai., 1992, Hokfelt, et
ai., 1987, Kashiba, et al., 1992, Noguchi, et ai., 1989, Shehab and
Atkinson, 1986, Shehab, et al., 1986). These neuropeptides newly
syntnesised in response to injury can be transported both to the central
projection of the DRG and to peripheral sites of nerve injury (Viliar, et al.,
1989, Shehab and Atkinson, 1986, Anand, et ai., 1990 McGregor, 1984)
where they may mediate both central and peripheral responses to axotomy.
The function of the injury induced peptides are currently under active
investigation (Hokfeit, et al., 1994). Gaianin expression, for example, may
be important in preventing self mutilation following axotomy and thus may
play a role in preventing chronic neuropathic pain (Ji, et ai., 1994, Verge, et
al., 1993). Similarly NPY has antinociceptive effects when applied
intrathecal^ due to its ability to biock sensory input or transmission at the
spinal level. This effect has been shown to be enhanced following
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axotomy of the sciatic nerve (Xu, et al., 1994). Conditioning stimuli applied
to the sciatic nerve increase the excitability of the hamstring flexor reflex.
This effect is mediated by substance P released from DRG neurons at their
central terminals. VIP has been reported to take over the role of substance
P in mediating afferent induced reflex facilitation following axotomy
(Wiesenfeld-Hallin, et al., 1990) and may play a role in neuropathic pain
associated with nerve injury. Biochemical studies have shown that VIP can
stimulate glycogenolysis and increases glucose utilisation in injured
neurons (Magistretti, et al., 1981, McCullock and Kelly, 1983, Magistretti
and Schorderet, 1984). VIP is also capable of stimulating glial cells to
increase their production of neuronal survival factors (Brenneman, et al.,
1987, Brenneman, et al., 1990). Thus VIP may enhance neural
regeneration through its neurotrophic actions and by stimulating glucose
metabolism.
Other proteins showing increased expression following axotomy of DRG
neurons include nitric oxide synthase (NOS), the enzyme responsible for
the synthesis of nitric oxide (NO), the growth associated protein GAP-43
and the transcription factors c-Jun, Jun D and CREB (Woolf, et al., 1990,
Verge, etal., 1992, Chong, et al., 1992, Herdegen, etal., 1992). The
functional role of NO is unknown. It is possible that it promotes
regeneration by increasing blood flow to the injured neuron due to its
potent vasodilatory properties (Moncada, et al., 1991). NO also stimulates
glial cell guanosine 3',5'-cyclic monophosphate (cGMP) second
messenger systems and may cause release of neurotrophic factors that aid
neuronal survival (Morris, et al., 1992). However, NOS expression is also
thought to be associated with neuronal death (Wu and Li, 1993) and may
play a role in the death that occurs in 25% of axotomised DRG neurons
(Aldskogius, et al., 1985). GAP-43 is a phosphoprotein transported to
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regenerating axons in the periphery (Bisby, 1988) where it is thought to
influence neurite elongation and synaptic formation (Benowitz and
Routtenberg, 1987).
Transcription factors expressed following axotomy may play a role in
regulating and co-ordinating the expression of a number of genes. Their
role in the axotomy response is discussed further in section 1.6.3 and
chapter 2. The mechanisms by which they may act are described in the
following sections.
It would appear that peripheral neurons mount an integrated response
to injury involving numerous changes in gene expression. How these
changes are initiated and co-ordinated are not clear. However, it is likely
that a study of mechanisms responsible for the expression of individual
genes will lead to an understanding of common pathways responsible for
the co-ordinated expression of a number of genes in axotomised sensory
neurons.
1.4 Mechanisms of action of transcription factors
The transcriptional selectivity of eukaryotic genes is mediated by a
variety of complex control sequences usually located within the 5' flanking
region (for a review see Johnson and McKnight, 1989). Combinations of
these control sequences, for example enhancers or transcriptional
activators, in tandem with promoter elements allow multiple distinct
regulatory proteins to bind and co-ordinately regulate RNA synthesis via
their interactions with the RNA polymerase II (pol II) transcriptional
machinery. Fractionation of HeLa cell transcriptional machinery has shown
it to be composed of seven general factors: TFIIA, TFIIB, TFIID, TFIIE, TFIIH
and TFIIJ (Conaway and Conaway, 1993, Zawel and Reinberg, 1993). In
the absence of an activator such as the transcription factors CREB, Jun or
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Fos, these factors assemble into a pre-initiation complex in a defined order
initiated by the binding of TFIID to the TATA motif (Zawel and Reinberg,
1993). TFIID is a multi-subunit protein containing a DNA binding subunit,
termed TATA binding protein (TBP) and multiple TBP associated proteins
(TAS) (Dynlacht, et al., 1991). Although TBP can mediate basal
transcription by pol II, the TAFs are necessary for a response to activators
(Dynlacht, et al., 1991). Two models exist to explain the mechanism of
activator induced gene transcription. One suggests that the activator
stimulates the step-wise formation of the pol II complex from individual
components. Alternatively the complex may be pre-assembled in solution
and the activator recruits and stabilises its binding to the DNA. Most
experiments have suggested that activators increase the number of poi II
transcription complexes instead of increasing the rate of their formation
(Johnson and Krashnow, 1992). A transcriptional coactivator which
provides a link between the activator CREB and the pol II transcription
complex has recently been discovered (Arias, et al., 1994, Kwok, et al.,
1994, Chrivia, et al., 1993). Experiments have shown that following binding
of CREB to its DNA recognition sequence (the CRE), phosphorylation of
CREB increases its affinity for a CREB binding protein CBP. An activation
domain of CBP is then thought to be directly able to interact with TFIIB
which then interacts with the TATA box binding protein TBP. By interacting
with TFIIB, the CBP protein is thought to be able to recruit the pol II
transcription factor complex to the promoter region of the DNA resulting in
enhanced gene transcription. CBP has also been implicated in mediating
the actions of the transcriptional activator c-Jun, as signal dependent
phosphorylation of c-Jun at serine 63 and serine 74, increases its affinity for
CBP (Arias, et al., 1994).
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It is possible that proteins binding to different regulatory sequences may
synergise in their ability to activate pol II. For instance proteins binding to
the CRE can synergise with the LIM family transcription factor lsl-1 to
promote expression of the somatostatin gene in pancreatic islet cells
(Comb, et al., 1988, Vallejo, et al., 1992) and an AP2 element can act
synergistically with the CRE sequence of the human proenkephalin gene
(Hyman, et al., 1989).
Transcription factors recognise DNA sequences by forming specific
structures (motifs) that are conserved between binding proteins. Several
different motifs exist, for example, the helix turn helix motif, the zinc finger
motif, the leucine zipper motif and the helix loop helix motif (Johnson and
McKnight, 1989). The helix loop helix motif consists of two a helices
bridged by a sharp p turn. One helix is oriented in a manner allowing close
positioning next to the major groove of DNA with specificity due to small
differences in the shape or projection of the helix-turn-helix motif. This motif
has been shown to be responsible for the DNA recognition characteristics
of homeobox proteins concerned with developmental regulation of gene
expression (Johnson and Herskowitz, 1985). The zinc finger motif is
characterised by an ordered arrangement of histidines and cysteines
forming a tetrahedral coordination complex (zinc finger) with a zinc ion
(Brown, et ai., 1985). This type of motif is found in the nuclear receptor
family of proteins that recognise steroid and thyroid hormones. Following
ligand binding the complex binds to a specific DNA sequence to regulate
transcription. DNA specificity is determined by spacing and orientation of
the zinc fingers. The helix loop helix is composed of two a helices
separated by a loop of variable length (Murre, et al., 1989). They comprise
a family of transcription factors able to form homodimers or heterodimers
via interactions between their helix loop helix motifs. Many members of this
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family have a domain of basic amino acids immediately upstream of the
helix loop helix domain that determines DNA binding specificity. Members
of the E box family of binding proteins are known to form helix loop helix
motifs (Murre, et al., 1989, Begley, et al., 1992). The motif termed the
leucine zipper is formed by the hydrophobic interactions between a helices
of two polypeptide chains. The helices, each containing a heptad repeat of
leucines, are flanked by highly basic regions thought to directly interact with
DNA (Landschulz, et al., 1989). Protein dimerisation brought about by
formation of the leucine zipper is necessary for DNA interactions
(Landschulz, et al., 1989, Gentz, et al., 1989). The leucine zipper family of
transcription factors includes CREB, Fos and Jun.
1.4.1 Cyclic AMP response elements (CREs)
A number of genes are known to respond to cAMP, for example VIP,
somatostatin, tyrosine hydroxylase, leuenkephalin, choriogonadotropin a
(CGa), c-Fos and phosphoenolpyruvate carboxykinase (Montminy, et al.,
1986, Hayakawa, et al., 1984, Silver, et al., 1987, Sheng, et al., 1990). By
analysing the response of reporter constructs to cAMP, together with
mutational analysis of sequences within these constructs, short DNA
sequences have been identified that confer a response to cAMP. These
genes often contain an exact or nearly perfect copy of an 8-bp palindrome
5'-TGACGTCA-3' (a cylic AMP response element: CRE) in their 5' flanking
regions (Montminy, et al., 1986, Comb, et al., 1986, Tsukada, et a!., 1987,
Fink, et ai., 1988). However, the minimal sequence required for cAMP
responsiveness is not known. For instance, while the 8bp core sequence,
5'-TGACGTCA-3', alone is sufficient to confer cAMP responsiveness on the
CGa gene promoter the activity of this sequence is highly dependent on
neighbouring nucleotides. Nucleotides flanking the CREs of either rat
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glucagon or bovine parathyroid hormone considerably reduce the activity
of the CGa CRE while flanking sequences from the somatostatin CRE have
no effect on the CGa CRE activity (Deutsch, et al., 1988). Similarly, the 10-
bp sequence 5'-CTGACGTCAG-3' from the rat somatostatin gene does not
confer cAMP responsiveness on the SV40 promoter although increasing its
size to include 21 bp of flanking sequence does result in a response to
cAMP. An 8-bp sequence 5'-TGACGTCT-3' from the human VIP gene is
considerably less active than an extended 17-bp sequence from the same
gene which contains the sequence 5'-CGTCA-3', 5 nucleotides upstream
from the TGACGTCT sequence. This CGTCA sequence has been shown
to be required for full cAMP responsiveness of the human VIP gene
(Tsukada, et al., 1987). The two sequences from the human VIP gene 5'-
CGTCA-3' and 5'-TGACGTCT-3' have also been shown to act
synergistically with each other in their response to cAMP.
One possible explanation for the large effect of neighbouring
nucleotides on CRE activity is that the consensus sequence is actually
larger than the 8bp suggested. Mutational analysis suggests that
nucleotides several bases removed from the 8bp consensus CRE are
involved. DNAse 1 footprinting studies (which identify protein binding sites)
have suggested that proteins are capable of binding to sequences adjacent
to the 8bp core and as such may regulate cAMP responsiveness (Montminy
and Bilezikjian, 1987). Further complications arise due to the fact that
some genes contain the identical 8bp palindrome in their 5' flanking
sequence, but are not known to be responsive to cAMP, for example the
bovine parathyroid hormone gene and the rat glucagon gene (Weaver, et
al., 1984). It is possible that active CREs posses a different secondary
structure to inactive CREs, a property that may be conferred by flanking
sequences. The presence of a short homopurine sequence, GAGAGAGA,
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just 3' of the CRE in both the human and rat somatostatin genes suggests
that in these genes at least secondary structure of flanking sequences is
important.
The human enkephalin CRE has been shown to be capable of
exhibiting a spontaneous conformational change from a duplex to a hairpin
formation (McMurray, et al., 1991). Mutations that are expected to enhance
hairpin (cruciform) formation have also been shown to increase the
enhancer like activity of the enkephalin gene (McMurray, et al., 1991).
Thus hairpin formation may allow alternative transcriptional regulation
through altered protein binding. One of the requirements for hairpin
formation is the presence of a palindrome. As many CRE sequences
contain perfect or near perfect palindromes, it is conceivable that they also
posses the ability to form cruciform structures resulting in alternative protein
DNA complex formation. Cruciform structure is probably greatly affected by
flanking sequences that can destabalize the palindrome dependent
structure. Alternatively sequences flanking inactive CREs may contain
repressor activity by binding to proteins that interfere with the activation of
transcriptional machinery.
When a mutant CRE like palindrome is placed in tandem with a perfect
CRE it is often able to increase cAMP responsiveness, while having no
effect when present on its own (Deutsch, et al., 1988). It is possible that
palindrome recognising proteins, for example CREB, could positively co¬
operate with each other when bound to adjacent sequences. As a full turn
of 3 DNA helices occurs every 10bp it is likely that binding sites must also
occur at 10bp intervals for full co-operativity to be observed. Experiments
have shown that this is the case for repressor binding to X DNA which
shows co-operativity when the binding sites are 10bp apart (Whitson, et al.,
1987). However for co-operativity between domains of the SV40 enhancer
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and multiple regulatory elements of the mouse metallothionein-l gene,
requirements for spacing intervals are far less rigid (Searle, et al., 1984).
It is known that the sequence between -94 and -67 of the human VIP
gene (Fig. 1.1) is capable of mediating a response to cAMP when in the
context of heterologous promoters and is capable of enhancing basal
stimulation in certain cell types (Tsukada, et al., 1987, Deutsch, et al.,
1988). It is possible that a similar sequence from the rat VIP gene (Fig. 1.1)
will mediate the increased transcription of VIP axotomised DRG neurons or
a response to elevated cAMP.
1.4.2 Transcription factors that bind the CRE
CREB, Fos and Jun belong to a class of transcription factors that contain
a conserved basic leucine zipper domain (bzip) required for DNA
recognition, DNA binding and protein dimerisation (Landschulz, et al.,
1989, Gentz, et al., 1989). The bzip containing transcription factors can be
divided into three families depending on the similarities of their structures,
their ability to dimerise with other bzip containing proteins and their DNA
binding specificities. The first family is that of the cAMP-response element
binding proteins (CREB) and activating transcription factor (ATF) proteins,
which bind to CRE sequences and regulate transcriptional responses to
cAMP and also to certain viral proteins (Hai, et al., 1989). The second
family is that of the Fos and Jun related oncoproteins which can
heterodimerise to form the AP1 transcriptional activating complex that can
respond to 12-0-tetradecanoyl-phorbol-13-acetate (TPA) induced stimuli
and bind to AP1 related sequences comprising of the 7 nucleotides
TGAC/GTCA (Curran and Franzen, 1988). Members of this family have
also been shown to be capable of binding to similar CRE sequences
(Nakabeppu, et al., 1988, Halazonetis, et al., 1988). The third family is
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composed of CAAT box/enhancer binding proteins (C/EBPs), which can
bind to CAAT box and related enhancer sequences to regulate gene
expression during cellular differentiation or in response to inflammatory
cytokines (Landschulz, et al., 1989). A great deal of heterodimerisation can
occur between proteins within each family via leucine zipper interactions.
In some cases proteins from different families are able to heterodimerise,
however, cross family dimerisation is more limited. Thus CREB and ATF1
form heterodimers (Hoeffler, et al., 1991) while ATF2, 3 and 4 can
heterodimerise with Fos, Jun or Fra-1 in vitro (Hai and Curran, 1991).
Similarly, C/EBP B has been shown to heterodimerise with C/ATF (a
member of the ATF family) (Vallejo, et al., 1993). Experiments have shown
that heterodimers can have different DNA binding affinities than either of
their parent homodimers (Halazonetis, et al., 1988, Hai and Curran, 1991).
It is also conceivable that inter and intra family heterodimerisation results in
complexes with different transcriptional regulatory activities or complexes
that respond differently to various signal transduction pathways. Activation
of different signalling pathways may result in the formation of different
complexes leading to alternative regulation. This is the case for the AP1
complex that has been shown to vary in composition in PC12 cells in
response to NGF and TPA (Quinn, 1991). As well as activators of gene
expression, proteins inhibiting expression are capable of binding to CRE
elements. For example CREB 2 has been shown to significantly repress
expression of CRE dependent transcription (Karpinski, et al., 1992), as has
ATF1 (Lemaigre, et al., 1993) and CREM (CRE modulating protein)
(Foulkes and Sassone-Corsi, 1992). Similarly a complex composed of c-
Fos and Jun B has been shown to inhibit expression of the proenkephalin
gene by binding to its CRE like sequence (Kobierski, et al., 1991).
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Combinations of all these effects greatly increase the number of
possibilities for control at the gene transcriptional level mediated by CRE
like sequences.
1.5 Mechanisms of calcium and cAMP signalling
1.5.1 cAMP
In eukaryotes the most common mechanism whereby the second
messenger cAMP acts is by stimulating the activity of the cAMP dependent
protein kinase A (PKA). Following cAMP binding to the regulatory subunit
of PKA the enzyme dissociates to yield a regulatory subunit dimer and two
identical catalytic subunits which catalyse the transfer of a phosphate group
from ATP to serine or threonine residues on specific protein substrates
(McKnight, 1991, Taylor, 1989). The catalytic subunit is necessary for
activation of cAMP induced gene expression (Montminy, et al., 1986,
Grove, et al., 1987). Once released from the regulatory subunit, the free
catalytic subunit can translocate from the cytoplasm to the nucleus where it
phosphorylates nuclear factors involved in transcriptional control (Adams,
et al., 1991, Meinkoth, et al., 1990). In mammals, the best characterised
transcriptional response to cAMP is mediated by CREB and its family
members (Montminy and Bilezikjian, 1987). Members of the CREB family
of transcription factors possess a domain that contains consensus
phosphorylation sites for a variety of protein kinases including PKA, protein
kinase C, casein kinase I and II and others (Brindle and Montminy, 1992).
PKA activates CREB by phosphorylation at a single serine residue at
position 133 (Gonzalez and Montminy, 1989) through a mechanism that
apparently does not change the affinity of CREB for its DNA binding site in
the gene promoter (the CRE) but can increase transcription. A number of
other proteins have also been implicated in cAMP dependent regulation of
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gene expression. For instance, the transcription factors Jun D and Jun B
have been shown to be involved in cAMP dependent proenkephalin
transcription (Kobierski, et al., 1991).
1.5.2 Calcium
Alterations in the free cytoplasmic calcium concentrations bring about
changes in numerous cellular processes, including changes in gene
transcription. Initial studies on transcriptional activation by calcium
employed the PC12 cell line. In these cells, KCI-evoked depolarisation
induces expression of the fos proto-oncogene (Sheng, et al., 1990, Morgan
and Curran, 1986). This effect is dependent on the influx of calcium
through dihydropyridine-sensitive calcium channels as well as on the
activity of the intracellular calcium binding protein calmodulin (Morgan and
Curran, 1986, Greenberg, et al., 1986). A CRE like element in the promoter
region of the c-fos gene functions as a calcium response element (Sheng,
et al., 1990). This element binds CREB and has the ability to mediate
activation of the c-fos gene in response to either cAMP or calcium (Sheng,
et al., 1990). In addition phosphorylation of CREB at serine 133 is required
for both cAMP and calcium induced stimulation of c-fos expression (Sheng,
et al., 1991). However, as membrane depolarisation has little effect on
cAMP metabolism in PC12 cells it is unlikely that PKA activation leads to
CREB phosphorylation in response to calcium influx (Sheng, et al., 1990,
Van Nguyen, et al., 1990). Instead as CREB has been shown to be an
excellent substrate for calcium/calmodulin dependent protein kinase it may
be phosphorylated by this kinase in response to increased calcium
concentrations (Sheng, et al., 1991, Dash, et al., 1991). Calcium may also
stimulate gene transcription by activating transcription factors capable of
binding to sites other than the CRE. For example, c-fos gene constructs in
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which the CRE element has been mutated without altering the rest of the
construct are still responsive to depolarisation (Sheng, et al., 1990). The
most characterised alternative element is the phorbol ester-response
element (TRE), that shares homology with the CRE element and can bind
proteins of the AP1 complex, (c-Fos and c-Jun heterodimers) (Lee, et al.,
1987). This element is also able to bind distinct complexes containing
other members of the Fos and Jun families, such as Jun B (Ryder, et al.,
1988), Jun D (Hirai, et al., 1989, Ryder, et al., 1989) and a Fos related
antigen Fra1 (Cohen and Curran, 1988). Alternative experiments using
macrophage and fibroblast cell lines have shown that calcium stimulates
c-Fos transcription by relieving a block in mRNA elongation within the first
intron. This blockage is removed in a calcium dependent manner, using
activators of PKC and PKA or a calcium ionophore (Mechti, et al., 1991,
Collart, et al., 1991).
It appears that pathways used by calcium and cAMP to regulate gene
expression may be dependent, at least in part, on common regulatory
mechanisms. However, when cells are treated with stimuli that increase
intracellular levels of both cAMP and calcium a greater than additive
(synergistic) increase in the levels of gene expression can occur. For
instance, the VIP gene, c-Fos gene, human chorionic gonadotrophin gene
and the human proenkephalin gene have all been reported to respond with
a synergistic increase in expression to combined activation of cAMP and
calcium dependent signalling pathways (Sheng, et al., 1990, Van Nguyen,
et al., 1990, Mulderry, 1993, Andersen, et al., 1988). This suggests that
phosphorylation of CREB at serine 133 is not the only mechanism whereby
both these signalling pathways are regulating gene expression.
Calcium and cAMP signalling pathways have been shown to interact at
several other levels in neurons. For instance, activation of dopamine D1
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receptors results in a cAMP and PKA-mediated increase in the activity of a
dihydropyridine-sensitive calcium current in bovine chromaffin cells
(Artalejo, et al., 1990). In certain neurons, including pyramidal and granule
cells of the hippocampus, a calcium activated adenylate cyclase is
expressed at high levels. Stimulation of these cells by glutamate results in
an NMDA receptor induced calcium influx followed by accumulation of
cAMP (Chetkovich, et al., 1991, Xia, et al., 1991). Cross talk between the
two pathways may also occur at the level of the protein kinase, as it has
been postulated that a calcium dependent activation of the protease
calpain results in the degradation of the regulatory subunit of PKA and
subsequent activation of the catalytic subunit (Aszodi, et al., 1991). The two
pathways may also result in alternative phosphorylation of transcription
factors involved in gene expression at sites other than serine 133 of CREB.
Multiple phosphorylation by the two different pathways may result in
antagonistic or synergistic activation of gene transcription.
It would appear that integration of multiple signals can regulate gene
expression as shown by the synergistic effect of cAMP and calcium
pathways. One situation in which synergy may play an important role is the
seizure model. During a seizure synchronous firing of many neurons
occur, resulting in the release of numerous transmitters such as glutamate,
capable of depolarising target neurons and other neuropeptides capable of
activating the cAMP or protein kinase C pathways. The high levels of
proenkephalin mRNA induction reported in the hippocampus in response
to seizures are consistent with a synergistic activation of expression by
cAMP and calcium (White and Gall, 1987).
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1.6 Regulation of VIP expression in DRG
1.6.1 Neurotrophic regulation of VIP expression
Many of the biochemical changes seen following axonal damage can
be reproduced in the absence of physical nerve damage by applying
vinblastine, an inhibitor of axoplasmic transport, to the peripheral nerve
(Kashiba, et al., 1992, Keen, et al., 1989). This results in decreased
expression of substance P and CGRP with a concomitant increase in the
expression of VIP and galanin. One interpretation of these data is that
neuropeptide expression is dependent on regulatory factors originating in
the periphery and carried to the cell bodies of DRG neurons by retrograde
axoplasmic transport. One possible candidate for such a factor is NGF, a
well-characterised trophic factor known to be important for the development
and maintenance of sensory neurons (Johnson, et al., 1986). NGF is
produced by target tissues, internalised at the axonal endings and
transported retrogradely to the cell body in the DRG (Yip, et al., 1984,
Richardson and Riopelle, 1984). Following axotomy, the peripheral supply
of NGF is effectively cut off, although Schwann cells in the distal stump of
the nerve begin to synthesise NGF (Fleumann, et al., 1987) and the
peripheral axon contains NGF receptors along its length (Richardson and
Riopelle, 1984). Thus it is likely that the cell body continues to receive
some NGF although in very much reduced quantities.
The application of NGF to a cut peripheral nerve of adult rats prevents
the cell loss usually seen in DRGs (Otto, et al., 1987, Arvidsson, et al.,
1986) and more than reverses the down regulation of substance P and
CGRP neuropeptides caused by axotomy (Inaishi, et al., 1992, Fitzgerald,
et al., 1985, Wong and Oblinger, 1991). Similarly experimental deprivation
of NGF in vivo by immunising animals against NGF (Keen, et al., 1989)
results in reduced substance P expression. Flowever, this appears to have
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no effect on VIP expression in DRG neurons (Keen, et al., 1989). Whereas
adult rat DRG neurons in culture require the presence of NGF for continued
expression of both substance P and CGRP, VIP expression appears to be
independent of NGF (Mulderry and Lindsay, 1990). Thus the effects of
peripheral axotomy on substance P and CGRP expression appear to be
due to a reduction in available NGF while VIP would appear to be
dependent on other factors. There is, however, some evidence that NGF
may suppress the expression of VIP in sensory neurons. Application of
anti-NGF antibodies to the sciatic nerve has been reported to increase VIP
expression in the dorsal horn of the spinal cord in adult rats in the absence
of nerve injury. This VIP probably originates from DRG neurons (Knyihar-
Csillik, et al., 1991). Also VIP expression in cultured neonatal rat DRG
neurons is suppressed by NGF (Mulderry, 1994). It would seem likely that
while NGF may play a role in VIP expression NGF deprivation alone is
insufficient for spontaneous VIP expression in adult rat DRG neurons
following axotomy.
DRG neurons are responsive to a number of neurotrophic factor
proteins other than NGF and these may also play a role in VIP expression
following axotomy. For instance, embryonic chick DRG neurons can be
kept alive in culture by other members of the NGF-related neurotrophin
family, including brain-derived neurotrophic factor (BDNF) and
neurotrophin 3 (Kalcheim, et al., 1987, Lindsay, et al., 1985, Maisonpierre,
et al., 1990, Rosenthal, et al., 1990). In addition, two cytokine-related
proteins ciliary neurotrophic factor (CNTF) and leukaemia inhibitory factor
(LIF, also known as embryonic stem cell differentiation inhibiting activity or
sympathetic neuron cholinergic differentiation factor), promote the survival
of embryonic mammalian DRG neurons in culture (Barbin, et al., 1984,
Murphy, et al., 1993, Murphy, et al., 1991) and LIF will promote the survival
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of axotomised rat DRG neurons in vivo (Cheema, et al., 1994). It is possible
that one or more of these alternative neurotrophic factors are responsible
for VIP expression following axotomy. Receptors for all these factors are
expressed in postnatal rat DRG neurons (Hendry, et al., 1992, Ip, et al.,
1993, Mu, et al., 1993) and binding results in internalisation and retrograde ,
axoplasmic transport of the factors to the cell body (Hendry, et al., 1992,
Curtis, et al., 1993, DiStefano, et al., 1992). It has also been shown that
nerve injury results in increased retrograde transport of CNTF and LIF in
sensory neurons and that expression of LIF is increased in the distal
section of the damaged nerve (Curtis, et al., 1993, Curtis, et al., 1994).
A spontaneous increase in VIP expression occurs in sympathetic
neurons grown in dissociated cell or explant cultures, or when these
neurons are axotomised. Expression is reduced when non-neuronal cells
are removed and increased following the addition of medium conditioned
by ganglionic non-neuronal cells. This increase is due to LIF produced at
elevated levels in non-neuronal cells following axotomy or in culture (Sun,
et al., 1994). In this context it is interesting to note that many genes
respond to infection, inflammation or other pathological conditions, with a
change in gene transcription termed an acute phase response. Several
cytokines have been shown to regulate these responses, for instance LIF,
interleukin 1 and 6 and glucocorticoids (Brasier, et al., 1990, Baumann and
Wong, 1989, Gauldie, et al., 1987). Relevant here is the fact that human
VIP 5' flanking region has been shown to contain an acute phase response
element, a consensus sequence that is thought to bind proteins that can
regulate gene transcription in response to inflammation (Symes, et al.,
1994). Furthermore CNTF and LIF have been shown to increase the
expression of VIP in a human neuroblastoma cell line (NBFL) by acting
through a short DNA sequence containing this same element (Symes, et
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af., 1994, Symes, et al., 1993). It is possible that increased LIF expression,
following axotomy of DRG neurons, results in changes in transcription
factor binding to an acute phase response element of the rat VIP gene.
This in turn could lead to increased VIP expression. However, adult rat
DRG neurons in culture show no change in VIP expression following
addition of exogenous BDNF, NT-3, CNTF or LIF (Mulderry, 1994). LIF
does increase VIP expression in neonatal rat DRG neurons cultured in the
presence of NGF (Mulderry, 1994) suggesting that LIF may be important for
VIP expression in neonatal rat DRG neurons.
1.6.2 Calcium and cAMP dependent regulation of VIP
expression
Due to the large electrochemical gradient across the plasma membrane
it has been calculated that intracellular calcium will reach millimolar levels
in the terminal 0.5mm of a cut axon (Meri, et al., 1983). Calcium is an
important regulatory ion acting on numerous proteins in neuronal cells.
Therefore, many of the neuronal changes that occur following axotomy may
be the result of alterations in intracellular Ca2+ levels. For instance,
chelating extracellular calcium can prevent peripheral nerve degeneration.
Conversely, elevating intracellular Ca2+ with the ionophore A23187 results
in axoplasmic disintegration similar to degeneration (Schlaepfer, 1974,
Schlaepfer, 1977). In contrast calcium is required for neuronal survival and
a sustained increase in intercellular Ca2+will increase the survival of
neurons in culture (Collins, et al., 1991). Changes in intracellular calcium
concentrations can lead to changes in gene expression (see section 1.5.2)
suggesting the possibility that calcium may regulate VIP expression
following axotomy. VIP expression can be stimulated in DRG neurons by
applying capsaicin (a neurotoxin) to an intact peripheral nerve (Anand, et
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al., 1990). Capsaicin induces calcium influx into DRG neurons in culture
(Wood, et al., 1988, Winter, 1987) and VIP expression may be regulated by
capsaicin in these neurons through activation of calcium dependent protein
kinase C. An increase in protein kinase C activity induced by the phorbol
ester TPA, results in a specific increase in expression of VIP in both
chromaffin cells and neuroblastoma cells (Agoston, et al., 1992, Pruss, et
al., 1985). Similarly, depolarisation with 40mM K+ has been shown to
increase VIP expression in rat superior cervical ganglion (sympathetic)
neurons (Sun, et al., 1992). Since this treatment is known to open voltage
sensitive calcium channels (Van Nguyen, et al., 1990) and can lead to a
sustained increase in intracellular calcium (Collins, et al., 1991) it seems
likely that VIP expression is being increased by calcium.
VIP expression can also be increased in a wide variety of cells by
treatment with drugs that elevate intracellular cAMP concentrations.
Hayakawa et al (1984) have shown that in human neuroblastoma cells VIP
gene transcription can be induced substantially by treatment with cAMP
analogues. Thus for example 1mM dibutyryl cAMP stimulates the synthesis
of pre-pro VIP-PHM-mRNA by up to 11 fold (Hayakawa, et al., 1984).
Similarly, treatment of bovine chromaffin cells with the diterpene forskolin,
an activator of adenylate cyclase (Seamon, et al., 1981), results in a 20 fold
increase in VIP expression. Elevated cAMP levels have also been shown
to increase expression of human VIP reporter constructs transfected into
either HeLa or PC12 cells (Fink, et al., 1991), suggesting that expression of
endogenous VIP could be increased by stimuli that raise cAMP levels.
Axotomy has been shown to increase protein kinase A (PKA) like activity in
certain neurons (Hall and Kosik, 1993). As PKA is directly regulated by
cAMP (see section 1.5.1) it is possible that cAMP dependent signalling
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pathways are responsible for changes in gene expression following
axotomy of DRG neurons.
1.6.3 Transcription factor expression in response to axotomy
Axotomy of peripheral neurons leads to changes in the expression of a
number of transcription factors some of which could be involved in
regulating expression of VIP. For instance, transection of the rat sciatic
nerve results in an increase in c-Jun immunoreactivity, in the ipsilateral
DRG, that is visible (by immunocytochemistry) after "lOh and remains
elevated for over 300 days (Herdegen, et al., 1992). This is probably due at
least in part to an increase in transcription as c-Jun mRNA has been shown
to increase in these neurons following axonal damage (Jenkins and Hunt,
1991). Similarly increased expression of both Jun D and CREB protein
occurs in DRG neurons in vivo following axotomy (Herdegen, et al., 1992).
Increased expression of Jun D protein becomes visible at 15h and declines
to control levels by 100 days. In contrast the detectable increase in CREB
expression does not occur until 10 days after transection and reaches its
maximum by 100 days. It has been suggested that the Jun proteins may
play a role in the immediate response to axotomy while all three
transcription factors may be involved in long term cell repair and survival
(Herdegen, et al., 1992). This effect is specific for c-Jun, Jun D and CREB
as no increase in expression of Jun B, Fos or the transcription factor Krox
24 could be detected in DRG neurons following axotomy (Herdegen, et al.,
1992). It is likely that increased expression of transcription factors results in
variations in the composition of transcription complexes binding to control
DNA sequences.
Transcription factors induced by axotomy are likely to play an important
role in the regulation of genes associated with regeneration (Leah, et al.,
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1991, de Felipe, et al., 1993, Herdegen, et al., 1993, Herdegen, et al.,
1993). As such they may be involved in the increased expression of
proteins such as neuropeptides and cytoskeletal elements that occurs
following axonal damage of DRG neurons. Jun D, c-Jun and CREB can all
form complexes capable of binding to a CRE consensus sequence in vitro
(Nakabeppu, et al., 1988, Fink, et al., 1991). Therefore, it is possible that by
binding to the rat VIP CRE these transcription factors are involved in VIP
gene expression following axotomy.
1.6.4 Transcriptional verses non-transcriptional regulation of
VIP
Spontaneous VIP expression in adult rat DRG neurons following
axotomy is paralleled by a similar increase in VIP mRNA levels making it
seem likely that regulation occurs at the level of transcription (Noguchi, et
al., 1989). As VIP can be regulated by cAMP and calcium at the level of
transcription and spontaneous expression of VIP may be due to
transcription factors expressed in response to axotomy (sections 1.6.3 and
chapter 2) it would seem likely that spontaneous VIP expression is due to
increased transcription. It is possible however that expression is due to
differential stability of mRNA, or alternative splicing as discussed further in
chapter 6.
1.7 A Model system for the study of VIP gene expression in DRG
In order to determine mechanisms responsible for VIP induction in DRG
neurons following axotomy, DRG neurons in culture were used as a model
system. Growth of DRG neurons in primary culture causes axotomy of all
neurons which then display many of the properties of DRG neurons
axotomised in vivo. Thus, for example, within 4 days in culture, adult rat
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DRG neurons grown in the absence of nerve growth factor (NGF), show a
decrease in expression of the neuropeptides substance P and CGRP while
at the same time VIP which is initially undetectable increases substantially
(Mulderry, 1993, Mulderry and Lindsay, 1990). VIP is expressed in DRG
neurons of both adult and neonatal rats following nerve injury (Anand, et
al., 1990). However, mechanisms leading to VIP expression are different
between adult and neonatal rat DRG neurons in culture (Mulderry, 1993,
Mulderry, 1994). Although adult rat DRG neurons spontaneously express
VIP, in culture, the level of expression can be increased by exposure to
drugs that raise intracellular calcium or cAMP individually during the first 4
days in culture (40mM K+ or 10/;M forskolin). When cells are grown in the
presence of both 40mM K+ and 10/vM forskolin during the first 4 days in
culture the resulting VIP concentrations are only slightly higher than with
forskolin alone and much less than would be expected if the effects of
depolarisation and forskolin were additive (Mulderry, 1993).
In contrast, VIP is not normally expressed in neonatal rat DRG neurons
grown in culture. However, expression can be stimulated by the addition of
drugs that increase intracellular cAMP or calcium concentrations. Cultured
newborn rat DRG neurons express detectable levels of VIP when grown in
the presence of either 40mM K+ or 10/vM forskolin alone (Mulderry, 1993).
However, when grown in the presence of 40mM K+ and 10/jM forskolin
together, concentrations of VIP obtained are significantly higher than the
sum of those resulting from forskolin or depolarisation alone. This indicates
a synergistic interaction between the two stimuli that does not occur in
cultured adult rat DRG neurons (Mulderry, 1993).
The effects of forskolin on VIP expression in adult and neonatal rat DRG
neurons could be reproduced using 8-bromoadenosine 3',5'cyclic
monophosphate, a membrane permeable cAMP analogue, or the cAMP
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phosphodiesterase inhibitor, IBMX. This suggests that the effect of forskolin
is due to an increase in intracellular cAMP. The synergistic response to
forskolin and depolarisation in neonatal rat DRG neurons could be blocked
by nifedipine, a calcium channel antagonist, which inhibits calcium channel
opening under depolarising conditions. The synergistic response can also
be mimicked by using forskolin together with Bay K 8644, a
dihydropyridine-sensitive (L-type) voltage gated calcium channel agonist,
which stimulates calcium channel opening at negative membrane
potentials. These results suggest that the effect of depolarisation on VIP
expression is due to an influx of calcium through voltage sensitive calcium
channels (Mulderry, 1993).
It is not known whether the spontaneous expression of VIP in adult rat
neurons in culture is dependent on increased cAMP or an influx of calcium.
However, the loss of a synergistic response to combined cAMP and
calcium dependent pathways in cultured adult rat DRG neurons parallels
the appearance of spontaneous VIP expression making it seem likely that
the two are related. Both cAMP and calcium can activate signalling
pathways leading to increased gene expression (see section 1.5).
Therefore, even if VIP expression in cultured adult rat DRG neurons is not
dependent on elevated intracellular cAMP and calcium it could be
dependent on a constitutive activation of later stages in these pathways.
Constitutive activation of these later stages could prevent further
expression due to combined cAMP and calcium. A constitutive activation
occurring in cultured adult but not neonatal rat DRG neurons could explain
why VIP is spontaneously expressed in cultured adult but not neonatal rat
DRG neurons. It could also explain why the synergistic response to
combined cAMP and calcium dependent pathways only occurs in cultured
neonatal rat DRG neurons.
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Calcium and cAMP dependent pathways are known to be able to
increase gene transcription by acting on transcription factors such as those
that bind to cyclic AMP responsive elements (CREs) (see section 1.4.2).
The last stage at which pathways leading to spontaneous or regulated
expression could converge is therefore at the point of transcription factor
binding to a CRE. The CRE located in the rat VIP gene 5' from its
transcription start site (Giladi, et al., 1990), may therefore be involved in
both the spontaneous expression of VIP in cultured adult rat neurons and
the response to cAMP and calcium that occurs in cultured neonatal rat DRG
neurons.
There is a strong precedence for the role of the CRE in both the
spontaneous and synergistically regulated VIP expression described
above. A CRE element can confer a synergistic increase in expression of
the proenkephalin gene in response to combined forskolin and
depolarising concentrations of K+ in PC12 cells (Van Nguyen, et al., 1990).
Also CREs including the human VIP CRE can increase the basal levels of
reporter gene expression (Deutsch, et al., 1988).
1.8 Expression of the VIP gene following axotomy: a hypothesis
Following the above discussion it is possible to propose a tentative
hypothesis showing mechanisms mediating the spontaneous expression of
VIP in cultured DRG neurons. This is shown in a schematic form in Fig. 1.2.
Stimulation of neurons with agents that activate cAMP and calcium
signalling pathways may lead to activation of transcription factors that bind
to the VIP CRE. Through interactions with the transcriptional machinery this
then leads to an increase in VIP transcription. The actions of cAMP and
calcium on CRE regulated expression may be synergistic in neonatal rat
DRG neurons. Plating adult rat DRG neurons in culture is thought to have
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an action similar to that of axotomy and leads to spontaneous VIP
expression. This may be may be due to constitutive activation of elements
within the cAMP and calcium dependent pathways (see section 1.7).
It is also possible that transcription factors such as c-Jun, which show
increased expression following axotomy, lead to increased expression of
VIP. These transcription factors may act by binding to sequences in the VIP
gene, perhaps even the CRE, to regulate transcription. The rat VIP CRE is
therefore likely to play a major role in the regulation of VIP expression in
cultured DRG neurons and following axotomy of DRG neurons in vivo.
1.9 Aims of this thesis
The aim of this thesis is to determine mechanisms responsible for the
spontaneous expression of VIP that occurs in cultured adult rat DRG
neurons with particular reference to the CRE. It is hoped that this will shed
light on the mechanisms responsible for VIP induction following axotomy in
vivo . These mechanisms may also play a role in the regulation of other
genes as part of the axotomy response.
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Figure 1.1. Human and rat VIP CRE sequences
A. The rat VIP CRE containing sequence from position -94 to -67 relative to
the transcription start site. Linkers allowing cloning into the unique Sa/1
restriction site of the c-fos minimal promoter are indicated in bold type.
B. The human VIP CRE sequence from position -94 to -67 relative to the
transcription start site.




Figure 1.2. Possible mechanisms leading to spontaneous
expression of VIP in cultured DRG neurons
It is possible that three main pathways exist for the regulation of VIP at the
level of transcription in cultured DRG neurons. The first two are the cAMP
and calcium signalling pathways which converge to act on transcription
factors that bind the VIP CRE leading to increased gene expression. The
actions of these two pathways are synergistic in neonatal but not adult rat
DRG neurons. The third pathway results from placing the neurons in culture
(thought to have an action similar to that of axotomy) which causes
spontaneous VIP expression in adult rat DRG neurons. Axotomy may result
in increased expression of transcription factors that increase VIP
transcription, perhaps by binding to the CRE, or it may act on components of
the cAMP/calcium pathway to activate transcription. The latter case may
explain why adult rat neurons spontaneously express VIP but don't respond
synergistically to cAMP and calcium. PKA refers to protein kinase A.
X=unknown transcription factor capable of binding to the CRE. IIB, F, H and
J refer to transcription factor complexes involved in the transcriptional







THE ROLE OF CRE BINDING PROTEINS IN THE EXPRESSION OF
VIP BY ADULT RAT DRG NEURONS IN CULTURE
2.1 INTRODUCTION
As described in chapter 1, the regulation of VIP production in sensory
neurons differs strikingly between neonatal and adult rats. When placed in
culture or axotomised in vivo, DRG neurons from adult animals
spontaneously express VIP peptide and mRNA (Nielsch and Keen, 1989,
Kashiba, etal., 1992, Noguchi, et al., 1989, Mulderry and Lindsay, 1990),
probably as the result of an increase in VIP gene transcription resulting
from changes in transcription factor binding to the VIP gene promoter (see
section 1.6.4). In contrast, DRG neurons from neonatal animals do not
spontaneously express VIP in culture, but a synergistic increase in VIP
expression occurs in response to combined activation of cAMP and calcium
dependent signalling pathways (Mulderry, 1993). The response of DRG
neurons from neonatal animals is likely to involve transcription factors
binding to the VIP CRE (see section 1.5). I propose that the same or similar
transcription factors may be constitutively activated in cultured adult rat
neurons, leading to spontaneous VIP expression through interactions with
the CRE (see section 1.7 and Dobson, et al., 1994). Axotomy results in
increased expression, in DRG neurons, of a number of transcription factors
that are capable of binding to CRE like sequences, including c-Jun Jun D
and CREB (Herdegen, et al., 1992, Nakabeppu, et al., 1988, Fink, et al.,
1991) (see section 1.7). Heterodimers between c-Jun and Fos are capable
of forming an AP1 transcriptional activation complex (Nakabeppu, et al.,
1988, Halazonetis, et al., 1988) and can also bind to the human VIP CRE in
vitro (Fink, et al., 1991). A cut or crush injury to the sciatic nerve leads to a
rapid increase in mRNA and immunoreactivity for c-Jun in axotomised DRG
neurons (Herdegen, et al., 1992, Jenkins and Hunt, 1991, de Felipe, et al.,
1993, Herdegen, et al., 1993, Herdegen, et al., 1993, Robinson, 1994).
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Levels of c-Jun remain elevated until regeneration has been completed
(Leah, et al., 1991, de Felipe, et al., 1993). An increase in c-Jun expression
also occurs in adult rat DRG neurons when placed in culture (de Felipe and
Hunt, 1994). Micro-injection of an antisense c-Jun oligonucleotide into
adult rat DRG neurons in culture resulted in significant and selective
decreases in c-Jun and VIP immunoreactivities (Mulderry and Dobson,
1995, submitted: Fig. 2.1). c-Jun is thus a strong candidate for one of the
transcription factors that may interact with the CRE to regulate VIP
expression.
The aim of the work described in this chapter was to ascertain the role of
the CRE in the regulation of VIP expression in adult rat DRG neurons in
culture. To determine the effects of CRE binding proteins on VIP
expression, a plasmid containing multiple copies of an oligonucleotide
corresponding to the rat VIP CRE was microinjected into DRG neurons. I
reasoned that CRE sequences in the microinjected plasmid should
compete with the endogenous VIP CRE, reducing transcription factor
binding to the endogenous CRE and decreasing expression of VIP. A
number of studies have reported the use of decoy oligonucleotides to
reduce gene expression by competition with endogenous genes or
exogenous reporter constructs for transcription factors (Dash, et al., 1990,
Lamb, et al., 1990, Bielinska, et al., 1990, Tanaka, et al., 1994). In parallel
experiments, electrophoretic mobility shift assays (EMSAs) were performed
to determine the ability of the AP-1 complex formed by c-Fos/c-Jun
heterodimers to bind to the rat VIP CRE in vitro (see Appendix A. 15).
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2.2 METHODS
2.2.1 Microinjection of DRG neurons with plasmids containing
multiple copies of the rat VIP CRE and quantitation by
immunofluorescence
Synthetic double-stranded oligonucleotides corresponding to the rat
VIP CRE (nucleotides -94 to -67) were synthesised (Oswel DNA Services,
University of Edinburgh) with a short 5' extension (TCGA) to allow insertion
into the unique Sal 1 site in the plasmid vector pUC18 (Fig. 1.1). This
vector contains no promoter regions that would bind proteins involved in
transcription. Following ligation the construct obtained was sequenced and
found to contain three tandem repeat copies of the CRE oligonucleotide
ligated into the Sal 1 site. DRG neurons were plated out on coverslips (as
described in appendix A. 19) that had previously been engraved with a
small square. After leaving overnight to attach, in the presence of 50ng/ml
NGF, all cells inside the engraved square were microinjected with construct
with no bias towards cell size or position. On the third day after injection,
neurons were fixed and stained for VIP immunofluorescence (as described
in appendix A.24). After first visualising stained cells under phase contrast,
cells that appeared healthy, i.e. possessing an apparently intact plasma
membrane, a clearly differentiated nucleus and lacking a granular
cytoplasm, were digitally photographed for immunofluorescence using an
MRC 600, Biorad laser scanning optical microscope (SOM) as described in
appendix A.25. Only healthy cells were photographed with no bias for size,
distribution or levels of immunofluorescence. For each coverslip
approximately 100 neurons from the engraved region (injected neurons)
and a similar number from outside the engraved region (uninjected
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neurons) were photographed. The fluorescence image obtained consisted
of 384 X 512 pixels (field area 105 X 140^m) with 256 levels of grey.
Higher values indicating stronger immunofluorescence. A phase-contrast
image of the same field was collected at the same time to help in later
identifying the boundaries of cells that contained only low levels of
fluorescence. The image analysis software (NIH Image) was used to
calculate the total value of all the pixels in each cell. This was used as an
index of the VIP content of the cell (appendix A.25). Total fluorescence
levels (total pixel values) for individual cells were then ranked and a non-
parametric Mann-Whitney U test was used to determine significance of
difference between injected and uninjected neurons. A non-parametric test
was chosen as the majority of DRG neurons do not stain for VIP
immunoreactivity and VIP immunofluorescence is not distributed normally.
The critical value for significance was taken as P<0.05.
Quantitative immunofluorescence was chosen as a preferable
technique over alternative methods such as in-situ hybridisation. Due to
the wide range of values attributable to each pixel value and the large
number of pixels per cell it is likely that immunofluorescence is a more
sensitive technique than in-situ hybridisation. It is also quicker to perform
than the in-situ hybridisation technique. As Immunofluorescence had been
used to demonstrate changes in c-Jun protein levels following injection of
antisense c-Jun oligonucleotide (Mulderry and Dobson, 1995), this
technique was already optimised in our laboratory.
2.2.2 Electrophoretic mobility shift assay (EMSA)
To determine the ability of AP-1 complexes containing c-Jun to bind to
the rat VIP CRE in vitro , EMSA experiments were performed as described
in appendix A. 15. Expression constructs encoding mouse c-Jun
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(Nakabeppu, et al., 1988) and mouse c-Fos (Halazonetis, et al., 1988) were
obtained from Dr. Daniel Nathans; John Hopkins University School of
Medicine, Baltimore, USA and from Dr. Philip Leder; Howard Hughes
Medical Institute, Harvard Medical School, Boston, USA respectively. c-Jun
and c-Fos constructs were transcribed and translated using a Promega
rabbit reticulocyte lysate in vitro translation kit as described in Appendix
A. 14. Translated material was then used in EMSA experiments to
determine the ability of c-Fos/c-Jun heterodimers to bind to a double
stranded oligonucleotide containing the rat VIP CRE (5'-
CCATGGGATCACCACTGTGACGTCl I lCA-3'). An oligonucleotide from Gibbon
Ape Leukaemia Virus (GALV: 5'-GCAGAAATAGATGAGTCAACAGC-3')
containing an AP-1 motif was used as a positive control for AP-1 activity
and an oligonucleotide containing an E-box motif from the
preprotachykinin-A (PPT) promoter (5'-GGAGAGTGTCACGTGGCTCTCCCTCGA-
3') was used as a negative control (see chapter 5.4.4). In some
experiments a rabbit polyclonal anti-c-Jun antiserum (Santa Cruz
Biotechnology, Inc.) was used to demonstrate "supershifts" (see appendix




In initial experiments, a range of concentrations of CRE containing
construct were microinjected into DRG neurons (2.2/jg/ml, 22/L/g/ml,
44^yg/ml, 88jL/g/ml and 116^/g/ml) and VIP immunofluorescence was
determined by eye with each cell being scored as either positively or
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negatively stained. Although this method was subjective and large
numbers of neurons have to be counted to provide statistically significant
results, it provided a rapid indication of the lowest concentration of
construct that produced a significant effect. It was considered desirable to
inject the lowest possible concentration of plasmid DNA to prevent effects
due to non-specific binding of proteins that may be involved in transcription.
When counting cells stained for VIP by eye only those that contained clear
strong staining in the cytoplasm (Fig. 2.2), together with staining in the
processes (usually concentrated in varicosities) and an absence of staining
from the nucleus were scored as positively stained. This staining
characteristic proved consistent with previous studies (Mulderry, 1993,
Mulderry, 1994). The lowest concentration of CRE containing construct to
give an observable decrease in VIP immunofluorescence when
microinjected into DRG neurons was 22pg/ml. This concentration was
used in all further experiments. Preabsorbtion of the VIP antiserum with
synthetic VIP peptide completely abolished VIP staining in DRG neurons
confirming the specificity of staining.
Using the SOM, a wide variety of VIP immunofluorescence levels were
obtained in uninjected neurons indicating a wide variation of VIP
concentrations between cells. It was not possible to determine from this
data whether VIP expression occurred predominantly in neurons of a
certain size (Fig. 2.3). There was no significant difference between the size
of neurons in the injected and uninjected populations indicating that cell
size could not account for differences in VIP immunofluorescence between
injected and uninjected neurons.
Microinjection of the pUC18 plasmid construct (22/vg/ml) alone into the
neurons had no significant effect on VIP immunofluorescence compared to
uninjected neurons (Table 2 and Fig. 2.4). However microinjection of the
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pUC18 plasmid construct containing 3 copies of the rat VIP CRE (22/vg/ml)
resulted in a significant decrease in VIP immunofluorescence compared to
uninjected neurons, P=0.039 or P=0.0128 two tailed test, for two separate
experiments: Table 2.1 and Fig. 2.4. This corresponds to a 15-18%
decrease in mean total VIP immunofluorescence in injected cells when
compared to uninjected controls.
To test the selectivity of the construct containing multiple copies of the
rat VIP CRE element its effect on substance P and CGRP
immunofluorescence was also determined. No significant difference
occurred between injected and uninjected populations of neurons stained
for either substance P or CGRP. Injection of pUC18 into these neurons
also did not cause any significant effect on either substance P or CGRP
immunofluorescence.
2.3.2 EMSA
When the rabbit reticulocyte transcription/translation mix alone was
incubated with radiolabeled oligonucleotides corresponding to the GALV
AP1, the VIP CRE or the PPT E-box, reproducible retardation of a number
of bands, corresponding to nonspecific binding by proteins in the in vitro
translation and transcription mix was observed (Fig. 2.5 lanes 13, 14 and
15). When mouse c-Jun was translated in vitro it was able to produce an
extra retarded band of higher molecular weight when in the presence of the
GALV AP1 oligonucleotide, but not in the presence of the VIP CRE
oligonucleotide (lanes 1 and 7 respectively), indicating that c-Jun could
bind as a homodimer specifically to the AP1 element but not to the VIP
CRE. This c-Jun band could be removed by co-incubation with an antibody
against c-Jun, producing a faint supershifted band of higher molecular
weight, lane 2. As expected mouse c-Fos on its own was not able to bind to
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either the AP1 element or the CRE (lanes 3 and 9). However, when mouse
c-Fos and mouse c-Jun were co-translated very strong binding to the AP1
element and moderately strong binding to the CRE element was observed
(lanes 4 and 10 respectively). This corresponds to binding of c-Fos and c-
Jun heterodimers which could be supershifted to a small extent using
antibodies to either c-Fos or c-Jun (see appendix A. 15 and lanes 5, 6, 11
and 12). Binding was shown to be specific for the CRE and the AP1
element as no binding to the PPT E-box motif could be detected (lane 16).
2.4 DISCUSSION
These results showed that microinjection of multiple copies of the rat
VIP CRE into adult rat DRG neurons in culture selectively reduced the
expression of VIP but not of PPT or CGRP. This suggests that the
microinjected CRE is competing for proteins binding to the endogenous VIP
CRE and that these proteins are required for spontaneous VIP expression
in culture. The lack of effect of the pUC18 plasmid alone on VIP
expression, shows that proteins important for VIP expression are binding
specifically to the CRE and not to the pUC18 plasmid.
The modest decrease in VIP immunofluorescence observed following
injection (a 15-18% decrease in mean total fluorescence) may reflect the
low transfection efficiency, since only a proportion of injected cells will have
been successfully transfected with DNA (Mulderry, et al., 1993) and this
assay is unable to distinguish between successfully or unsuccessfully
transfected cells. There is also a variation in the volume of solution
delivered to individual cells by the microinjection procedure so that the
concentration of plasmid in individual cells after injection varies over a
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broad range. Alternatively it is possible that the decrease in VIP
immunofluorescence is modest because the CRE is only partially
responsible for VIP induction. Alternative sites may exist elsewhere in the
VIP gene that also play a role in spontaneous VIP expression. Co-injection
of the decoy CRE with decoy oligonucleotides corresponding to alternative
sites (for instance those suggested in chapter 5), into DRG neurons, may
have a much larger effect on VIP expression than the decoy CRE alone.
A larger decrease in VIP immunofluorescence may be obtained if only
successfully transfected cells are counted. This could be achieved by co-
injection of the CRE containing pUC18 construct with fluorescently labelled
marker DNA to permit the detection of successfully transfected cells. The
marker DNA would have to have a different emission wavelength to the
streptavidin-linked fluorescein isothiocyanate used for VIP
immunofluorescence. This could be accomplished by using for example,
Rhodamine conjugated marker DNA. Control cells would also have to be
injected with the marker DNA alone.
EMSA experiments showed that, although c-Jun could bind to the GALV
AP-1 motif as a homodimer, it could bind to the VIP CRE only in the form of
a heterodimer with c-Fos. c-Fos expression cannot be detected in DRG
neurons in vivo under normal conditions or following axotomy (Herdegen,
et al., 1992, Leah, et al., 1991) although a c-fos transgene has been shown
to be expressed in DRG of transgenic mice following axotomy. However, it
is not known this c-fos transgene is present in neuronal or non-neuronal
cells of the ganglia (Smeyne, et al., 1993). Transient c-fos expression has
also been observed in cultured DRG neurons (Lindsay, et al., 1990). It is
possible that a transient expression of c-Fos during the early phase of c-
Jun induction could result in stable c-Fos/c-Jun heterodimers that persist
beyond the period of active c-Fos expression and contribute to the
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regulation of VIP and other genes. Alternatively, it is possible that c-Jun
can bind to the CRE in the form of a heterodimer with other members of the
Jun family for instance Jun B, Jun D or the ATF/CREB families. Complexes
containing either Jun B or Jun D are capable of binding to CRE sequences
and c-Jun can heterodimerise with either Jun B or Jun D (Nakabeppu, et
al., 1988). c-Jun will also heterodimerise with CREB, ATF2, 3 and 4,
forming complexes that can bind DNA (Benbrook and Jones, 1990, Karin
and Smeal, 1992). Both Jun D and CREB are expressed in DRG neurons
(Herdegen, et al., 1992). Although the CREB/c-Jun complex has been
shown to be incapable of activating transcription (Benbrook and Jones,
1990), it remains to be seen whether this is the case for other c-Jun
containing complexes that bind to CREs.
These results together with data showing that VIP expression is
dependent on c-Jun (Mulderry and Dobson, 1995 and Fig. 2.1) suggest that
c-Jun, is involved in spontaneous VIP expression. Since c-Jun can bind to
the CRE in the form of a heterodimer and proteins binding to the CRE are
involved in the spontaneous expression of VIP, it is likely that the CRE is
one site of action of c-Jun.
It is possible that c-Jun may also act indirectly by altering expression of
proteins, including c-Jun itself, that subsequently regulate VIP expression
or that c-Jun may act on sites in the VIP gene other than the CRE.
Expression of c-Jun is known to be regulated through proteins binding to
an AP-1 like element located in its promoter region (Angel, et al., 1988). It
is possible that the CRE containing construct microinjected into DRG
neurons competes for proteins that would normally regulate c-Jun
expression. If this occurs, a resulting decrease in c-Jun expression could
lead to a concomitant decrease in VIP expression. This is unlikely since
previous work in our laboratory showed that a reduction in c-Jun
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expression resulted in a large increase in CGRP immunofluorescence
(Mulderry and Dobson, 1995) which was not observed in this study. To
eliminate this possibility, the effects of the CRE containing construct on c-
Jun expression should be examined.
Quantitative immunofluorescence of VIP peptide can not distinguish
between loss of peptide to the neurites and a decrease in VIP expression,
as measurements are only made on the cell body, the neurites being too
long and inter-twined to make accurate measurements of VIP content per
cell. However, neurons with peptide staining in the neurites invariably
display cell body staining as well. Also, although VIP peptide is transported
to the peripheral site of injury and to central terminals its concentration
remains high in dorsal root ganglia axotomised in vivo (Villar, et al., 1989,
Shehab and Atkinson, 1986). Changes in cell body staining are therefore
likely to be a reliable index of changes in total peptide content. Much of the
published evidence for altered peptide expression after axotomy in vivo
also comes from changes in cell body immunostaining (Shehab and
Atkinson, 1986).
The decrease in VIP immunoreactivity that occurs following
microinjection of the CRE containing construct is most likely due to a
decrease in transcription. To test this experiments to measure transcription
will be required, such as nuclear run on assays, though these will be
limited by the difficulty in isolating the large numbers of DRG neurons that
would be required.
VIP and c-Jun show different patterns of expression in DRG neurons, c-
Jun being expressed in approximately 80% of adult rat DRG neurons (de
Felipe and Hunt, 1994) and VIP being expressed in approximately 30% of
neurons (Mulderry, 1994) as arbitrarily determined by eye. The
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heterogeneity of VIP immuno-staining compared to c-Jun immuno-staining
suggests that factors other than c-Jun must regulate VIP expression.
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Figure 2.1. c-jun aniisense oligonucleotide injection biocks c-
Jun and VIP expression in DRG neurons
Scanning optical microscope measurements of ViP immunofluorescence in
DRG neurons after injection of a c-jun antisense oligonucleotide (left) or the
complimentary sense oligonucleotide (right) compared with measurements
from a similar number of control celis in each case, independent
experiments using similar methodology (P.K. Muiderry, unpublished )
showed that the effects of the antisense oligonucleotide on ViP are selective
in that they are not reproduced for substance P or CGRP. The graphs
represent the frequency distribution of c-Jun or ViP immunofluorescence
ieveis in individual neurons. Celis show a reduction of ViP
immunoreactivity in response to injection of the antisense oligonucleotide
(p<0.002, Mann-Whitney U-test), but no change in response to the sense
oligonucleotide. Overall reduction in ViP or c-Jun immunofluorescence is
due to fewer ceils exhibiting high Ieveis of fluorescence and
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Figure 2.2. VIP immunofluorescence in adult rat DRG neurons
A. Digital photograph of 2 adult rat DRG neurons after 4 days in culture,
stained with a rabbit antiserum against VIP. Photographs were taken using
an MRC 600 biorad confocal laser scanning microscope. The neuron on
the right shows high intensity staining, the one on the left shows lower
intensity staining.
B. The same field seen under phase contrast.
A B
Figure 2.3. Relationship between mean VIP
immunofluorescence and cell size
Uninjected DRG neurons stained for VIP immunoreactivity were analysed
for mean fluorescence and cell area. Values shown correspond to the
number of pixels per cell (directly proportional to cell area) or the mean
pixel intensity (VIP immunofluorescence). Results are for 196 uninjected
neurons obtained from two coverslips. Cells on each coverslip were treated
the same and were plated out, stained and analysed on identical days.
o m >
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Figure 2,4. Injection of a CRE containing construct reduces VIP
expression in DRG neurons
Scanning optical microscope measurements of VIP immunofluorescence in
DRG neurons after injection of the CRE containing pUC18 construct (left) or
pUC18 alone (right) compared with measurements from a similar number of
control cells in each case. The graphs represent a frequency distribution of
VIP immunofluorescence levels in individual neurons. Injection of the CRE
containing pUC18 construct results in a significant shift to the left (p=0.0128
Mann-Whitney U-test), due to fewer cells exhibiting high levels of
fluorescence and correspondingly more cells exhibiting low levels of







































Table 2.1. Effects of a microinjected CRE containing construct
on VIP, substance P and CGRP immunofluorescence
Scanning optical microscope measurements of VIP, substance P or CGRP
immunofluorescence in DRG neurons after injection of the CRE containing
pUC18 construct or pUC18 alone as indicated. In each case fluorescence
levels of injected neurons were compared to those from a similar number of
uninjected neurons. As absolute levels of fluorescence varied between
each experiment values were normalised to those of uninjected cells
(100%). The values shown for normalised average total fluorescence
provide an indication of the size and direction of the change in
immunofluorescence following injection. Significance of difference
between injected and uninjected cells on the same coverslip were obtained
using a Mann-Whitney U-test. pUC18 with or without the CRE had no effect
on immunofluorescence levels of either substance P or CGRP. pUC18
alone also had no effect on VIP immunofluorescence. The CRE containing
pUC18 construct did cause a significant decrease in VIP immunoreactivity.
*
= significant differences p<0.05.




VIP pUC18+CRE 87 82.6±6.4 0.0390*
Uninjected 94
VIP PUC18+CRE 97 85±10.2 0.0128*
Uninjected 104
VIP pUC18 92 103±7.8 0.410
Uninjected 96
VIP pUC18 75 113±16.1 0.407
Uninjected 97
Substance P PUC18+CRE 97 127±15.7 0.108
Uninjected 101
Substance P pUC18 87 96±8.9 0.111
Uninjected 91
CGRP PUC18+CRE 95 93.4±8.4 0.615
Uninjected 86
CGRP pUC18 110 85.5±7.2 0.056
Uninjected 104
Figure 2.5. Electrophoretic mobility shift assay showing mouse
c-Jun and c-Fos binding to the rat VIP CRE and GALV AP1
sequence
Double stranded oligonucleotides containing either the rat VIP CRE, 5'-
TCGACCATGGGATCACCACTGTGACGTCTTTCA-3' (lanes 7-12 and lane
14), the GALV AP1, 5'-GCAGAAATAGATGAGTCAACAGC-3' (lanes 1-6 and
lane 13), or the PPT E Box motif, 5'-
GGAGAGTGTCACGTGGCTCTCCCTCGA-3' (lanes 15 and 16) were 5'
labelled with 32p as described in appendix A. 16. Labelled oligonucleotides
(1ng) were incubated with mouse c-Jun or c-Fos (expressed using a rabbit
reticulocyte transcription/ translation mix) as follows. Lanes 1 and 7, mouse
c-Jun. Lanes 2 and 8, mouse c-Jun in the presence of an anti c-Jun
antibody. Lanes 3 and 9, mouse c-Fos. Lanes 4, 10, 15 and 16, co-
translated mouse c-Jun and c-Fos. Lanes 5 and 11, co-translated mouse c-
Jun and c-Fos in the presence of an anti c-Jun antibody. Lanes 6 and 12,
co-translated mouse c-Jun and c-Fos in the presence of an anti c-Fos
antibody. Lanes 13 and 14, rabbit reticulocyte transcription/translation mix,
in the absence of expressed c-Fos or c-Jun.
 
CHAPTER 3
THE ROLE OF THE RAT VIP CRE IN REGULATING REPORTER
GENE EXPRESSION
3.1 INTRODUCTION
The data presented in Chapter 2 suggest that factors binding to the CRE
like sequence found at position -94 to position -67 of the rat VIP gene play
a role in regulating expression of VIP in adult rat DRG neurons in culture.
Previous studies have indicated that the CRE in the promoter of the human
VIP gene can mediate the effects of cAMP and Ca2+ influx on gene
expression in a variety of cell types (Tsukada, et al., 1987, Deutsch, et al.,
1988, Fink, et al., 1991). Although not identical in sequence to the CRE
found in the human VIP gene, it would seem likely that the rat VIP CRE is at
least partly responsible for the synergistic response to forskolin and K+-
evoked depolarisation seen in neonatal rat DRG neurons in culture. CRE
like elements from a number of genes, including the human VIP gene, have
also been shown to enhance the expression of heterologous reporter
genes when transfected into appropriate cell lines (Vallejo, et al., 1992,
Tsukada, et al., 1987, Deutsch, etal., 1988, Deutsch, et al., 1987,
Delegeane, et al., 1987). The aim of the studies described in this chapter
was to determine whether the isolated rat VIP CRE is capable of driving
expression of a reporter gene in DRG neurons from adult and neonatal rats.
The rat pheochromocytoma (PC12) cell line (Greene and Tischler, 1976)
provides a clonal cell line model for the study of VIP expression in which
bulk transfection methods can be used (Tsukada, et al., 1994). Therefore
reporter constructs containing the rat VIP CRE were also transfected into
PC 12 cells.
Previous studies, described in Chapter 1, showed that VIP is expressed
spontaneously in adult rat DRG neurons in culture, a phenomenon that may
be directly relevant to the spontaneous expression that occurs in DRG
neurons following axotomy in vivo. In cultured neonatal rat DRG neurons,
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VIP expression can be induced synergistically by the combined effects of
potassium evoked depolarisation (resulting in Ca2+ influx) and drugs that
increase intracellular cAMP concentrations (Mulderry, 1993). These
studies led me to the hypothesis that the pathways responsible for
spontaneous VIP expression in adult rat neurons and for synergistically
induced expression in neonates might converge on a common regulatory
element which, being constitutively activated in adult neurons, is no longer
capable of responding to combined activation of cAMP and Ca2+-
dependent signalling pathways (Dobson, et al., 1994). By comparing the
role of the CRE in adult and neonatal rats, it was hoped that developmental




Cells were transfected with plasmid constructs containing a synthetic
oligonucleotide sequence corresponding to the rat VIP CRE inserted
upstream of the c-Fos minimal promoter (Gilman, et al., 1986) driving
expression of a chloramphenicol acetyl transferase (CAT) reporter gene.
The reporter gene vector, FOS, containing the mouse c-Fos promoter
(nucleotides -56 to +106 relative to the transcription start site, Fig. 3.1:
Gilman, et al., 1986), linked to the CAT gene was used as the basis for
reporter piasmid construction. The endogenous c-Fos promoter contains a
CRE like element at position -69 relative to the transcription start site that is
known to respond to membrane depolarisation and cAMP (Sheng, et al.,
1990). This is removed in the minimal promoter and replaced with a Sail
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site into which CRE containing oligonucleotides were cloned. Thus it is
likely that sequences downstream from the CREs cloned into the FOS
reporter construct are responsive to CRE regulated expression.
The CRE in the rat somatostatin gene (nucleotides -37 to -45), which is
probably the best-characterised CRE and is known to be capable of
mediating a response to forskolin when in the context of specific promoters
(Montminy, et al.. 1986, Deutsch, et al., 1988), was used as a positive
control with which to compare the rat VIP CRE results (Fig. 3.2). A
sequence from the rat PPT (preprotachykinin-A) gene (nucleotides -200 to
-185) that shows homology with a CRE was also cloned into the same
position in the FOS reporter construct (Fig. 3,2). The element from the PPT
gene is known to direct high levels of expression of the FOS reporter
construct when transfected into PC12 cells (Morrison, et al., 1994). The use
of CRE-like sequences from the PPT and somatostatin genes, which are
regulated quite differently to the VIP gene in DRG neurons (Mulderry and
Lindsay, 1990, Noguchi, et al., 1993), provides an indication of the changes
in transcriptional response that may occur as a result of nucleotide changes
within the CRE sequence.
Synthetic double-stranded oligonucleotides corresponding to the rat
VIP CRE (nucleotides -94 to -67), the rat somatostatin CRE (nucleotides -45
to -37) and the rat PPT CRE like sequence (nucleotides -200 to -185) were
synthesised (Oswel DNA Services, University of Edinburgh) with 5'
overhangs to allow insertion into the unique Sal I restriction site
immediately upstream of the c-Fos promoter (Fig. 3.2). The sequences of
all clones were determined by sequence analysis using a primer
corresponding to a sequence within the c-Fos promoter.
In addition to a construct containing a single copy of the rat VIP CRE, a
construct containing 3 tandem copies of the CRE, in the reverse orientation
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to that found in the endogenous VIP CRE, was obtained. Since it is well
documented that certain enhancer sequences, including CREs, can work in
either orientation (Deutsch, et al., 1987) and that multiple regulatory
sequences often synergise in their effects on transcription (Deutsch, et al.,
1988), the activity of this construct was also examined.
3.2.2 Transfection of PC12 cells .
In initial studies, constructs containing the three CREs were transfected
into the PC12 rat phaeochromocytoma cell line (Greene and Tischler,
1976). FOS constructs containing other enhancer elements have
previously been shown in our laboratory to respond to combined forskolin
and K+-evoked depolarisation (Morrison, et al., 1994) when transfected into
PC12 cells. Although PC12 cells do not normally express VIP, stimulation
with forskolin or other agents that also raise intracellular cAMP results in an
induction of VIP mRNA (Tsukada, et al., 1994). The human VIP gene
promoter will also direct cAMP-dependent expression of a reporter gene
when transfected into PC12 cells (Tsukada, et al., 1987, Tsukada, et al.,
1994). PC12 cells may therefore contain transcription factors that are
capable of binding to the rat VIP CRE to regulate gene expression in
response to cAMP. Transfection of PC12 cells with constructs containing
the CRE is likely to show whether the rat VIP CRE is an active DNA element
capable of regulating transcription.
3x106 cells were electroporated at 200V in the presence of 5jug of
reporter construct DNA. 1.5x106 undifferentiated cells were then plated out
per petri-dish and left overnight in the presence of 50ng/ml NGF to attach.
The following day the medium was removed and medium containing 40mM
KCI, 10/vM forskolin and 50ng/ml NGF was added. Although 10/vM
forskolin and 40mM K+ act to differentiate PC12 cells, the presence of NGF
47
in the medium results in the differentiation of all cells and should act to
minimise differences between forskolin and 40mM K+ treated and
untreated cells.
Leaving cells to recover from electroporation overnight, before addition
of forskolin and 40mM K+, should also help to minimise any differences due
to cell survival by allowing cells to die that may have been rescued by
immediate addition of forskolin and K+.
Cells were left for 96h before lysates were assayed for CAT
immunoreactivity using an enzyme-linked immunosorbent assay kit
(Boehringer-Mannheim), see appendix A.22. Consistent transfection of
PC 12 cells was obtained, as measured by comparing CAT expression
between parallel transfections.
3.2.3 Microinjection
DRG neurons were transfected with reporter constructs by
microinjection of plasmid DNA. Using microinjection as a method for
transfecting cells we were able to obtain high specificity for neurons
combined with reasonable levels of expression in a CAT assay. A number
of other transfection methods using a variety of calcium phosphate
precipitation procedures and lipofection reagents have been attempted.
These resulted either in low transfection efficiency or simultaneous
transfection of non-neuronal cells (P. Mulderry and authors own
unpublished observations). Microinjection was carried out as described in
appendix A.20 and Mulderry et al. 1993. Cultures were plated on shallow
10mm diameter polystyrene wells at a density of 4000-10000 neurons per
well. Three hundred and fifty neurons per well were injected with plasmid
(appendix A.20). Following injections neurons were left overnight in
normal medium before addition of medium containing 40mM K+ or 10pM
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forskolin. For depolarisation experiments, medium containing 40mM K+
was prepared as described in appendix A.21 (Mulderry, 1993). Forskolin
(Sigma), stock solution dissolved in ethanol at 10mM was added at 1:1000
to yield a final concentration of 10/vM. All cells were supported in culture




PC12 cells transfected with the control plasmid construct FOS, or the
plasmid containing 1 copy of the rat VIP CRE element showed no
significant increase in CAT immunoreactivity (under basal conditions or
under conditions of combined forskolin and K+-evoked depolarisation) over
the low levels detected in untransfected cells. Transfection of cells with the
plasmid containing 3 tandem copies of the rat VIP CRE resulted in no
significant increase in CAT immunoreactivity under basal conditions or
when in the presence of 40mM K+. However in the presence of forskolin
alone a significant level of expression could be detected that was
approximately 14 fold greater than the expression levels under basal
conditions. Combined forskolin and K+-evoked depolarisation resulted in
an approximately 77 fold increase in expression above that obtained under
basal conditions (Fig. 3.3).
3.3.2 Neonatal Rat DRG Neurons
Following injection of the control plasmid, FOS, into neonatal rat DRG
neurons, there was no significant increase in CAT immunoreactivity (under
basal conditions, or in the presence of forskolin or under depolarising
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conditions alone) over the low levels detected in uninjected cultures.
Under conditions of combined forskolin and depolarisation, however,
significant concentrations of CAT immunoreactivity, approximately 4 fold
greater than those obtained under basal conditions, were detected (Fig.
3.4). Injection of the plasmid containing one copy of the VIP CRE resulted
in CAT expression significantly different from that seen with FOS only under
conditions of combined forskolin and depolarisation, when CAT levels were
approximately 4-fold higher than those in cultures injected with FOS (Fig.
3.4). Injection of the plasmid containing the somatostatin CRE resulted in
significant levels of CAT expression under basal conditions. This was not
significantly altered by forskolin or depolarisation alone, but was increased
to levels similar to those seen with the VIP CRE construct under conditions
of combined forskolin and depolarisation (Fig. 3.4).
3.3.3 Adult Rat DRG Neurons
Injection of FOS into adult rat neurons produced similar results to those
seen in neonates. There was no significant CAT under basal conditions
but combined depolarisation and forskolin treatment resulted in the
appearance of detectable CAT immunoreactivity. Results obtained from
adult rat cells injected with the VIP CRE construct differed from those
obtained in neonates, however, in that CAT concentrations were not
significantly different from those seen with the FOS plasmid under basal or
stimulated conditions (Fig. 3.5). Adult rat neurons injected with the
somatostatin CRE construct did not express significant levels of CAT under
basal conditions but did express CAT at significantly higher level
(approximately 1.6-fold) than FOS under conditions of combined
depolarisation and forskolin treatment (Fig. 3.5). Adult rat neurons injected
with the PPT construct expressed CAT at significant levels under basal
50
conditions. This level was approximately 1.3-fold greater than that
obtained with FOS under conditions of combined depolarisation and
forskolin treatment. Cells transfected with the PPT enhancer and incubated
under conditions of combined depolarisation and forskolin treatment
expressed CAT at approximately 2.2 fold greater levels than those obtained
with FOS under the same conditions. Both neonatal and adult rat DRG
neurons expressed CAT at high levels under conditions of combined
depolarisation and forskolin treatment following injection of the construct
containing 3 copies of the VIP CRE element. As absolute levels of CAT
activity varied between experiments results from different experiments were
normalised against values obtained with the construct containing 3 copies
of the CRE under conditions of combined 10/jM forskolin and 40mM K+
(normalised to 100 in Fig. 3.4 and 3.5).
If the absolute levels of expression of the FOS plasmid were much
higher in DRG neurons from adult rats than in neonates, then this might
obscure any effect of the VIP CRE and hence lead to the apparently
different result. This could be due to the FOS plasmid expressing CAT at
close to its maximum levels such that the CRE element could have little
effect. Expression levels of the FOS plasmid were compared as directly as
possible using adult and neonatal rat DRG cultures prepared, injected and
assayed at the same time (Table 3.1). The results of this experiment
showed that absolute levels of FOS expression differed by no more than 2-
fold between neonatal and adult rat neurons, indicating that the different
results obtained with the CRE-containing constructs are due to a
differences in CRE function.
3.4 DISCUSSION
3.4.1 PC12 Cells
Constructs containing three tandem copies of the rat VIP CRE were
capable of responding to forskolin and depolarisation, when transfected
into PC12 cells, suggesting that the CRE can bind proteins required for this
response and may play a role in the response of endogenous VIP to these
stimuli in DRG neurons.
However, since the expression of CAT in cells transfected with the FOS
construct was below the sensitivity of the assay under all experimental
conditions, it is not possible to determine whether the CRE element can
respond synergistically to combined forskolin and depolarisation or if the
CRE acts simply to enhance the response of the FOS construct to forskolin
and depolarisation. To distinguish between these possibilities it would be
necessary to perform similar experiments with the CRE inserted into a
different promoter that is capable of expressing detectable levels of CAT in
PC12 cells under basal conditions.
It is not known why 3 copies of the CRE are required for a response to
combined forskolin and depolarisation. It is possible that factors capable of
binding to the CRE synergise (co-operate) in their stimulatory action on
proteins that initiate transcription. Co-operativity between transcription
factors has been observed for proteins binding to sites in the lactose
repressor, such as the yeast transcriptional activators GAL 4 and GCN4
proteins (Giniger and Ptashne, 1988, Hope and Struhl, 1987). Co-
operativity between non identical DNA binding proteins has also been
reported in higher eukaryotic organisms (Reinberg and Roeder, 1987, Lu
and Bensadoun, 1993). As a full turn of DNA helices occurs every 10bp it
is likely that binding sites must also occur at 10bp intervals for full co-
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operativity to be observed. Experiments have shown that this is the case
for repressor binding to DNA which shows co-operativity when the binding
sites are 10bp apart (Whitson, et al., 1987). It is possible that
multimerisation of the CRE containing oligonucleotide can result in
alternative positioning of different binding sites relative to one another
perhaps allowing optimal co-operativity between two or more transcription
factors. Alternatively 3 tandem copies may provide 3 or more binding sites
for proteins. As each one of these binding sites will be in the presence of
different flanking sequences and flanking sequences have shown to exert
large effects on the activity of CRE sequences (Deutsch, et al., 1988) it is
possible that one of these positions is more permissive for transcription
than positions that occur in the construct containing 1 copy of the CRE. It is
also possible that insertion of tandem copies of the CRE into a plasmid
generates alternative and perhaps novel transcription factor binding sites,
resulting in unpredictable regulation of the relevant reporter gene.
As the 3 tandem copies of the CRE are all in the reverse orientation,
relative to the transcription start site and the orientation of CRE containing
enhancers has been shown to result in differences in ability to activate
transcription (Deutsch, et al., 1987), it is also possible that the orientation of
the VIP CRE plays some role in its ability to stimulate transcription.
3.4.2 DRG Neurons
A single copy of the rat VIP CRE was capable of enhancing the
response of the c-Fos promoter to forskolin and K+ in neonatal rat DRG
neurons. This is the first demonstration that a single copy of this element
can act as a functional enhancer. No such effect was seen in adult rat
neurons, suggesting that the responsiveness of the CRE to cAMP and
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depolarisation declines as the neurons mature, in parallel with the
response of the endogenous VIP gene.
The construct (FOS) containing only a minimal c-fos promoter also
exhibited a synergistic response to combined depolarisation and forskolin
in neonatal and adult rat neurons. The cause of the FOS response in
neonatal and adult rat neurons is unknown. This construct does not
respond to combined depolarisation and forskolin treatment in transfected
PC12 cells even though associated CREs do confer responsiveness to
these stimuli (Morrison, et al., 1994).
It is not possible to say from these results whether the effect of the VIP
CRE on CAT expression in neonatal rat neurons was due to a response on
the part of the CRE itself to cAMP and depolarisation or only to an
enhancement of the FOS response.
As the magnitude of the FOS response is virtually identical in neonatal
and adult rat DRG neurons, the differences seen with the VIP CRE construct
can be attributed to properties of the CRE. These results therefore support
the view that the VIP CRE is likely to participate in regulating the
endogenous VIP response to combined depolarisation and forskolin seen
in neonatal rat neurons (Mulderry, 1993).
The different results obtained following transfection of either PC12 cells
or neonatal rat DRG neurons with the construct containing a single copy of
the CRE may be explained by different signal transduction pathways being
available in these cell types allowing expression from the reporter construct
only in neonatal rat DRG neurons. Alternatively the different results may
reflect different roles for the CRE in these cell types or may merely reflect
differences in the methods of transfection.
Results obtained with the somatostatin and PPT CREs in both neonatal
and adult rat neurons were significantly different to those obtained with the
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VIP CRE. These results suggest that different CREs can confer specific
patterns of gene expression.
The rat VIP CRE (TGACGTCT) identified by Giladi et al. (Giladi, et al.,
1990), bears a 7/8 homology with the somatostatin consensus CRE
sequence (TGACGTCA) (Montminy, et al., 1986). However, it has been
shown that mutating the final adenosine nucleotide of the somatostatin
CRE into a thymidine, as in the VIP CRE, can affect its enhancer activity
(Deutsch, et al., 1988). The different results obtained with the two CREs
may therefore reflect this slight sequence difference. On the other hand,
the human VIP CRE has been shown to contain two adjacent CRE-like
sequences, one identical to that in the rat and another upstream of it, that
are both required for full enhancer activity (Fink, et al., 1988). Our rat VIP
CRE oligonucleotides were designed to include not only the consensus
CRE identified by Giladi et al. (Giladi, et al., 1990) but also a second
sequence (TGGGATCA) upstream of it that has 5/8 homology with the
consensus CRE and whose position corresponds approximately to the
second element in the human VIP gene (Fig. 1.1). It is possible that this
sequence also contributes to the enhancer function of the CRE.
Although the PPT enhancer shows a 6/8 homology with the
somatostatin CRE it also shows a 6/7 homology with a consensus AP1
binding site (TGAGTCA). Gel retardation assays have shown that the PPT
element does not bind the same proteins as the somatostatin CRE in HeLa
nuclear extract, but it does compete with a consensus AP1 element for
binding proteins (Morrison, et al., 1994), suggesting a molecular basis for
the different levels of CAT expression observed with the CRE-like
sequence from the PPT gene.
Although the lack of effect of the VIP CRE on CAT expression in adult rat
neurons is consistent with the absence of synergistic response to cAMP
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and depolarisation by endogenous VIP in these neurons (Mulderry, 1993)
the CRE did not direct spontaneous expression as is seen for endogenous
VIP. The idea that spontaneous VIP expression in adult rat neurons and
induced expression in neonatal rat neurons might both be mediated
through the CRE is therefore not supported by the present results. It is
likely that in adult neurons, the rat VIP CRE participates in the control of
gene expression in association with other regulatory elements.
A difficulty with the interpretation of these results is that endogenous VIP
expression is seen in only approximately 30 % of DRG neurons in culture
(Mulderry, 1993). Since the microinjection technique is not selective for
specific neuronal subpopulations (Mulderry, et at., 1993) and a difference
in CRE function in DRG neurons at different stages of maturity has been
shown, it is conceivable that CRE function also differs in different
subpopulations of DRG neurons. Further studies involving localisation of
reporter gene and endogenous VIP expression will be needed to
determine whether this is so.
The mechanisms responsible for the synergistic response to cAMP and
depolarisation and the reasons for its disappearance in mature neurons
are unknown. One possibility lies in cAMP-sensitive Ca2+ channels whose
abundance in rat DRG neurons declines as the neurons mature (Fedulova,
et al., 1991). However, the uniform response of the FOS plasmid, to
combined forskolin and depolarisation, in neonatal and adult rat neurons
argues against this possibility and suggests that the different responses
mediated by the VIP CRE may reflect differences in the cellular transcription
factors that bind to the CRE. The nature of these factors remains to be
determined.
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Figure 3.1. c-Fos minimal promoter sequence
Nucleotides -56 to +109 relative to the start of transcription of the c-Fos
promoter. Hatched box indicates the TATA box binding site for transcription
factor II D. The transcription start site is indicated by an arrow and in the
reporter plasmid FOS directs expression of the chloramphenicol acetyl
transferase reporter gene.
mmm
-56 GIOCATGCAT TCACAGCQCT TCIAIAAAGG CGCCAGCIGA GGQGCCTACT
ACICC?kcra CGACIGCAGC GAGCAACIGA GAAGACIGGA TAGAGCCGGC
GGTICCGCGA ACGAGCAGIG ACCGCGCICC CACQCAGCIC TCCICIGCAG
109 CIQCCACCAG TGICT
Figure 3.2. Reporter constructs containing the c-Fos promoter
Oligonucleotide sequences cloned into the unique Sal 1 restriction site 5' of
the c-Fos minimal promoter (hatched box). The oligonucleotides containing
the somatostatin CRE and the c-Fos minimal promoter cut with Sal 1 were
blunt ended using Klenow before ligation (see appendix A.7). Numbers
refer to nucleotides 5' from the transcription start site (arrow). Black box
indicates site of the chloramphenicol acetyl transferase reporter gene.
Arrows above the sequences indicate the core 8bp CRE motif.
TCG AAA TTG CGT CAT TTC
TT AAC GCA GTA AAG AGC T PPT ENHANCER
GAT CGT GAC GTC AGG
CA CTG CAG TCC CTA G
SOMATOSTATIN ORE
TCG ACC ATG GGA TCA CCA CTG TGA CGT CTT TCA
GG TAC CCT AGT GGT GAC ACT GCA GAA AGT AGC T
VIPCRE
c-fos CAT
Figure 3.3. Effects of forskolin (10pM) and 40mM K+ on
reporter gene expression in transfected PC12 cells
1.5x106 PC12cells were electroporated in the presence of 5/jg of the
respective reporter construct DNA. Cells were left overnight in normal
medium before addition of medium containing forskolin or K+, as indicated.
Cultures were then maintained in experimental media for a further three
days before assaying for CAT immunoreactivity. NGF was present at all
times after electroporation. ND. = not done. Each value is mean ± standard
error for 3 separate culture wells. *= Values significantly increased above




































UNTRANSFECTED FOS 3xVIP ORE
L
CONSTRUCT
Figure 3.4. Effects of forskolin (10pM) and 40mM K+ on
reporter gene expression in neonatal rat DRG neurons
Reporter constructs as described in the text were microinjected into
neonatal rat DRG neurons. The following day cultures were treated as
indicated and left for 72h before extracting and assaying for CAT
immunoreactivity. ND. = not done. Each value is mean ± standard error for
at least 4 separate culture wells. As absolute levels of CAT
immunoreactivity varied between experiments, results were normalised
against values obtained with an internal control (cells microinjected with the
construct containing 3 copies of the VIP CRE and stimulated with 10/7M
forskolin and 40mM K+). Background = cultures that had received no











Figure 3.5. Effects of forskolin (10pM) and 40mM K+ on
reporter gene expression in adult rat DRG neurons
Reporter constructs as described in the text were microinjected into adult rat
DRG neurons. The following day cultures were treated as indicated and left
for 72h before extracting and assaying for CAT immunoreactivity. Each
value is mean ± standard error for at least 4 separate culture wells. As
absolute levels of CAT immunoreactivity varied between experiments,
results were normalised against values obtained with an internal control
(construct containing 3 copies of the VIP CRE stimulated with 10/lvM
forskolin and 40mM K+). Background = cultures that had received no
injections. *= Values significantly increased above those obtained for
uninjected cells (P<0.05). **=Values significantly increased above those
obtained for the FOS construct under conditions of combined 10/7M


































Table 3.1. Comparison of CAT immunoreactivlty in neonatal
and adult rat DRG neurons microinjected with FOS plasmid
construct
Comparison of absolute levels of CAT immunoreactivity (pg/well), between
adult and neonatal rat neurons, following microinjection with FOS plasmid.
Adult and neonatal rat DRG neurons were plated out at similar densities on
alternate days and 350 neurons/well were microinjected with FOS plasmid.
Following stimulation with combined 10/vM forskolin and 40mM K+as
indicated, extracts were assayed simultaneously for CAT immunoreactivity.




Uninjected basal conditions 3.83 + 1.82 8.40 + 0.79
Neurons injected with FOS 13.06 + 4.14 28.74 + 5.26
Basal conditions
Neurons injected with FOS 59.48 + 18.20 109.86 + 18.52
1(fyyM forskolin + 40mM K+
CHAPTER 4
THE ROLE OF 5' FLANKING SEQUENCES FROM THE RAT VIP
GENE IN MEDIATING VIP GENE EXPRESSION
4.1 INTRODUCTION
Although the results described in chapter 3 suggest that the rat VIP CRE
is capable of conferring a response to stimuli that raise cyclic AMP and
intracellular calcium on the reporter construct FOS, the CRE alone is not
capable of conferring spontaneous expression of the FOS promoter in adult
rat DRG neurons. Thus, other regulatory sequences from the VIP gene are
probably required, in combination with the CRE, for spontaneous VIP
expression.
This chapter describes experiments in which a reporter construct
containing 1697bp of upstream (5' flanking) sequence, including the rat VIP
CRE and promoter (Giladi, et al., 1990, Lamperti, et al., 1991), the first exon
of 151 bp and approximately 950bp of the first intron, was transfected into
DRG neurons.
Typically, sequences within a few hundred base pairs of the promoter
regions of genes play a key role in regulating transcription (for a review see
Johnson and McKnight, 1989). Previous experiments have demonstrated
high levels of expression in DRG neurons of reporter constructs containing
up to 3356bp of 5' and 527bp of 3' sequence from the rat PPT promoter
(Mulderry, et al., 1993). Deletion studies using reporter constructs
containing up to 5.2kb of 5'-flanking sequence from the human VIP gene
show that multiple regulatory sequences exist in this region of the DNA
(Waschek, etal., 1992).
As rat VIP expression has been shown to be inhibited by NGF in
neonatal rat DRG neurons (Mulderry, 1994), NGF deprivation may play a
role in VIP induction (see chapter 1.6.1). VIP has been reported to be
induced by LIF in sympathetic superior cervical ganglion neurons (Sun, et
al., 1994) and in neonatal rat DRG neurons grown in the presence of NGF
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(Mulderry, 1994). As an induction of LIF expression occurs following
axotomy of DRG neurons (Curtis, et al., 1993, Curtis, et al., 1994), LIF may
be partly responsible for inducing VIP expression in axotomised DRG
neurons (see chapter 1.6.1). The response of constructs to combinations of
LIF and NGF was therefore determined.
4.2 METHODS
4.2.1 Construct Design
Three constructs containing either 1697bp , 960bp or 279bp of 5'
flanking sequence from the rat VIP gene (termed construct 1697, construct
960 or construct 279 respectively) followed by exon 1 of 151 bp,
approximately 950bp of the first intron and a 3 galactosidase reporter gene
(Fig. 4.1) were designed as described in Fig. 4.2 and Fig. 4.3. A full length
clone of the rat VIP gene, approximately 15kbp, in bacteriophage Charon
4A was obtained from Professor lllana Gozes, Sackler School of Medicine,
Tel Aviv, Israel (Giladi, et al., 1990). The host cells Eschericia Coli LE392
were infected with the phage stock and a large scale plate lysate
preparation of the bacteriophage was grown up from a single clone
(appendix A.2). This clone containing the endogenous promoter was
digested with the restriction enzyme EcoR1 to generate 7 fragments (Fig.
4.2). The largest two of 19,500bp and 10,500bp, correspond to the
bacteriophage DNA (not shown in Fig. 4.2), while the remaining 5
fragments of 5200bp, 4300bp, 4000bp, 900bp and 700bp correspond to
the genomic VIP DNA as described by Giladi et al (1990). The fragment of
5200bp, containing the transcription start site, the first two exons and
approximately 3kb of 5' flanking sequence was isolated and cloned into
the EcoR 1 site of the plasmid vector pUC18. The orientation of the
fragment within this plasmid was determined by restriction mapping with
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the enzyme Pst1 which cuts once in the plasmid vector and at three
positions in the 5200bp fragment. Orientation was also determined by
sequence analysis as described in chapter 5. Both orientations were
obtained. Digestion of the appropriate clone with Pst1 yielded an
approximately 2800bp fragment containing the VIP promoter that was
cloned into the Pst1 site of pUC18. Digestion with the enzymes Nco1,
which cuts twice within the fragment and Xba 1 which cuts once within the
polylinker of the pUC18 plasmid, were used to determine the orientation of
the fragment. The 2800bp fragment was removed from the appropriate
pl)C18 clone using the restriction enzymes Hindi11 and Xba1 that cut either
side of the fragment within the pUC18 polylinker and ligated into plasmid
prPPT-(3GAL3 (Muiderry, et al., 1993) upstream of the E. coli lacZ gene (Fig.
4.3). Before ligation prPPT-3GAL3 was digested with Hind III and Xba1 to
remove a fragment containing a separate promoter. The 2800bp VIP
fragment was ligated into the Hind III and Xba1 sites of the 6726bp prPPT-
6GAL3 plasmid vector in a known orientation. The final construct (construct
1697) contained 1697bp of 5' flanking sequence (including the CRE
element and the endogenous VIP promoter) followed by the transcription
start site, the first exon and approximately 950bp of the first intron (Fig. 4.3).
The lacZ gene was located a further 500bp downstream. The first
translation start site downstream of the VIP promoter in this construct is
located in the 8 galactosidase gene, since the first exon of the VIP gene
contains no translation start sites.
Construct 1697 was digested with the restriction enzymes Apa1 and
Xba1 resulting in two fragments the smaller of which (1418bp) was
discarded. The larger fragment was gel purified, the ends were filled in
with klenow and ligated back together (appendix A.6-8) to generate
construct 279 (Fig. 4.3).
59
Construct 1697 was digested fully with the enzyme Xba1 followed by a
partial digest with the enzyme Nco1 which cuts in two positions within the
VIP gene (Fig. 4.3). This resulted in 5 fragments (737bp, 867bp, 1604bp,
7922bp and 8789bp) in addition to the linearised plasmid (9526bp). The
fragment of size 8789bp, generated by the removal of a 737bp Xba1-Nco1
fragment (Fig. 4.3), was isolated (see appendix A.5-6) the ends were filled
in with klenow and ligated back together (appendix A.7-8) to generate
construct 960 (Fig. 4.3).
4.2.2 DRG neurons; transfection and treatment
DRG neurons were prepared and transfected with constructs by
microinjection as described in appendix A. 19 and appendix A.20.
Following microinjection of reporter constructs cells were left overnight in
normal medium before addition of medium containing 40mM K+ and 10pM
forskolin (as described in appendix A.21) or fresh normal medium. For
comparisons between reporter constructs all cell were plated at a density of
4,000 cells per well and were supported in culture with NGF (50ng/ml).
NGF was present at all times before and after microinjection.
In studies of the effects of NGF and LIF, cells were maintained in the
absence of NGF or LIF (approximately 10,000 cells/well) for 2 days prior to
microinjection. Following injection cells were then left 24h before addition
of either NGF (50ng/ml), LIF (100U/ml) or a combination of the two. LIF
concentrations are expressed in units of mouse embryonic stem cell
differentiation inhibiting activity (Smith, 1991, Smith, et al., 1988). Cells
were left in the presence of growth factor for 72 hours before harvesting
and assaying for 8 galactosidase activity as described in appendix A.23.
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Maintaining all cells under similar conditions prior to microinjection
eliminates any differences in cell survival or morphology that may result in
differences in microinjection efficiency between each well.
Statistical analysis of (3 galactosidase activity was performed using a 2-
way analysis of variance for all combinations of injected construct and
treatment of cells after injection. A post-hoc Student Newman-Keuls test
was used to detect significance of individual comparisons. The critical
value for significance of differences between group means was taken as
P<0.05.
4.3 RESULTS
4.3.1 Response to forskolin and depolarisation
When microinjected into neurons from adult rats and assayed under
basal conditions none of the constructs expressed 6 galactosidase at levels
significantly higher than the background level (presumably due to
endogenous 3 galactosidase activity) obtained in uninjected cells (Fig. 4.4).
However, significant levels of B galactosidase activity (approximately 8-fold
higher than the non-specific levels obtained under basal conditions) were
detected in cells microinjected with construct 1697 or construct 960 and
stimulated with 10juM forskolin and 40mM K+ (Fig. 4.4). In contrast, B
galactosidase activity in neurons microinjected with construct 279 was not
increased in the presence of forskolin and K+
Similar results were obtained when constructs 1697, 960 and 279 were
microinjected into neurons from neonatal rats: under basal conditions,
none of the constructs expressed B galactosidase at levels significantly
higher than the background level obtained in uninjected cells. Cells
injected with constructs 1697 or 960 expressed significantly increased
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levels of 13 galactosidase activity following stimulation with forskolin and K+,
when levels were approximately 7.5-fold higher than those obtained under
basal conditions. Cells injected with the construct 279 did not express
significantly increased levels of 6 galactosidase in the presence of forskolin
and K+, above those obtained when incubated under basal conditions
alone (Fig. 4.5).
4.3.2 Response to NGF and LIF
In order to determine the effects of NGF and LIF on gene transcription,
cells grown in the absence of NGF and LIF were transfected with construct
1697. DRG neurons from adult rats, transfected with this construct, did not
express significantly increased levels of 6 galactosidase above the low
levels obtained in uninjected cells, in response to NGF alone, LIF alone or
a combination of NGF and LIF (Fig. 4.6). Cells maintained in the absence
of either NGF or LIF did not express significantly altered levels of 6
galactosidase. Transfected cells could be made to express significantly
increased levels of 3 galactosidase when cultured in the presence of 10/vM
forskolin and 40mM K+ when levels reached approximately 8-fold higher
than those obtained under basal conditions, showing that the neurons had
been transfected successfully.
Although up to 70% of DRG neurons from neonatal rats die when
cultured in the absence of growth factors, a significant proportion do survive
(Mulderry, 1994). However, this population of neurons did not express 3
galactosidase when transfected with the construct containing 1697bp of 5'
flanking sequence and grown in the presence of either NGF alone, LIF
alone or a combination of NGF and LIF. Cells maintained in the absence of
NGF or LIF following microinjection, also did not show any significant
difference in 3 galactosidase expression when compared to uninjected
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cells. Again the construct could be induced in these cells to levels
approximately 5.3 fold higher than those obtained under basal conditions,
in response to combined stimulation with 10juM forskolin and 40mM K+
(Fig. 4.7).
4.4 DISCUSSION
4.4.1 Reporter construct expression
As no expression from any of these constructs could be detected in
adult rat DRG neurons, under basal conditions, it appears that sequences
in addition to those present in the 2800bp VIP gene fragment are required
for the spontaneous increase in endogenous VIP expression that occurs in
cultured DRG neurons. As expression could be detected from these
constructs under conditions of forskolin and K+, the construct is known to be
present in these cells. However, as no significant difference was obtained
between transfected and untransfected cells the construct is not being
transcribed at levels high enough to be detected in the absence of forskolin
and K+.
4.4.2 Response to LIF
No response to LIF could be detected in adult or neonatal rat DRG
neurons injected with construct 1697. Experiments performed by P.
Mulderry (Mulderry, 1994) with the same preparation of LIF showed that
endogenous VIP is regulated by LIF in neonatal rat DRG neurons and that
the preparation of LIF was biologically active. It would be informative to
examine the expression of construct 1697 in NBFL cells or sympathetic
neurons where endogenous VIP gene expression has been shown to
respond to LIF (Sun, et al., 1994). Although exogenous LIF has been
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shown to have no effect on VIP expression in cultured adult rat neurons
(Mulderry, 1994), it is possible that LIF may already be present
endogenously at high enough levels to be partly responsible for the
spontaneous expression seen in adult rat neurons. Experiments remain to
be performed to see if removal of endogenous LIF from cultures of adult rat
DRG neurons results in a reduction in VIP gene expression. If this is the
case it is likely that construct 1697 does not contain all the sequences
required for a response to LIF. This may also explain the lack of expression
from this construct in neonatal rat DRG neurons where endogenous VIP is
expressed when cells are cultured in the presence of LIF but not NGF.
4.4.3 Response to NGF
Although NGF has been shown to be capable of altering transcription
levels of certain genes, by acting on response elements within 150bp 5' of
the transcription start site (DeFranco, et al., 1993, Watson and Latchman,
1995) and NGF has been shown to inhibit VIP expression in DRG neurons
from neonatal rats (Mulderry, 1994), no response to NGF could be detected
on 6 galactosidase expression from construct 1697 in either adult (Fig. 4.6)
or neonatal (Fig. 4.7) rat DRG neurons. Although no expression could be
detected in the absence of NGF it is still possible that if longer constructs
were made that did spontaneously express a reporter gene, expression
could be inhibited by NGF. Results from this experiment provide no
evidence that sequences found in construct 1697 may be involved in a
transcriptional response to NGF.
It is possible that NGF may act postranscriptionally to regulate
translation or post-translational processing as has been observed for other
genes (Nishizawa, 1994), in which case NGF would be expected to have
no effect on reporter gene expression.
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4.4.4 Response to 10pM forskolin and 40mM K+
Although constructs 1697 and construct 960 expressed increased levels
of 6 galactosidase in response to combined forskolin and K+ the shorter
construct containing 279bp of flanking sequence did not respond, even
though it contains the CRE sequence. This suggests that sequences
between -279bp and -960bp are required, in addition to the CRE, for the
response to forskolin and K+. These results contrast with those described
in Chapter 3, where it was shown that the VIP CRE was capable of
responding to combined forskolin and K+when placed in the context of the
c-fos promoter. There are two possible explanations of these apparent
discrepancies:
(1) Alternative sequences may be present in the FOS construct that act
together with the CRE to give a response to forskolin and K+. Alternatively,
the structure of the c-Fos promoter, used in the FOS construct, may be such
as to make these sequences unnecessary. The Fos promoter contains only
a single TATA box between the CRE and the transcription start site (Fig.
3.1) (Gilman, et al., 1986), whereas the rat VIP promoter contains a TATA
box on either side of the CRE and a CAAT box only 28bp 5' of the CRE
(Giladi, et al., 1990). These different structures may affect the response of
the CRE to forskolin and K+(Deutsch, et al., 1988).
(2) Construct 279 may contain sequences capable of binding to proteins
that repress gene transcription. This effect may be overcome by proteins
that bind to sequences between -279bp and -960bp 5' from the
transcription start site in response to forskolin and K+. A similar situation
exists for the somatostatin gene, where a repressor is thought to bind to a
sequence between -425 and -345, the effect of which is overcome by the
presence of sequences between -750 and -425 (Vallejo, et al., 1992).
65
Such a repressor is probably not present in the Fos promoter, allowing
CRE regulated gene transcription. A repressor may play an important role
in preventing VIP gene transcription in DRG neurons in vivo before
axotomy, when VIP expression can not be detected (Nielsch and Keen,
1989, Shehab and Atkinson, 1986).
It is not known whether these constructs respond synergistically to
forskolin and K+ in a similar manner to endogenous VIP in neonatal rat
DRG neurons, while at the same time showing a less than additive
response to forskolin and K+ in adult rat DRG neurons. To determine if this
is the case and therefore whether these sequences can direct similar
developmental alterations on gene expression, seen for the CRE
containing FOS construct in chapter 3, further experiments must be
performed showing the response of these constructs to forskolin alone and
K+ alone.
Differences in the developmental response of construct 1697 and
endogenous VIP to forskolin alone and K+ alone would indicate that
sequences outside the region studied are involved. However, the CRE is
responsible for developmental alterations in reporter gene expression
analogous to endogenous VIP expression (Dobson, et al., 1994 and
chapter 3). Therefore the CRE is likely to play a large role in any
developmental alteration of construct 1697 in response to forskolin and K+.
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Figure 4.1. iB Galactosidase expressing reporter constructs for
VIP genomic sequences
Reporter constructs containing the rat genomic VIP promoter together with
950bp 3' from the transcription start site (arrow) and up to 1697bp 5' from
the transcription start site as indicated. The fB galactosidase reporter gene
(filled box) is located a further 500bp downstream from the 3' end of the
genomic VIP sequences. Hatched box indicates VIP genomic sequence.
















Figure 4.2. Structure of the rat VIP gene
A full length VIP genomic clone (15kb), showing the relative positions of the
7 exons (filled boxes). Digestion with the restriction enzyme EcoR1 yielded
5 fragments, the largest of which (5200bp) was cloned into the EcoR1 site of
pUC18. This 5200bp EcoR1 fragment was further digested with the enzyme
Pst1 to yield a fragment of 2800bp which was cloned into the Pst1 site of
pUC18 in either orientation. Orientation was determined as described in
the text. The appropriate clone was digested with Xba1 and HindiII which
each cut once within the polylinker of pUC18. The resulting 2800bp
fragment was then cloned into the plasmid prPPT-BGAL3 cut with Xba1 and
Hindi11 to yield plasmid construct 1697 (Fig 4.1). Restriction enzyme sites











Figure 4.3. Construction of construct 960 and construct 279
The 2800bp pstt-pst 1 genomic VIP fragment from the rat VIP gene was
cloned into the vector prPPT-BGAL3 cut with Xba1 and HindiII to generate
construct 1697. Restriction sites are indicated by text. Filled box indicates
the first exon of the VIP gene. Arrow indicates transcription start site.
Removal of the 737bp Xba 1 to Nco 1 fragment (as described in the text)
resulted in the formation of construct 960. Removal of the 1418bp Xba 1 to
Apa 1 fragment resulted in the formation of construct 279.
 
Figure 4.4. Effects of 10pM forskolin and 40mM K+ on
expression of genomic VIP reporter constructs in adult rat DRG
neurons
Following microinjection of neurons with reporter constructs 1697, 960 or
279, cells were left overnight before changing to experimental media as
indicated. After 72 hours cultures were extracted and assayed for 3
galactosidase enzyme activity. Each value is mean ± standard error for 3
separate culture wells. Uninjected = cells that have received no injections.
*= Values significantly increased above those obtained for uninjected cells
(P<0.05).
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Figure 4.5. Effects of 10^M forskolin and 40mM K+ on
expression of genomic VIP reporter constructs in neonatal rat
DRG neurons
Following microinjection of neonatal rat DRG neurons with reporter
constructs 1697, 960 or 279, cells were left overnight before changing to
experimental media as indicated. After 72 hours, cultures were extracted
and assayed for 6 galactosidase enzyme activity. Each value is mean ±
standard error for 3 separate culture wells. Uninjected = cells that have
received no injections. *= Values significantly increased above those
obtained for uninjected cells (P<0.05).
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Figure 4.6. Effects of 50ng/ml NGF and 100U/ml LIF on
expression of genomic VIP reporter constructs in adult rat DRG
neurons
Cultured DRG neurons incubated for 2 days in the absence of added growth
factors were microinjected with reporter construct 1697 and left overnight
before changing to experimental media as indicated. After 72 hours
cultures were extracted and assayed for 6 galactosidase enzyme activity.
Each value is mean ± standard error for 3 separate culture wells.
Uninjected = cells that have received no injections. *= Values significantly
















































Figure 4.7. Effects of 50ng/mi NGF and lOOU/rni L!F on
expression of genomic V!P reporter constructs in neonatai rat
DRG neurons
Cultured DRG neurons incubated for 2 days in the absence of added growth
factors were microinjected with reporter construct 1837 and left overnight
before changing to experimental media as indicated. After 72 hours
cultures -were extracted and assayed for 8 galactosidase enzyme activity.
Each value is mean ± standard error for 3 separate culture wells.
Uninjected - cells that have received no injections. *- Values significantly
























































SEQUENCE ANALYSIS OF THE 5' FLANKING REGION OF THE RAT
VIP GENE
5.1 INTRODUCTION
The rat VIP CRE could not direct spontaneous expression of a reporter
construct, in adult rat DRG neurons, when alone or in the context of up to
1697bp of VIP 5' flanking sequence (chapters 3 and 4). Therefore it would
seem likely that sequences outside this region of the VIP gene are required
for spontaneous expression. However, in view of the results obtained in
chapter 2 it would seem likely that proteins capable of binding to the CRE
are important for this expression. There are numerous examples of
regulatory elements, including CREs, that synergise in their effects on
transcriptional regulation (Vallejo, et al., 1992, Hyman, et al., 1989, Lu and
Bensadoun, 1993). Thus it is possible that elements within the 1697bp
region are required, together with the CRE and sequences outside the
1697bp region for spontaneous VIP expression.
This chapter describes the sequence analysis of 1697bp of 5' flanking
sequence from the VIP gene. This information was obtained (1) in order to
establish the structure and orientation of the reporter constructs used in
chapter 4. (2) To extend our knowledge of the sequence of the 5' flanking
region of the gene (only 242bp 5' of the transcription start site had been
published), (3) to allow the identification of elements showing homology
with consensus transcription factor binding sites that may be relevant for
spontaneous VIP expression and (4) to identify regions of homology with
the published sequence of the human VIP gene. Any sequences showing
a high degree of homology between the rat and the human genes have





The pUC18 vector containing 2800bp of the rat VIP gene (Fig. 4.2) was
sequenced by the Sanger dideoxy method (appendix A. 17) using the
pUC/M13 -40 forward primer and the pUC/M13 reverse primers from
Promega. The plasmid was digested with restriction enzymes that cut once
within the polylinker of the pUC18 vector and at one or more sites within the
VIP clone (Kpn1, Acc1 and Nco1 see Fig. 4.3). The resulting VIP clone
fragment was removed and the remaining intact vector containing a
shortened VIP fragment was religated and sequenced using the same
primers. Fragments were aligned using the computer programme
Genejockey II and gaps were filled in by designing primers to allow
sequencing across gaps. Each fragment obtained was sequenced at least
twice in a single direction. A total of 1910bp from the 5' end of the 2800bp
fragment was sequenced.
5.2.2 Search for consensus transcription factor binding sites
In order to identify possible binding sites in construct 1697 that may be
involved in interactions leading to spontaneous VIP expression a scan for
putative transcription factor binding sites was carried out using the program
SIGNAL SCAN provided by the UK. Human Genome Mapping Project
Resource Centre (Prestridge, 1991).
5.3 RESULTS
5.3.1 Sequencing
Following sequencing of the 5' flanking region we were able to show
that construct 1697 included sequences corresponding to the first exon
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(151 bp), 242bp of 5' flanking sequence and 61 bp of the first intron of the
published rat VIP sequence (Giladi, et al., 1990). Our sequence differed
from the published sequence at 4 nucleotides, none of which were within
the ORE sequence (Fig. 5.1). It is likely that the 4 differences represent
errors in the published sequence. Our sequence showed greater
homology to the published sequences of the mouse (Lamperti, et al., 1991)
and human (Yamagami, et al., 1988) genes at two of the positions where
there were discrepancies (between the two TATA boxes at positions -148
and -146: Fig. 5.1 and 5.2). To determine if these represent errors in the
published sequence it will be necessary to isolate and sequence
independent clones of the VIP gene.
A comparison of the 1910bp of rat VIP DNA sequenced in this study with
the published 5' flanking sequence from the human VIP gene, using the
UK. Human Genome Mapping Project Resource Centre, genetics computer
group (Wisconsin) package, revealed a homology of 67.1% (Fig. 5.2). This
is similar to the 67.8% homology observed between the 454 nucleotides of
published rat 5' VIP sequence (Giladi, et al., 1990) and the published
human VIP gene (Yamagami, et al., 1988).
5.4 DISCUSSION
Several consensus transcription factor binding sites were identified
using the SIGNAL SCAN program. Identified sites are shown below.
Positions refer to the number of nucleotides from the 5' end of the known
sequence (nucleotide 1 corresponds to -1697 nucleotides 5' from the start
of transcription). Numbers in brackets refer to the position relative to the
transcription start site
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5.4.1 LIF response element
A 180bp sequence from the human VIP gene has been shown to confer
a response on a reporter construct to LIF when transfected into NBFL cells
(Symes, et al., 1994). This sequence has been shown to contain at least 4






A sequence 100% homologous to G3 was found at position 424bp from
the start of sequencing (-1273bp from the transcription start site). G3 has
been shown to be absolutely required for the LIF response of reporter
constructs transfected into NBFL cells (Symes, et al., 1994). A sequence
showing a 16/19bp match with G4 was found at 468 (-1229bp) and an
18/19bp match for G5 at 521 (-1176bp). G6 shows the least homology with
the rat VIP gene with a 10/17bp match at 573 (-1124bp) (Fig. 5.2). The
position of all these elements relative to the transcription start site
corresponds very closely with the positions of homologous elements within
the human VIP gene. Although construct 1697 (Fig. 4.1) contains
sequences necessary for a LIF response, no such response was obtained
in DRG neurons transfected with construct 1697 (Fig. 4.6 and 4.7). Further
experiments are necessary to determine whether this construct will respond
to LIF in NBFL cells.
5.4.2 AP1 element
Three sequences showing homology to a consensus AP1 site (5'-
TGAC/GTCA-3') (Curran and Franzen, 1988) were found at 546 (-1151 bp
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TGATTAA) , 953 (-744bp TGATTCA) and 1852 (+155bp TGAGTAA).
Although the last of these sites is downstream from the start of transcription,
it is a property of enhancer proteins that they can act from long distances
away (several hundred to thousand nucleotides) either upstream or
downstream from the transcriptional start site (for review see Johnson and
McKnight, 1989). As AP1 elements are known to bind the transcription
factors Jun and Fos in the form of heterodimers and can also bind Jun/ATF
heterodimers or Jun homodimers (Nakabeppu, et al., 1988, Halazonetis, et
al., 1988, Hai and Curran, 1991) it is likely that the homologous sites
described above will also bind these proteins. As Jun has been shown to
be important for spontaneous VIP expression in DRG neurons (Peter
Mulderry manuscript submitted), binding of Jun to any of these sites may be
important for this expression. As AP1 elements are capable of binding
many transcription factors that also bind to CRE sequences (see chapter 2
and Nakabeppu, et al., 1988) it is possible that these sites are also involved
in the response of endogenous VIP to forskolin and K+.
The only putative AP1 element to be 100% conserved between the
human and rat VIP sequence and thus most likely of these three sequences
to be important in transcriptional regulation, is that at position 546 (-1151).
5.4.3 AP2 element
Three sequences were found showing homology to a consensus AP2
element (5'-CCCCAGGC-3') (Mitchell and Wang, 1987). CCCAAGGG at
1844 (+147bp), CCCCGCGC at 1807 (+110bp) and CCCATGGG at 1603 (-
94bp). Of these sites, only the one at position 1603 (-94) is conserved
between human and rat VIP. This position is adjacent to the TGACGTCTTT
sequence of the CRE and the last 7 nucleotides (CCATGGG) of this
putative AP2 site are included in the CRE containing oligonucleotide used
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in the studies described in Chapter 3. The consensus AP2 sequence is
thought to bind a 52kd protein known to bind to enhancer regions of the
SV40 and human metallothionein 11A genes, stimulating RNA synthesis
(Mitchell and Wang, 1987). An AP2 like element of the human
proenkephalin gene has also been shown to act synergistically with an
adjacent CRE to confer a maximal response to cyclic AMP and phorbol
esters (Hyman, et al., 1989). DRG neurons are also known to express AP-2
binding proteins (Mitchell, et al., 1991). It is therefore conceivable that the
sequence at position 1603 (-94bp) is capable of binding AP2 and may play
a role in modulating responses of the CRE to forskolin and depolarisation.
The AP-2 sequence may be required together with the CRE for the
spontaneous VIP expression seen in adult rat DRG neurons. It is also
possible that proteins binding to this AP-2 element could prevent the
binding of proteins to the CRE element or vice versa. Further information
on the possible role of the AP2 site in regulating the function of the adjacent
CRE could be obtained by DNAse 1 footprinting experiments to show which
nucleotides are important for binding proteins in adult rat DRG neurons.
Additional information could be obtained by performing electrophoretic
mobility shift assays (EMSA) using consensus AP-2 or CRE
oligonucleotides to compete with proteins in adult rat DRG neurons for
binding to a radiolabeled oligonucleotide containing the CRE and AP2
sequences from the rat VIP gene. This would confirm whether AP-2 and/or
CRE binding proteins are capable of binding to this sequence.
5.4.4 E-box
An element (CAGCTG) which corresponds to the consensus E-box motif
CANNTG was identified at position 472 (-1225bp). The E-box motif is
recognised by dimeric protein complexes composed of helix-loop-helix
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and basic helix-loop-helix leucine zipper families of proteins (Murre, et al.,
1989, Sawadogo and Roeder, 1985). Binding of these proteins to the E-
box motif can result in a 10 to 20 fold increase in transcription (Sawadogo
and Roeder, 1985). E-box binding proteins are known to be expressed in
DRG neurons (Begley, et al., 1992). It is interesting that adult rat DRG
neurons transfected by microinjection with a reporter construct containing
the E-box motif CACGTG in front of the c-Fos promoter spontaneously
express the corresponding reporter gene at high levels (Paterson, et al.,
1995). If E-box binding proteins from adult rat DRG neurons are capable of
binding to the sequence CAGCTG 5' from the rat VIP gene transcription
start site they may have a strong effect on VIP expression.
Since no spontaneous expression was obtained from the constructs
containing 1697bp of 5' flanking sequence (chapter 4) any stimulatory
effects of the CAGCTG sequence may be antagonised by alternative
binding sites or the sequence CAGCTG may be inactive in the context of
the rat VIP gene. As the rat VIP CRE sequence has been shown to respond
to forskolin and K+ when together with the c-Fos promoter, but not its
endogenous VIP promoter, as discussed above, it is possible that the
response with the CACGTG E-box sequence is only fortuitously obtained
when using the c-Fos promoter and would not be obtained when in the
context of the rat VIP promoter. Experiments to determine if this is true will
require a fragment of the VIP gene that can be used in a reporter construct
and that does direct spontaneous expression. Mutation of the E-box motif
in this construct will determine its importance in the spontaneous
expression of VIP. Similar experiments to those performed in chapter 2
could also be performed, but using this E-box motif instead of the CRE to
compete binding proteins off the endogenous VIP gene.
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5.4.5 C/EBP site
CAAT box/enhancer binding proteins (C/EBP) are a leucine zipper
containing protein family originally identified due to interactions with the
CCAAT motif of the herpes virus thymidine kinase promoter (Landschulz, et
al., 1989, Graves, et al., 1986). It is possible that members of this family
may bind to the sequence CAAT at position 1572 (-125bp) as identified by
Giladi et al (Giladi, et al., 1990) or to a sequence identified at position 1861
(+164bp) as TCTTACTC which conforms to the consensus C/EBP site of
TCNTACTC where N can be any of the four nucleotides (Costa, et al.,
1988). It is known that certain members of the C/EBP family can dimerise
with proteins capable of binding CRE elements resulting in a complex with
altered DNA binding specificity (Vallejo, et al., 1992). Thus proteins
binding to the CAAT box may compete with the CRE for CRE binding
proteins. This may explain why the CRE containing FOS construct
responds to forskolin and K+ while the CRE containing construct 279 does
not. C/EBPa has been shown to be able to act as a repressor of
transcription, when in the context of certain promoters (Lopez-Cabrera, et
al., 1990) and may also be responsible for repressing the expression
directed by construct 279 in response to forskolin and K+ as discussed
previously in section 4.4.4.
5.4.6 Conclusions
To obtain a complete understanding of the regulatory sequences
necessary for spontaneous VIP gene expression it will be necessary to
create longer constructs that respond in a similar manner to endogenous
VIP. Binding sites such as the CRE that are thought to play a role in this
expression (see chapter 2) could then be mutated individually to determine
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their effects. Although a number of sites that may be involved in
spontaneous VIP expression have been identified in this study, the ability of
any of these sites to regulate gene expression is unknown. This will
require further analysis of their binding characteristics together with
functional studies, for example of their ability to confer expression on a
reporter construct or their ability to reduce VIP expression when
microinjected into DRG neurons. Footprinting studies performed on the
2800bp fragment of the rat VIP gene will allow identification of sites within
this sequence capable of binding transcription factors. However due to the
heterogeneity of DRG neuronal cultures footprinting studies using extracts
from these cells may be difficult to perform. Useful information may instead
be obtained from footprinting studies performed with cultured HeLa cells,
which are known to express a large array of transcription factors that are
also expressed in DRG neurons, or with VIP producing cell lines such as
the neuro-blastoma cell line SH-SY-5Y (Ross, et al., 1983). This approach
has already been used successfully to characterise potential regulatory
elements within the rat PPT gene (Mendelson and Quinn, 1995).
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Figure 5.1 Comparison of Sequenced and Published Rat VIP 5'
Flanking Region
Nucleotides are numbered from the start of the known sequence. The top
line indicates previously published rat VIP sequence. The lower line indicates
sequence obtained from clones containing fragments of the rat VIP gene as
described in the text.
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1 ...ACTAAGTAAAGATTAAAGCATCACACACCCAGCTCAGTAC TTTTGT 46




I I I I I I I I I I I I I I I I I I I I I I IIIIII I II I I I I II I I I I I I I I I I I I
1501 TAAAAAAAAAAGTACATTTCCTCTCTCTTGAACTTGTTTGCTATAAATGT 1550
96 ATTATAAATCAGGCATGATGACAATTTAATAAGAACTTCAAGACCTGTTC 145
I II I I I I I I II I I II I II II I I I I II I I I I I I II I I I I I I I I II I I I II
1551 A.TATAAATCAGGCATGATGACAATTTAATAAGAACTTCAAGACCTGTTC 1599
146 ATCCCATGGGATCACCACTGTGACGTCTTTCGAGGAGCCTTCTGATTGCT 195
I I II I I I I I I I I I II I II I I I II I I I I II I I II I I I I I I I I I I I I I II I I
1600 ATCCCATGGGATCACCACTGTGACGTCTTTCGAGGAGCCTTCTGATTGCT 1649
196 CAGCCCTAAGCACAAGCCCTATAAAATGAGGAACTTTGAGATGCTGGTCA 245




I II I I I II I I I II I II I I II I I I I II I I II I II I I II I I I II I I I II I I
1700 GGTTGTAGTGCAGAGCACTAGCGGCTACTGCCAACCTTTCCCCAGGACCA 1749
295 GGGGCAGACTCCGTGGAGCCTTCTCCCAAGCAGAACTTCAGCACCCCAGA 344
II I I I II II I I I I I I I II I I I I I I I I I I I I I II I I I I I I I I I I I I I I II I
1750 GGGGCAGACTCCGTGGAGCCTTCTCCCAAGCAGAACTTCAGCACCCCAGA 1799
345 CAGCTCCCCCGCGCCGGAGAGACGGTCCTGCCAGAAGGAAAGACCCAAGG 394
II I II I II I II II I I II II I II I I I I II I II I II I I I I I I I II I II I I I I
1800 CAGCTCCCCCGCGCCGGAGAGACGGTCCTGCCAGAAGGAAAGACCCAAGG 1849
395 GTGAGTAAAATCTTACTCTTCTTCATTTCCTCTTCGCCTTCGGGACTTTG 444
II I I I I I I II I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I II II I
1850 GTGAGTAAAATCTTACTCTTCTTCATTTCCTCTTCGCCTTCGGGACTTTG 1899
445 AATAGGAGGG 454
I I II I II II I
1900 AATAGGAGGG 1909
Figure 5.2. Comparison of rat VIP 5' flanking region sequenced in
this study with previously published human VIP 5' flanking region
Previously published human VIP sequence is shown on the bottom line
(Yamagami, et al. 1988). The top line indicates the 1910 nucleotides of sequence
obtained from clones containing fragments of the rat VIP gene as described in the
text. Nucleotides are numbered from the start of the known sequence. There is
67.1% homology between the two sequences.




LIF response element G3
1 LIF response element G4
K5SaSSSH
CAGCTG




1 ATGGTGCTGTGATTCTA TG 19
I I I I I I I I I I I II II II
151 AATTAAAACTTTGAACCTGCAGATGGTGCTATGATTCCATTTTCAAATTG 200
20 AGTTTATGTCCTATTTCACTTTGTAGCAAGAACT AACTTTGGTTTA 65
II III I I I II I II I III I I I I I I I I
201 TTTTGCTTTCTAGTTTAAATTCATAAGAGAAAATGCAGTTGTTTGGTTGA 250
66 GTCTATTTTTGTCAATAGGTAA.AAATAAGGTTAAATTCTCTTTATTATT 114
I I I II I I II I I I I I I I I I I I I I I I I I I II I I I I
251 GTTTACTTTTATTCAGAGGTAATAAAATTGAATTATTTCTTTTTATTTTA 300
• • • • •
115 TTGTTTTATTGTGATGATGG GAGAAA CAGTTTTTATTATTGTGGAAATAT 164
I I I I I I I I I I I I I I I I I I I I II I I II II I I I I
301 TCTTATTATTATTATAATAGAAGCAATTGTCTTTTGTATTG G GAAAAG CT 350
165 ATCACAGTTACTCTTCACAAACACCGAATGCTTCCTTAGACCAACATATG 214
I I I I II I II I I I III I I I II I I I I I I I I I I III
351 ACTATAGTTACTCTTTGTAAATGCTAAGTGCTTGCCTAGGCCAAATAATG 400
215 AGAAGCCTT.GATGTGATTTTTTTTTI I I I I I ITTTTTTGCTTCTCATCC 263
I I I I I I III I I I I I I I I I I I I I I I I I I
401 ATCAGCTTTACATCTTTTATGTTTAAAATTTTTCTTCTTATCATTCAGCA 450
• • • • •
264 TGGAGTCCTCTGTGATCCCTAATCTA.TTTATTTCCAGGTACCACTCTTA 312
II I I I I I I I I I III III I I I I I I I I I I I I I
451 GTCATTTGTCTGTGA C C CTCAATTAA GTTGCTTTG CTGTTTCTG CTCTTA 500
• • • • •
313 AATGAAATCGTTTCACCAAGGATTTGGTAACAATGATCTCAAGATAAAAA 362
ill I I I I I II I I I III III III I I II II I I I I I II I
501 AATAAAATTGGTTCACTAAGAATTGGGTGATGAAGAGCTAAGGATAAAA. 549
363 AAGAAAATCCATATGAAAATCATTTTAACCTCTACTTTGTAACAATTGGT 412
III I I II I I I I I II III I I I I I I II I I I II I I II I
550 ...AAATTCCATATGAGAACTGTTTCAACCTCTAGTTTGTAATAA T 592
413 TAAGAAAAAAAGATTTCCTGGAATTAAGCCACAGGAACTCTGGCTTAAGT 462
I I I I II I I I I I I I I I I IIII I I I I I I I I I IIII I I I I I I I II I I I I I
593 CAGGTAAAAAAGATTTCCTGGAATTAAGCCACAGGAACTCTGGCTTAAGT 642
463 CAGACCf^fCAGCTGGACAAC^ATTCCAGACATTTTGAAATTTAATTC 512
II I I II I I I I II I I I I II II I II I II I I I I I I I I II I I I I II I I
643 CAGAGCTGTCAACTGGGAAACAAATTTCCAGACATTTTGAAACTTAATTC 692
513 GTmAmmTfGTAAO^Am^AGAATAraffMGCCCTAGCAA 562
I I I I I I I I I I I I I I II I I I II I I I I I I I I I I I I I I I I I I I II II
693 ATTTAATTTTTCTGGTAACTGGATTAGAAAATATGATTAAG.CATAGCAG 741
563 GATAACGTCTCGTCCTGCATTGGCCTGTCCTCAGTGCAACAAGGAGATAC 612
I I I I III II I I I I II I I I I I II I II I I I
742 GATA.. TTCTTTTACTGGATCAGTCTGACTTTGAACGAGGAAATAGATAC 789
613 TGAAATCTTAGAGGAGAAGAGAGTAAAGGAGACTGAGA GCTATAT 657
I I I I I II I II I I I I I II I I I I I II
790 TACAATCTTAAAGTAGAAGAAAGAGGACTGTAAAGCCATTCTGTCTTATG 839
658 TTCCCTGAAGAGATACGTAATAGAACACACACACATACACACCGGGACTT 707
II I I I II II I II I I I I I I I I II
840 AAACTTAGAAACAAATGTAAAATAATACACATGGCAGAAGCCTTTAAATA 889
708 TAAAACGAAAGGGCAGTGTCTTTGTTTTGCCATGGCACTCTTATGATAGC 757
II I II II I I I I I I I I II I II I I I III
890 AAAGGAAAAATGGCATTTTC.CTCTGTTGTTTAGGAAATTTTCATGTGGC 938
758 TGCATTTTGACATTAAGTCCCAATTAAATGTATGTCAGGCTGCTCTGAGG 807
I I I I I I I I I I I I I I I I I II I II I I I II I II III
939 TGCATTTT.ACCTTAAACTCTGATTGAATGTGTGCTAGACTACCTTTAGT 987
808 GTAAAATCAACAAAAAGAAATCAAGCATCCTTCACAGACTCTTCAAAGGT 857
II I I I I II I I I I I II I I I I I II I I I I II
988 TACAAATCCACAAATAGAAGTGAAGTATTTATCAAAGTACTATATAAATG 1037
858 CTTTTATCTGACCCTTTGAAATCACCTTTATGTAAAGCGATTGAGTTGAG 907
I I I II II II I I I I I II I II I II II II I II I
1038 CTTTT...CAACTATTTGAAGCCACC....TGTCAAGTGATTGAATCAGA 1080
908 GATGTTCAAA CTCTGAAGTAGGGTGAGTTTTGAG GGCAAAC 948
I I I I I IIII I II I II I I I I II I I I I I
1081 AATGTTCAAAACTGGTTTGAGTATGTGTGTGTGTTGGGGAT vjAuG'ij I AuA ll30
949 ACAGTGATTCAACATTATACAAAGAAATAAAATGAGGA GAATGCC 993
I II II I I I I I II I I I I I I II I I II II II I
1131 AAACTAATTCTACATTATGCAAAGACTTATAAAAGTGATGAGGAAAATCT 1180
994 TTTGAAGAGAAAGAGAGATTCAGTCCCCGGAGTATACAGTCTGAGCATTA 1043
II II II II II I Mil I II II II I I I I I I I
1181 TTAAAAAGAAAAGACAATTAAATTCCTTGAGGTATATAGCCTGACAACAA 1230
• • • • •
1044 TTTA.TTTTTGGAACATTTGATATAGTGTGTGAAGAAAAGGAGTGGGAAT 1092
I I I I I I I I II I I I I I II I I I I I I II II I II I I I I I I I I I
1231 TTTATTTTTTGGATCATTTGACACAGTGTATGTAAAAGTGCATTGGGAAT 1280
1093 TACACTATTTTAAACAAAGTGTGGAAGGGAGGTAGTGCTATGGCTTACAC 1142
I I I I I I I II I II I I II II II II II
1281 TGTG CCATTTTATA CAAATATGAAATAGCACTACTTGTACTGCTTTGTAC 1330
• • • • •
1143 AACAGTGTGCATGTTATAGCATCTTAGACATTTAATGGGACCTCTGTCAC 1192
I I I I I I I II I I I II I I I I I I I I I I I II II II I
1331 AACAGCGTGCATATCTTACTATCTTAGAGACTTTCTGAAACACTTAT..C 1378
1193 TGCGAATTAGCCTCAACAAAAAAGAAATGTAATAACAGAAAGATCCACAA 1242
I I I I I I I I I I I II I II I I I I I I I I I I I I II I I I I I II
1379 TTGGAATTAGTTTCAACAAAGACGAAATGTAATAATAGGAAGGTGAAAAT 1428
1243 TCATTTATGGTTGCTTTTAAAATTAAAATAGGTTCCAAGAAAACTTTAAT 1292
I I I I I I I I I I I II I I II II I I I I I I II I I I I I I
1429 TATCTCTAG..AGCTTTTAAAGTTAGGATAGATTTCAAGAAAGATTAAAT 1476
1293 TGGGATCTGCATAAGCAGCATAAAGATAAAAAAGCATTAAAGAAATTGAC 1342
I I II 1 III I I II I I I I I I I II I I I I I I I II I I I I
1477 CTGGAACTATATGAATAGCATAAAAATTAAAAA.TATTAAGAGAATTGAT 1525
1343 ACCTTGGCACAACAAACA 1360
I I I I I III II
1526 ACTTTGTAATAAAGTATAATTATACTTTTATAAGCGTAATGAACATAAGT 1575
• • • • •
1361 CGAGTTTTCTGCATTCGTTCCTGAAGA..AAGTCCTTATTTTCTCA 1404
I I I I I I II I I I I I II II I I I I I I I II I I I I I I
1576 GTTTGTTGCTTTATGCATTTGTTTCTACACATGAAGTCTTTATTTTCTGA 1625
1405 ..GGAATCACTGGGCCCTGTCTGTAACGTAATCGTC.TTCCAGTTCATCA 1451
II I II I I I I I I I II I I I II I I I II
1626 AGGAATCCCAATGGCCCTGGCTATAACACTACAATCATTTTCTTATTTTA 1675
1452 CAACTAAGTAAAGATTAAAGCATCACACACCCAGCTCAGTACTTT.TTGT 1500
II I I I I II I II II I I I I I I II I I I I I I I I I I I I I I
1676 CAATTAATTAAAGGTTAAAACATTTCACATTGAGCTTGCTACTTTGTTTG 1725
1501 TAAAAAAAAAAGTACATTTCCTCT CTCTTGAACTTGTTTGCT 1542
I IIII I IIII I I I I I I I I I I I I I II II II I II
1726 TTTAAAGAAAAGTAAATTTCCTCTTATCTTACATTTTGAAGTTGCTCACT 1775
W//////M w///wm • ill
1543 ATAAATGTATATAAATCAGGCATGATGACAATTTAATAAGAACTTCAAG 1592
I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I II I I I I I I I I I
1776 ATAAACTTATATAAATTAGGCATAATGACAATTAAGTAAGAACTTCAAG 1824
1593 ACCTGTTCATCCCATGGGATCACCACTGTGACGTCTTTCGAGGAGCCTTC 1642
II I I I I II I I I II I I II II I I I I I II II I I I III
1825 CCCTATTCAT^CCATGGC^GTCATACTGTGACGTCTTTCAGAGCACTTTG 1874
1643 TGATTGCTCAGCCCTAAGCACAAGCCCTATAAAATGAGGAACTTTGAGAT 1692
I I I I I I I I I I I I I I I I I I II I I I I I I I II I II I I I I I I I I I II
1875 TGATTGCTCAGTCCTAAGTATAAGCCCTATAAAATGATGGGCTTTGAAAT 1924
]"fcAGGl1693 GCTGGTCA TTGTAGTGCAGAGCACTA GCGGCTACTGCCAACCTT 1738
I II I I I I I I I I IIII I I II I I III I II I II I I I I
1925 GCTGGTCAGGGTAGAGTGAGAAGCACCAGCAGGCAGTAACAGCCAACCCT 1974
1739 TCCCCAGGACCAGGGGCAGACTCC..GTGGAGCCT...TCTCCCAAGCAG 1783
I III I I I II I I I I I I I I I I II I I III I III
1975 TAGCCATTGCTAAGGGCAGAGAACTGGTGGAGCCTTTCTCTTACTCCCAG 2024
1784 AACTTCAGCACCCCAGACAGCTCC...CCCGCGCCGGAGAGACGGTCCTG 1830
I I I I I I I I I II I IIII I I I I I I I II I I I I II
2025 GACTTCAGCACCTAAGACAGCTCCAAAACAAACCAGAACAGTCAGCTCCG 2074
1831 CCAGAAGGAAAGACCCAAGGGTGAGTAAAATCTT ACTCTTCTTCAT 1876
II I I I II I I I II I I I I I I I I I II
2075 GGGGAGCACGACTGGGCGAGGTAAGTGAAAACTTTACCTTTCCTCTTCTT 2124
1877 TTCCTCTTCGCCTTCGGGACTTTGAATAGGAGGG 1910
I I I I I I II I I I I II I I
2125 TTTCCCTCCTGCCTCTGGAACTTTTCTCACAAAATAATGAATTTTTCTCT 2174
CHAPTER 6
OVERALL DISCUSSION AND FUTURE DIRECTIONS
CHAPTER 6
This thesis has provided an insight into the role of 5' flanking sequences
in the regulation of VIP gene expression in DRG neurons in culture
(Mulderry and Lindsay, 1990). I have shown that proteins that bind to the
CRE are required for VIP gene expression and have identified proteins that
may fulfil this function. I have also demonstrated that sequences other than
the CRE are required. The experiments described in Chapter 4 indicate
that at least some of these sequences must be located outside the 2800bp
sequence (1697bp 5' and approximately 1100bp 3' from the transcription
start site) analysed in reporter constructs.
This study provides evidence for the importance of transcription factors
which bind to the CRE in the regulation of VIP gene expression following
axotomy. I have shown that the rat VIP CRE is a functional element that can
act to increase gene expression in neonatal rat DRG neurons in response
to cAMP and calcium dependent pathways. However, the VIP CRE does
not respond to these stimuli in cultured adult rat DRG neurons, either in
isolation or in the context of the endogenous VIP promoter. Therefore, if
cAMP and calcium dependent pathways play a role in VIP expression by
cultured adult rat DRG neurons it is unlikely that they regulate transcription
factors binding to the CRE.
I have shown that c-Jun is a candidate transcription factor regulating VIP
expression through binding to the CRE. However, it is not clear how a
signal originating at the site of axotomy could regulate c-Jun or other
transcription factors binding to the CRE. NGF and LIF, which are candidate
mediators of such a response, are incapable of increasing gene expression
by CRE-containing reporter constructs and appear to have no effect on VIP
expression by cultured adult rat DRG neurons (Mulderry, 1994). However,
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a CRE sequence from the CGRP gene has been shown to be necessary for
NGF responsiveness of CGRP (Watson and Latchman, 1995). Therefore, it
is possible that the CRE is required for NGF responsiveness of VIP by
cultured neonatal rat DRG neurons (Mulderry, 1994).
Other possible mediators of the response to axotomy are GTP-binding
proteins, which are known to mediate signal transduction in diverse cell
types by a variety of receptors (Bourne, et al., 1990, Gilman, 1987) In their
basal inactive state these proteins bind GDP. Following interaction with a
receptor-ligand complex GDP is released. GTP then binds shifting the
protein to its active conformation allowing it to activate various second
messenger systems. Fast axonal transport is modulated by cycles of GTP
hydrolysis and nucleotide exchange by one or more GTP-binding proteins
(Bloom, et al., 1993). Changes in VIP and c-Jun expression very similar to
those seen after peripheral axotomy can be produced without physical
nerve damage by applying vinblastine, an inhibitor of axoplasmic transport
(Kashiba, et al., 1992, Keen, et al., 1989, Leah, et al., 1991). As activation
of GTP-binding proteins inhibits fast axonal transport it is possible that one
of the initial stages in the axotomy response is activation of these proteins
(Bloom, et al., 1993). Certain GTP binding proteins, for instance RAS, have
also been implicated in the control of c-Jun expression by regulating the
MAP kinase signalling pathways (Maruta and Burgess, 1994). Addition of
inhibitors such as thiophosphorylated derivatives of GTP or the protein
phosphatase CL100 that act on G proteins or MAP kinases respectively will
help in the identification of pathways responsible for the axotomy response
(Alessi, et al., 1993, Strittmatter, et al., 1992). It is possible that c-Jun may
become phosphorylated, following axotomy or once cells are placed in
culture, and may regulate its own expression by binding to an AP-1 like
element located in its own promoter (Angel, et al., 1988). Candidate
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proteins that may phosphorylate Jun include the stress-activated protein
kinases known as JNKs (Kyriakis, et al., 1994).
The identity of additional sequences that must be involved, together with
the CRE, in the expression of VIP following axotomy remain unknown.
Experiments using reporter constructs containing sequences from the
human VIP gene have shown that sequences more than 2.5kb 5' of the
transcription start site are required for a basal level of VIP expression
(Waschek, et al., 1988). A full understanding of the regulation of VIP gene
expression will require the identification of reporter constructs which are
expressed with the same tissue distribution and under the same
physiological regulation as the endogenous VIP gene. Such constructs
may require extensive regions of flanking DNA. Constructs may require
sequences 3' from the transcription start site including introns before
reporter gene expression parallels VIP expression. Introns can contain cis-
acting regulatory elements, are capable of increasing transcriptional
efficiency in transgenic mice and may be required for cell type specific
gene expression (Aronow, et al., 1989, Brinster, et al., 1988). Experiments
using transgenic mice show that sequences within the introns of the
cytoskeletal gene peripherin are required to direct expression to DRG
neurons and for expression in response to neuronal injury (Belecky-
Adams, et al., 1993). Similarly, intronic sequences are required for
expression of a GAP-43 8 galactosidase transgene in DRG neurons of
transgenic mice following sciatic nerve crush (Vanselow, et al., 1994).
Introns from the GAP-43 gene are also required to direct expression to
neurons (Vanselow, et al., 1994). Transgenic mice containing up to 5.2kb
of human VIP 5' flanking sequence, but with no introns, fused to a reporter
gene fail to show expression of VIP in the CNS. As yet no transgenic mice
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have been constructed containing sequences from the rat VIP promoter or
introns of the VIP gene.
If constructs containing larger regions of the VIP 5' flanking region can
be shown to mimic the expression of the endogenous VIP gene when
microinjected into DRG neurons, mutation of the CRE in these constructs
will provide confirmation of its role in VIP expression. Footprinting studies
performed on such larger constructs would also help to identify sites that
are required, together with the CRE, for VIP expression. Experiments could
then be performed to show that these same sequences are capable of
mediating analogous expression in vivo following nerve injury. This could
be accomplished by making transgenic mice containing these same VIP
sequences linked to a reporter gene. Regulatory DNA sequences
necessary for this response could be identified by creating transgenic mice
containing the same sequences but with mutations of elements thought to
play a role in injury induced VIP expression, for example the CRE.
It is possible that VIP expression is controlled at alternative levels to
transcription. Since the increase in VIP expression following axotomy is
paralleled by a similar increase in VIP mRNA (Noguchi, et al., 1989), it
would seem unlikely that regulation occurs at the level of translation as has
been shown to occur for VIP in neurons of the human gastrointestinal tract
(Bredkjaer, etal., 1991). However, regulation could occur through changes
in mRNA stability or in the processing of the primary RNA transcript. It is
known that the degradation rates of different eukaryotic mRNAs are
determined by sequences within the RNA molecule itself and can vary by
more than 2 orders of magnitude. The polyadenylation of certain mRNAs,
and hence their stability, has been shown to vary following physiological
stimuli (Sachs and Wahle, 1993, Carter and Murphy, 1989, Carter, et al.,
1993). In addition untranslated sequences from a number of mRNA
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species have been shown to contain destabilizing sequences (Hamilton, et
al., 1993). At least two different mRNAs coding for VIP are transcribed in
the rat anterior pituitary, differing in their degree of polyadenylation and
stability (Chew, et al., 1994). It is therefore possible that differences in the
stability of VIP mRNA between adult and neonatal rats could account for the
spontaneous expression of VIP seen in adult but not neonatal rats.
Experiments analysing the structure and stability of VIP RNA in both adult
and neonatal rats are required to determine if this is so.
Previous experiments have shown that alternative splicing of introns can
influence the production of stable mRNA (Buchman and Berg, 1988).
Alternative splicing can be developmental^ regulated (Breitbart, et al.,
1985) and could account for developmental differences in VIP expression.
It is unlikely that this is the case for developmental differences in the
response of VIP to cAMP and calcium dependent signalling pathways as
these were shown to be mediated by the CRE in Chapter 3. Northern blots
would be able to show if splicing variants of VIP occur in either neonatal or
adult rat DRG neurons.
NGF can act on untranslated regions to increase mRNA stability
(Nishizawa, 1994). Therefore, developmental differences in splicing could
account for regulation of VIP by NGF in cultured neonatal but not adult rat
DRG neurons (Mulderry, 1994).
It will be important to determine whether mechanisms leading to the
spontaneous expression of VIP in response to injury are also relevant to
expression of other genes induced by injury. For instance it will be
interesting to determine the role that a CRE-like sequence in the galanin
gene, identified by Anouar et al (Anouar, et al., 1994), plays in galanin
expression following axotomy. This may be performed by methods similar
to those used in Chapter 2 in which antisense oligonucleotides,
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corresponding to transcription factors, or dummy CREs are microinjected
into DRG neurons. The effects of reduced transcription factor expression or
transcription factor binding on other genes expressed in response to
axotomy will provide an indication of the importance of these transcription





20mM HEPES, 20% glycerol, 0.1M KCI,
0.2mM EDTA
pH8.3; 108.9 g/l Tris base, 55.7 g/l boric
acid, 4.7 g/l EDTA. pH8.8; 162 g/l Tris
base, 27.5 g/l boric acid, 9.5 g/l EDTA
MATERIALS AND METHODS
A.1 Solutions







A stock of ampicillin was made up at
50mg/ml and stored at -20°C.
50mM glucose, 25mM Tris HCI pH8.0,
10mM EDTA.
L-broth to which 1 % bacto-agar was
added.
B-broth to which 1% agarose was
added.
10g/l tryptone, 8g/l NaCI.
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L-Agar plates: L-agar was melted in a microwave oven and left to cool
to 30-40°C. Ampicillin was added to the agar to a final concentration of
0.05mg/ml before pouring into plates and leaving to set at room
temperature. Once set plates were dried at 37°C for 1-2 h before being
used or stored at 4°C.
L-agarose: L-broth to which 1 % agarose was
added.
L-broth: 10g/l tryptone, 5g/l yeast extract, 5g/l
NaCI.
MOPS: 41.8g/l MOPS, 4.1 g/l NaOAc,
3.4g/l EDTA
PBS: 137mM NaCI, 2.7mM KCI, 10mM
phosphate buffer pH7.3.
SM Phage dilution buffer: 0.1 M NaCI, 0.015M MgS04, 0.05M Tris
HCI pH 7.5, 0.01% gelatine (w/v)
TE: 10mM Tris HCI (pH8), 1mM EDTA.
Tris saturated phenol: Frozen phenol was thawed by bringing to room
temperature and then heating in a water bath to 68°C. The phenol was
extracted with an equal volume of 0.5M Tris HCI (pH8.0) and then extracted
with equal volumes of 0.1 M Tris HCI (pH 8.0) until buffer pH was >7.0.
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Phenol was finally stored at 4°C under a layer of 0.1 M Tris HCI (pH8.0).
0.1% hydroxyquinoline was added as a preservative.
A.2 Lambda DNA preparations from plate lysates
Eschericia coli (E.coli) LE 392 were grown overnight in L-broth
containing 0.2% maltose and 15mM MgSC>4. The following day 170/vl of
the appropriate dilution of bacteriophage was mixed with 600/71 of LE 392
cells and incubated at 37°C for 20min. Following incubation the cells and
bacteriophage mix was added to 7ml of melted soft top agarose at 37°C.
This was mixed and immediately poured on top of a 145mm B-agarose
plate. After setting, the plates were incubated at 37°C for 6-1 Oh until
confluent lysis had occurred. 10ml of SM buffer was then applied to each
plate and plates were left gently shaking overnight at 4°C. Phage DNA was
prepared from the plate lysates using the Qiagen lambda kit Midi columns
according to the manufacturers instructions.
100/7I of buffer L1 (20mg/ml RNase A, 6mg/ml DNase 1, 0.2mg/ml BSA,
10mM EDTA, 100mM Tris/HCI, 300mM NaCI, pH7.5) was added to 50ml
plate lysate and incubated at 37°C for 30min. 10ml of ice cold buffer L2
(30% polyethylene glycol (PEG 6000), 3M NaCI) was then added and the
reaction was incubated on ice for 60min. Phage particles were then
pelleted by centrifugation at 10000rpm for 10min at room temperature in a
Sorvall SS-34 rotor. The pellet was then resuspended in 3ml of buffer L3
(100mM Tris/HCI, 100mM NaCI, 25mM EDTA, pH7.5), followed by the
addition of 3mI of buffer L4 (4% sodium dodecylsulfate). The solution was
incubated at 70°C for 10min and then cooled on ice. 3ml of buffer L5 was
then added (2.55M potassium acetate, pH 4.8) and the solution spun at
12,000rpm in an SS-34 rotor to obtain a particle free clear lysate. The
supernatant was applied onto a Qiagen-tip 100, previously equilibrated
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with 3ml buffer QBT (750mM NaCI, 50mM MOPS, 15% ethanol, 0.15%
Triton X-100, pH7.0) and allowed to enter the resin by gravity flow. The tip
was washed with 10ml of buffer QC (1.0 M NaCI, 50mM Tris, 15% ethanol,
pH7.0) and then the DNA was eluted with 5ml of buffer QF (1.25 M NaCI,
50mM Tris, 15% ethanol, pH8.5). The DNA was precipitated with 0.7
volumes of isopropanol and pelleted by centrifugation in an eppendorf
centrifuge at 4°C. The DNA was washed with 70% ethanol, air-dried for
5min and resuspended in dH20
A.3 Minipreparation of plasmid DNA
Mini-prep DNA was prepared by the alkaline lysis method. Colonies
were picked from agar plates into 3ml of L-broth containing 0.05mg/ml
ampicillin and grown overnight at 37°C in a rotator. The following day
1.5ml of overnight culture was pelleted in an eppendorf tube by
centrifugation (bench top centrifuge) 30 seconds 14,000rpm. The
remaining culture was stored at 4°C for use in a large scale preparation of
plasmid DNA (appendix A.4). Pellets were resuspended in 100ml of ice
cold GTE buffer and mixed by vortexing. 20/71 of freshly prepared alkaline-
SDS solution (0.2M NaOH, 1%(v/v) SDS) was then added, gently mixed
and tubes were placed on ice. 150ml of ice cold potassium acetate (3.0M
KAc, 11.5% (v/v) glacial acetic acid) was added followed by a 5 min
incubation on ice. Samples were then centrifuged for 5min and
supernatants were added to fresh eppendorf tubes. Samples were
extracted with 0.5 volumes of Tris-saturated phenol and 0.5 volumes of
chloroform:isoamyl alcohol (24:1 v/v). The aqueous phases were
precipitated with 0.7 volumes of propan-2-ol at room temperature for 5min.
After centrifugation for 5min in an Eppendorf bench top centrifuge, the
pellets were dried at 37°C and resuspended in 50/71 of TE containing
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20jL/g/ml of DNase-free pancreatic RNase (Sigma) (prepared by boiling a
stock of 1mg/ml for 10min and storing at -20°C). Mini-prep DNA was stored
at -20°C and 5-1 Opl were used for restriction analysis.
A.4 Large scale preparation of plasmid DNA
2ml of overnight cultures, containing individual colonies picked from
agar plates, were diluted into 300ml-500ml of L-broth, containing
0.05mg/ml ampicillin and grown overnight in an orbital shaker at 37°C. The
following day cultures were pelleted by centrifugation at 6000 rpm for 5min
at 4°C in a Sorvall RS-5B centrifuge using a GSA rotor. After decanting the
supernatant, bacterial pellets were resuspended in 12ml of ice-cold GTE
buffer. 24ml of freshly prepared alkaline-SDS (0.2M NaOH, 1% (v/v) SDS)
was then added and suspensions were left on ice for 5min. 16ml of ice
cold potassium acetate (3.0M KAc, 11.5% (v/v) glacial acetic acid) was
added and suspensions were incubated for a further 10min on ice. This
was followed by centrifugation at 4000rpm for 15min in a Sorvall GSA rotor
at 4°C to pellet out cell debris and cellular DNA. Supernatants containing
the plasmid DNA were strained through butter muslin into 250 ml centrifuge
pots and precipitated with 0.6 volumes of isopropanol at room temperature
for 30min, Plamid DNA was recovered by centrifugation at 5000rpm for
15min at room temperature in a Sorvall GSA rotor. Supernatants were
drained away and the pellets were washed with 70% ethanol, dried and
resuspended in 1 ml of TE. The DNA samples were then brought to a total
volume of 4ml with TE after which 400ml of ethidium bromide (10mg/ml)
was added. Exactly 4.4g of CsCI was then dissolved into the solutions
followed by a 5-10 min incubation on ice. The solutions were centrifuged in
15ml polypropylene tubes (Corning) at 5000rpm for 5min at room
temperature. Supernatants were transferred to 6ml polyallamer
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ultracentrifuge tubes (Du Pont) and topped up with a stock solution
containing 1.1 g of CsCI in 1.0ml of H2O. Ultracentrifuge tubes were then
sealed with an ultra crimp tool and centrifuged in a Sorval TV-1665
ultracentrifuge rotor at 45000rpm for 16h at 20°C. Supercoiled plasmid
DNA bands were visualised by daylight and recovered with a large bore
needle and syringe. Ethidium bromide was removed by extracting several
times with equal volumes of butan-1-ol. The plasmid preparations were
then dialysed for 24 h against three 2 litre changes of H2O at 4°C. The
concentration of recovered plasmid was determined by spectrophotometry
(OD26O 10 = 50mg DNA/ml)
A.5 Restriction enzyme digests of DNA
DNA was digested using 1 unit of restriction enzyme per 1/vg of DNA.
For DNA that contained multiple restriction sites corresponding to the
enzyme being used, the amount of enzyme was adjusted accordingly. 1 x
reaction buffer, as specified by the manufacturer and dH20 were added to
a final volume large enough to give a final enzyme dilution of 1:10. This
reduced the glycerol content, in which the enzyme is stored, to a level
where it would not inhibit digestion. Digests were electrophoresed through
an agarose gel (appendix A. 10)
A.6 Recovery of DNA from agarose gels
DNA fragments greater than 500bp were electrophoresed through a 1%
TBE agarose gel and recovered using a Geanclean Kit (BIO 101, inc),
according to manufacturers instructions.
Briefly, DNA was visualised using a UV transilluminator and gel slices
containing the required DNA band were excised using a clean scalpel
blade. Slices were weighed and 0.5ml of TBE modifier (supplied with kit)
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together with 4.5ml of Nal were added per gram of agarose. The mixture
was incubated at 55°C until the gel was completely dissolved. 1jl/I of glass
milk suspension (a silica matrix supplied with the kit) was added per yg of
DNA and the mixture incubated on ice for 15min to allow binding of DNA to
the glass. The glass beads were pelleted by centrifugation and washed 3 x
with 10 to 50 volumes of New wash. The DNA was eluted from the glass
beads by resuspending pelleted beads in an equal volume of dh^O at
55°C for 2-3min.
A.7 Generating blunt ends following restriction enzyme digest
DNA with 3' recessed ends were filled in using the klenow proteolytic
fragment of DNA polymerase 1. DNA from a restriction digest was
precipitated by adding 1/10 the volume of 3M NaAc and 3 volumes of EtOH,
incubating in a dry ice/ethanol bath for 15min and centrifuging at full speed
in an eppendorf bench top centrifuge. The DNA was washed in 3 volumes
of 70% EtOH before resuspending at 50/vg/ml in 10mM Tris-HCL (pH7.5),
5mM MgCI_2, 7.5mM dithiothreitol and 33/vM dNTPs. 1 unit of Klenow was
added per yg DNA (1 unit is the amount of enzyme required to convert 10
nmoles of dNTPs into an acid-insoluble form in 30 minutes at 37°C). The
reaction was left at 25°C for 30min and terminated by heating to 75°C for
10min.
A.8 DNA ligation
Ligation reactions were performed in a total volume of 10/jI, containing
'\y\ of 10 x ligation buffer (0.5M Tris HCI pH7.6, 100mM MgCl2, 10mM DTT),
1mM ATP, 1 unit of T4 DNA ligase (BCL) and a 1:1-1:5 molar ratio of vector
DNA:insert DNA. Typically approximately 50-1 OOng of vector DNA was
used. Ligation reactions were incubated between 10°C and 25°C for 3h -
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overnight. Ligations were then transformed into E.coli as described in
appendix A.9
A.9 Preparation and transformation of competent E. coli
A single colony of E.coli strain DH5a was grown overnight in 3ml of L-
broth, diluted into 40ml of L-broth and grown in an orbital shaker at 37°C to
an OD540 of 0.3-0.5. Cells were harvested by centrifugation at 6000rpm in
a Sorvall SS34 rotor for 5min at 4°C. Cell pellets were placed on ice,
resuspended in 0.25vol of ice cold 0.1M MgCl2 and pelleted as before.
The pellet was then resuspended in 0.05vol of ice cold 0.1M CaCl2 and left
on ice for 45min. Cells were pelleted and resuspended in the same
volume of a buffer containing 0.1M MOPS pH6.5, 50mM CaC^and 20%
glycerol and left on ice for a further 20min to acquire full competence.
Competent cells were aliquoted into 1ml eppendorf tubes, snap frozen in a
dry ice bath and stored at -70°C.
For transformation of competent cells, 1 -5/lvI of ligation mix (appendix
A.8) or 10ng of plasmid DNA was added to 100-200/71 of competent cells.
The mixture was left on ice for 30min before being heat shocked at 45°C for
2min and returned to ice for 2min. The cells were added to 1ml of L-broth
and incubated at 37°C for 1h. They were then pelleted, resuspended in
100/vl of L-broth and subsequently spread on L-agar plates containing
0.1 mg/ml of Ampicillin. The plates were incubated overnight at 37°C.
Colonies that grew on the selective medium were picked for mini-prep
analysis as described in appendix A.3.
A.10 Horizontal agarose gel electrophoresis
The percentage of agarose used depended on the size range of the
linear DNA to be separated. 1% (w/v) agarose (Agarose MP, Boehringer)
89
was used to separate DNA fragments of =7kb to 0.56kb, 1.5% to 2% (w/v)
agarose was used to separate DNA fragments of =1kb to 0.1 kb and 5%
(w/v) agarose (NuSeive GTG) was used to separate DNA fragments of
oligonucleotides of <0.1 kb.
100ml horizontal gel slabs (140mm x110mm x3Qmm) or 25ml mini
agarose gels (83mm x 57mm x 30mm) containing the correct percentage of
agarose were placed in gel electrophoresis apparatus (Gibco BRL, Model
HS or Gibco BRL, Model Horizon 58 respectively) containing sufficient 1 x
TBE buffer to cover the gel. Samples were loaded in 0.2 volumes of
loading buffer and gels were usually electrophoresed at 100 V for as long
as required to see sufficient band separation. After electrophoresis gels
were stained in 1 x TBE buffer containing ethidium bromide (0.5^/g/ml) for
5min and DNA fragments were visualised using a long wave UV
transilluminator. DNA was photographed using Asa Polaroid film type 667
in a Polaroid Cu-5 camera.
A.11 Vertical gel electrophoresis
a) Non-denaturing (native)
6% native polyacrylamide gels were prepared by mixing 10ml of 30%
33:1 acrylamide:bisacrylamide (BDH, premixed) with 2.5ml of 10 x TBE in a
final volume of 50ml. Gel polymerisation was catalysed by the addition of
50/j\ of TEMED (N, N, N', N',-tetramethylethylenediamine) and 0.5ml of
10% ammonium persulfate. The mixture was then immediately poured into
150mm x 170mm x 1.5mm glass sandwiches for use in electrophoretic
mobility shift assays (appendix A. 15). 20 tooth (1.5mm) combs were placed
in the top of the gels and the gels were then left to polymerise. Polymerised
gels were attached to vertical gel electrophoresis apparatus (Gibco BRL ,
Model V16-2) containing 0.5 x TBE buffer and pre-electrophoresed for up
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to 4 h at 100V. Samples were loaded while still running and
electrophoresed for a further 2-3h at 150V. Following electrophoresis, gels
were transferred to Whatman No. 1 paper and dried using a heated
vacuum gel drier (Biorad Model S83). Radiolabelled samples were
visualised by exposing the dried gels to autoradiographic film for 1-24 h
(appendix A. 12).
b) Denaturing
6% denaturing gels were prepared by dissolving 42g of urea (Aristar,
BDH), 20ml of 30% (33:1) acrylamide:bisacrylamide (BDH, premixed) and
10ml of 10 x TBE pH 8.8, in a final volume of 100ml. The solution was
filtered through Whatman membrane filters (0.45/v) under vacuum and
degassed before adding 0.55ml of 10% APS and 55/71 of TEMED.
Solutions were immediately poured into 300mm x 400mm glass
sandwiches previously sealed with 5% agarose. 20-tooth combs (0.4mm)
were inserted and the gels were left to polymerise. After polymerisation,
gels were attached to vertical gel electrophoresis apparatus (Gibco BRL,
Model S2) containing 1 x TBE buffer. Gels were pre-run at approximately
2000V (less than 50W) for 30min prior to loading. Following loading, gels
were run at 2000V for 3-4h before transferring to Whatman No 1. Gels
were covered with Saran wrap and dried using a heated vacuum gel drier
(Biorad Model 583). Saran wrap was removed from the dried gels and
radiolabelled samples were visualised by autoradiography (appendix
A.12).
A.12 Autoradiography
Detection of radiolabelled material was carried out using Fuji RX X-ray
film. For 32P, X-ray film was placed against dried gels inside cassettes. An
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intensifying screen was placed on the opposite side of the film to the gel
and the film was exposed at -70°C. For 35S containing gels no intensifying
screen was used and gels were exposed at room temperature. Following
the required amount of exposure time films were developed for 2min in
Kodak LX-24 developer (1:4 dilution), fixed for 1min in Kodak FX-40 fixer
(1:4 dilution), rinsed in water and dried.
A.13 Multimerisation of DNA oligonucleotides
Two separate phosphorylation reactions were performed, each
containing one out of a pair of complimentary oligonucleotides, as follows.
2/yg of the oligonucleotide was mixed with 5/vl of 10 x kinase/ligase buffer
(500mM Tris CI pH7.6, 100mM MgC^), 2.5//I 100mM dithiothreitol, 10mM
ATP and 2//I of bacteriophage T4 polynucleotide kinase (8 units//vl). The
volume was made up to 50/71 with dh^O and the reactions were left at 37°C
for 1 h to allow phosphorylation of the 5' termini of the two oligonucleotides.
At the end of 1h the two reactions were mixed and the oligonucleotides
annealed together by incubating for 2min at 85°C, 15min at 65°C, 15min at
room temperature and 15min on ice. The resulting 5' phosphorylated
double stranded oligonucleotide was then ligated into a vector as
described in appendix A.8 except that a series of ligation reactions were
performed containing different molar ratios of vectoninsert. For example,
1:0.01, 1:0.1, 1:1, 1:10, 1:100.
A.14 In Wfro-transcription/translation
Genes cloned downstream from either the SP6 or T7 promoters were
transcribed and translated using the Promega TNT coupled Reticulocyte
Lysate System according to the manufactures instructions. Typically 2pg of
a single DNA expression construct or 1/vg of each of two constructs to be
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co-translated were mixed with 25/lvI of TNT rabbit Reticulocyte Lysate, 2/71
TNT Reaction buffer, 1/7l TNT polymerase (SP6 or T7 or 1/vl of each if
necessary), 1 /7I of amino acid mixture minus leucine (1mM), 1/vl of amino
acid mixture minus methionine (1mM), 1/vl of RNasin ribonuclease inhibitor
(40u//vl) and nuclease free water to make the total volume up to 50/vl. The
reaction was incubated at 30°C for 120min and immediately used for an
EMS A assay (appendix A. 15) or frozen at -70°C.
A.15 Electrophoretic mobility shift assay
Electrophoretic mobility shift assays, as outlined below were based on
the method of Singh, et al., 1986 with a few modifications.
A typical electrophoretic mobility shift assay contained approximately
1ng of double stranded end filled oligonucleotide (appendix A. 16), 0.5-
2.5/vg (depending on batch lot) of non specific competitor poly d(l-C)
(Boehringer), 10-30/vg of protein extract and sufficient OmM or 100mM
buffer D to bring the final reaction concentration to 100mM salt, in a volume
10-15/vl.
In vitro translated protein extracts (typically 3/vl out of 50/vl, see appendix
A. 14) were mixed with buffer D and poly d(l-C) and left on ice for up to
20min. Where appropriate 1/vl of anti-c-Jun antibody (1/vg//vl, Santa Cruz
Biotechnology, Inc) or 1/vl of anti c-Fos and fos-related antigens (generous
gift from Dr. M. ladarola, NIH) were added before the 20min incubation.
Following incubation 1/vl labelled oligonucleotide probe (1ng see appendix
A. 16) and 2/vl of dye mix (2% (w/v) bromophenol blue, 2% (w/v) xylene
cyanol) were added and the reaction mixtures were incubated at room
temperature for 20min. Reactions were then loaded onto 6% native
polyacrylamide gels (appendix A. 11) and protein/DNA complexes were
resolved from unbound DNA by electrophoresing at 150V for 1.5-2.5h.
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Antibody bound to protein/DNA complexes resulted in greater retardation of
the complexes within the gel, resulting in "supershifts". Dried gels were
exposed to autoradiographic film for 16-72h (appendix A. 12).
A.16 Labelling of double stranded DNA oligonucleotide probes
Double stranded oligonucleotides containing 5' overhangs were
radioactively labelled with 32P dATP by incubation with 1pl of 0.1M DTT,
2jj\ of labelling mix (7.5mM dCTP, 7.5mM dGTP, 7.5mM dTTP, diluted 1:5 in
dH20), 5mCi of (32P) dATPaP (NEN, 3000Ci/mmol) and 2fj\ of Sequenase
Version 2.0 (diluted 1:8 in enzyme dilution buffer: 10mM Tris HCI pH7.5,
5mM DTT, 0.5mg/ml BSA) at room temperature for 20-30min. 50/71 of dH20
was then added and the reactions terminated by extraction with an equal
volume of Tris saturated phenol (appendix A.1). Labelled oligonucleotide
was separated from unincorporated label by centrifugation through Nu-
Clean sephadex D25 disposable spun columns (IBI) and the total volume
was brought up to 100/vl with dH20.
A.17 Dideoxy sequencing
Plasmid DNA was sequenced using Sequenase version 2.0 according
to manufacturers instructions (USB).
DNA samples (5-10/7g) were denatured in a final volume of 75/vl
containing 15/7l of 2M NaOH, at 37°C for 10min. DNA samples were then
precipitated by adding 15//I of 3M NaAc and 300/yl of EtOH, incubating in a
dry ice/ethanol bath for 15min and centrifuging at full speed in an
eppendorf bench top centrifuge. Pellets were resuspended in 7//I of dH20.
The DNA samples were then annealed to the appropriate primer in a final
volume of ~\0fj\, containing 2/vl of 5 x sequenase buffer (5 x; 200mM Tris
HCI pH7.5, 100mM MgCl2, 250mM NaCI), 7pl of denatured DNA and 10ng
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of primer. Reactions were heated at 80°C for 2 min and slowly cooled to
room temperature. Annealed DNA samples (10/jI) were then radioactively
labelled with 35S dATP by incubation with 1^1 of 0.1 M DTT, 2/7l of labelling
mix (7.5mM dCTP, 7.5mM dGTP, 7.5mM dTTP, diluted 1:5 in dH20), 5mCi
of (35S) dATPaS (Amersham, 1000Ci/mmol) and 2/vl of Sequenase
Version 2.0 (diluted 1:8 in enzyme dilution buffer: 10mM Tris HCI pH7.5,
5mM DTT, 0.5mg/ml BSA) at room temperature for 2-5min. Reactions were
terminated by the incubation of 3.5/vl of each labelled DNA sample with
2.5jul aliquots of one of the four ddNTPs at 37°C for 10-20min. 4/lvI of stop
solution was then added and samples were boiled for 2min before loading
onto 6% denaturing polyacrylamide/urea gels (appendix A.11). Gels were
electrophoresed at 1500V for 3-4 h and fixed for 30min in 5% methanol,
15% acetic acid before drying and exposing to autoradiographic film
(appendix A. 12), typically for 16 h.
A.18 PC12 cells maintenance and electroporation
PC 12 cells were maintained in Dulbecco's modification of eagle
medium (ICN biomedicals inc.) containing 10% horse serum, 5% foetal calf
serum, 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco). Cells were
incubated at 37°C in 5% CO2 95% air and differentiated following
transfection with 50ng/ml NGF. Consistent transfection of PC12 cells, as
measured by comparing CAT expression between parallel transfections,
was obtained by electroporation of 3x106 cells at 200V in the presence of
5fjg of reporter construct DNA using a Biorad gene pulser™. 1.5x106
undifferentiated cells were then plated out per petri-dish and left overnight
in the presence of 50ng/ml NGF to settle down.
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A.19 Preparation of Dorsal Root Ganglion Neurons
DRG with attached roots were dissected aseptically from the cervical,
thoracic and lumbar regions (40-48/animal) of adult (200-250g) or neonatal
(first-second postnatal day) Wistar rats and collected in Ham's F-14 growth
medium (Imperial Laboratories) containing 4% Ultroser G serum substitute
(Gibco). Ganglia were carefully separated from roots and capsular
connective tissue before being enzymatically treated with 0.125%
collagenase (Worthington) for 3h (adults) or 30min (neonates). Cells were
washed in serum free F-14 medium and treated with 0.25% trypsin
(Worthington) in serum free F-14 for 30min. Cells were dispersed by
mechanical trituration through a glass Pasteur pipette and suspended in
F14 containing Ultroser G. Neuronal enrichment was achieved by plating
neurons from 1 adult rat on a 60mm diameter petri dish, previously coated
with polyornithine (500pg/ml). After leaving overnight to allow non-
neuronal cells to firmly attach to the dish, most of the dead cells and axonal
and myelin debris were discarded prior to selectively removing weakly
adherent neuronal cells with a stream of medium from a Pasteur pipette.
Neurons from neonatal rats or enriched cells from adult rats were plated at
a density of 4,000 to 10,000 neurons per well on shallow 10mm diameter
polystyrene wells (Cel-Cult, Sterilin) previously coated with polyornithine
(500/vg/ml) and laminin (5jug/ml) and maintained in Ham's F14 medium
(Imperial Laboratories) containing 100 U/ml penicillin, 100 mg/ml
streptomycin (Gibco), 4% Ultroser G serum substitute (Gibco) and 50 ng/ml
mouse salivary gland NGF when required (generous gift from Dr. J. Winter,




Plasmid DNA was diluted to 200 pg/ml in 10mM Tris-HCI buffer, pH7.5
and loaded into Eppendorf femtotip injection pipettes, tip diameter
0.5±0.2pm. Microinjection was performed using an Eppendorf
microinjector 5242 and micromanipulator 5170 system. Plasmid constructs
were microinjected at 200/;g/ml 1-4 days after plating with a standard
injection time of 0.5s.
DRG neurons were easily distinguished from the non-neuronal cells
present in the cultures by morphological criteria alone. These include a
relatively large rounded cell body with distinct nucleus and nucleolus,
together with a phase bright plasma membrane.
Although attempts have been made to position the pipette for
microinjection into the neuronal nucleus, cell movement in response to the
injection pipette together with the relatively large volume of perinuclear
cytoplasm in DRG neurons meant that most injections were actually
cytoplasmic.
It has previously been estimated (Mulderry, et al., 1993) using a
standard injection time of 0.5s and injection pressure of 100-400hPa that
the average volume delivered per injection is in the order of 10"13-10~12
litres. At a DNA concentration of 200pg/ml this would correspond to
approximately 103-104 plasmid copies. However due to differences in tip
diameter, injection pressure and characteristics of individual cells it is likely
that the volume of individual injections and hence the number of introduced
plasmid copies per cell is highly variable. The efficacy of this system of
neuronal transfection has been assayed previously (Mulderry, et al., 1993),
by injecting Cascade Blue-labelled dextran. After 2 days, the number of
neurons of healthy appearance labelled by Cascade Blue fluorescence,
expressed as a proportion of the number of injections, was fairly consistent
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from one well to another. This efficiency was not significantly different
between cultures grown in the presence or absence of NGF.
A.21 Oepolarisation and forskolin treatment of DRG neurons
For depolarisation experiments F14 medium was diluted to 75% of
normal strength by addition of 11.25g/l KCI. This produced isotonic
medium containing 40mM K+. For control cells medium was diluted to 75%
of normal strength by addition of 7.6g/l NaCI. Calcium content was not
adjusted and the diluted medium therefore contained 1.5mM Ca2+.
Forskolin (Sigma) was dissolved in ethanol to a concentration of 10mM.
This was then diluted into the above medium at 1:1000 to give a final
concentration of 10/vM.
A.22 Chloramphenicol acetyl transferase assay
Cells transfected with reporter constructs capable of expressing
chloramphenicol acetyl transferase (CAT) were lysed and CAT expression
was quantified using a CAT ELISA kit (Boehringer Mannheim), according to
the manufacturers instructions.
Briefly, cells were washed twice with 100/vl of PBS before lysis in 200/-/I
buffer (kit lysis buffer) for 30 min at room temperature. The cell extract was
centrifuged for 15 min at full speed (14,000rpm) in an eppendorf bench top
centrifuge to remove cellular debris. The supernatant was transferred to a
microtitre plate module (MTP) which had been coated previously with anti-
CAT antibodies (polyclonal sheep antibody). After incubation at 37°C for
2h the solution was discarded and the modules were washed 4 x with
250/71 of washing buffer. 200//I of a digoxigenin labelled anti-CAT antibody
(2/7g/ml) was added to each well and incubated at 37°C for 1h. The
solution was discarded and the modules were washed 4 x with 250/vl of
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washing buffer. 200/71 of a peroxidase-conjugated antibody to digoxigenin
(150mU/ml) was added to each well and incubated at 37°C for 1h. The
solution was discarded and the modules were washed 4 x with 250/71 of
washing buffer. After the last wash 200/71 of peroxidase substrate was
added to each well and the samples were incubated at room temperature
until a green colour was obtained resulting from cleavage of the peroxidase
substrate. The absorbance of the samples was measured at 410nm using
a Dynatech MR600 microplate reader with the resulting absorbance being
directly proportional to actual CAT concentration. Calibration curves were
obtained for each reaction by using CAT standards of known concentration.
A.23 B Galactosidase assay
Cells transfected with reporter constructs capable of expressing 13-
galactosidase were lysed and expression was quantified using a 4-methyl
umbelliferyl 13-D-galactosidase (MUG) assay for f3-galactosidase. Cells
were rinsed in PBS before transferring to 400/71 of MUG reaction solution
(60mM Na2HP04, 40mM NaH2P04, 10mM KCI, 1mM MgS04, 0.1% Triton
X-100, 0.2mg/ml MUG, pH7.0). Cells were incubated with shaking
overnight at 4°C followed by addition of 200/71 of stop buffer (300m M
glycine, 15mM EDTA, pH11.2). 100/71 aliquots were diluted into 4ml of
distilled water in a quartz cuvette and methylumbelliferone fluorescence
was measured using a spectrophotofluorometer ( with an excitation
wavelength of 360nm and an emmision wavelength of 450nm. Assays




For immunocytochemistry cells were cultured and maintained on glass
coverslips to allow easy visualisation of staining. Cultures were rinsed
briefly in PBS and fixed for 30min at room temperature with 4%
paraformaldehyde in PBS. They were then rinsed in PBS containing 0.1%
Triton X-100 and incubated overnight at 4°C with antisera diluted in PBS
containing 0.1% Triton X-100, 10% horse serum and 0.004% sodium azide.
VIP immunoreactivity was stained using a rabbit antiserum purchased from
Immuno-Nuclear Corporation (Stillwater, Minnesota) at 1:3000 and
substance P and CGRP immunoreactivities were stained using antisera
from Peter Mulderry, rabbit anti-substance P 7/0310, diluted 1;5000 and
rabbit anti-rat a-CGRP 18/2305, diluted 1:15,000. Cultures were rinsed
briefly in PBS containing 0.1% Triton X-100 and incubated in 50/71 of
biotinylated anti-rabbit second antibody for 45min. Following a further rinse
in PBS containing 0.1% Triton X-100 the cultures were stained with
streptavidin-linked fluorescein isothiocyanate. In all cases specificity of
immunostaining was checked by preincubation of antisera with the relevant
synthetic peptide antigens (porcine VIP, substance P and rat a-CGRP at a
concentration of 150nM) preventing any labelling of cultured cells.
A.25 Confocal microscopy
Fluorescent and phase contrast images of immunostained cells were
taken using an MRC-600 confocal laser scanning optical microscope with
the detection aperture set at maximum to prevent any optical sectioning.
Epi-illumination was used (sample illuminated and detected from the same
side) to provide a positive correlation between sample concentration and
fluorescent intensity (Rost, 1991). Samples stained with fluorescein
conjugated antibodies were excited and visualised through a standard
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FITC filter set. The excitation and emission spectra for fluorescein do not
overlap preventing emitted light from being reabsorbed (Pearse, 1980).
This prevents a negative correlation between antibody concentration and
fluorescence intensity. The images obtained are composed of pixels each
of which can take a value of 0-255 depending on fluorescence intensity.
NIH Image software was used to calculate the average pixel value and the
number of pixels per cell. These two values were multiplied together to
provide a total pixel intensity, used as an index of VIP content of the cell.
Average pixel intensity per cell was not used as it is not known whether a
small strongly stained cell contains the same amount of VIP as a large
weakly stained cell.
A.26 Statistics
For all parametric statistics, results were analysed first using a 2-way
analysis of variance for all combinations of injected construct and treatment
of cells after injection. Statistical significance of difference between
treatments or constructs was determined by either a post-hoc Student
Newman-Keuls one way analysis of variance or by a Students T test using
an F distribution. For the non-parametric results obtained in chapter 2, a
Mann-Whitney comparison by rank test was performed. For all tests the
critical value for significance was taken as P<0.05.
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RAT VIP CYCLIC AMP RESPONSIVE ELEMENT MEDIATES EXPRESSION
IN NEONATAL RAT DORSAL ROOT GANGLION NEURONS. S.P. Dobson,
P.K. Mulderry, J.P. Quinn, J.A. Morrow, I. Gozes*, A.J. Harmar, SPON; Brain
Research Association. MRC Brain Metabolism Unit, Royal Edinburgh
Hospital, Edinburgh U.K. *Sackler school of medicine, Tel Aviv University,
Israel.
Cyclic AMP and calcium influx caused by depolarization act
synergistically to stimulate high levels of VIP expression in neonatal rat
dorsal root ganglion (DRG) neurons in culture (Mulderry, Neuroscience 53:
229, 1993). The aim of this study was to investigate the role of a putative
cyclic AMP responsive element (CRE), 5' to the rat VIP transcription start
site, in regulating VIP gene expression in response to potassium (K+)
evoked depolarisation and a forskolin-stimulated increase in cyclic AMP.
Neonatal rat DRG neurons grown in culture wells were transfected by
microinjection (Mulderry et al, Mol.Cell. Neurosci. 4: 164, 1993) with a
plasmid containing 3 tandem copies of the rat VIP CRE, in the form of a 33
bp synthetic oligonucleotide, preceding the c-fos promoter and CAT reporter
gene. After injection of plasmid into 350 neurons/well, expression of CAT
was undetectable (<3pg) when cells were grown in medium alone or
medium plus forskolin (10/vM). Elevated K+ (40mM) resulted in expression
of 3.5-1 Opg/well whilst K+ combined with forskolin resulted in 35-49 pg/well.
A control plasmid containing the c-fos promoter and CAT reporter gene but
no CRE expressed 3-9 pg CAT/well in response to combined forskolin and
K+ whilst expression was undetectable when forskolin or K+ were used
alone. Thus, the CRE can mediate synergistic transcriptional responses to
combined stimulation with forskolin and depolarization in DRG neurons.
DRG neurons were also microinjected with a plasmid containing 1.5kb of 5'
flanking sequence (including the CRE) from the rat VIP gene preceding a
LacZ reporter gene. This construct showed 10-13 fold higher levels of
expression in the presence of forskolin and K+ than under control
conditions. Our results indicate that the rat VIP CRE could mediate the large
increase in VIP expression induced by cyclic AMP and depolarization in
DRG neurons.
Neuroscience Letters, 167 (1994) 19-23
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The rat vasoactive intestinal polypeptide cyclic AMP response element
regulates gene transcriptional responses differently in neonatal
and adult rat sensory neurons
S.P. Dobson, J.P. Quinn, J.A. Morrow and P.K. Mulderry*
MRC Brain Metabolism Unit. Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF, UK
(Received 1 October 1993: Accepted 22 November 1993)
Key words: Microinjection; Forskolin: Depolarisation: Reporter gene: Vasoactive intestinal polypeptide; Cyclic AMP responsive element; Trans-
fection; c-fos
We studied the ability of the rat vasoactive intestinal polypeptide (VIP) cyclic AMP responsive element (CRE) to regulate reporter gene expression
through a c-fos promoter in rat sensory neurons transfected in culture by plasmid microinjection. The CRE enhanced the synergistic response of the
promoter to combined potassium-evoked depolarisation and forskolin treatment in neonatal but not adult rat neurons. This corresponds to en¬
dogenous VIP expression which is induced synergistically by the same stimuli in neonatal but not adult rat neurons. We conclude that VIP expression
in sensory neurons, which is induced by axotomy in vivo, could be regulated through the CRE.
Vasoactive intestinal peptide (VIP) is one of several
neuropeptides whose expression is increased in sensory
neurons of the dorsal root ganglia (DRG) in response to
peripheral axotomy [1-4], There is pharmacological evi¬
dence that VIP functions as a neurotransmitter of pri¬
mary afferent terminals in the spinal cord specifically
after nerve injury [5] suggesting that plasticity of neu¬
ropeptide expression may be an important feature of pri¬
mary afferent function. It is therefore of interest to know
the mechanisms responsible for this plasticity.
We have used DRG neurons in culture to investigate
mechanisms regulating VIP expression. Our previous
studies have shown that adult rat neurons grown in cul¬
ture exhibit a spontaneous induction of VIP similar to
that seen after peripheral nerve injury [6]. Unlike their
counterparts from adult animals, neonatal rat DRG neu¬
rons supported in culture with NGF do not spontane¬
ously express VIP. However, VIP expression can be in¬
duced in these cells by the synergistic effects of combined
potassium-evoked depolarisation (resulting in Ca2+ in¬
flux) and drugs that increase intracellular cyclic AMP
(cAMP) concentrations [7]. Although forskolin, an acti¬
vator of adenylate cyclase, and depolarisation each indi¬
vidually have modest effects on VIP concentrations in
adult rat DRG cultures, there is no synergistic interac¬
tion of the kind seen in neonatal rat DRG neurons [7],
♦Corresponding author. Fax: (44) (31) 447-2081.
These observations led us to hypothesise that spontane¬
ous VIP expression in adult rat neurons and synergisti¬
cally induced expression in neonates might depend on a
common regulatory mechanism which, being spontane¬
ously activated in the mature cells, is no longer capable
of mediating a response to combined activation of
cAMP- and Ca2+-dependent signalling pathways.
The effects of cAMP and Ca2+ influx on VIP levels in
neonatal rat DRG cultures were of interest in view of the
reported presence of a consensus cAMP responsive ele¬
ment (CRE) DNA sequence in the 5'-flanking region of
the rat VIP gene [8,9], Similar DNA sequence elements
from other genes have been shown to mediate synergistic
transcriptional responses to cAMP and Ca2+-influx [10],
indicating that VIP expression in neonatal rat DRG cul¬
tures could result from increased VIP gene transcription
following specific binding of cellular transcription fac¬
tors to the CRE. Furthermore, CREs have been shown
to participate in driving constitutive gene expression in
certain cell types [11], suggesting that the CRE might
also be a site through which spontaneous VIP expression
in mature DRG neurons is regulated. Although the rat
VIP CRE has not been shown to be functional, a similar,
but not identical, DNA sequence element associated with
the human VIP gene is known to function as an enhancer
of gene transcription [12-14]. The aim of the present
study was to examine the extent to which the rat VIP
CRE could mediate patterns of gene expression analo-
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gous to those seen for endogenous VIP in rat DRG neu¬
rons in culture, with the goal of assessing the likelihood
that this element mediates VIP induction in response to
axotomy in vivo.
We have taken the approach of using a reporter plas-
mid containing a synthetic oligonucleotide sequence
comprising the rat VIP CRE inserted upstream of the
previously characterised c-fos minimal promoter driving
expression of a chloramphenicol acetyl transferase
(CAT) reporter gene. A reporter gene vector. FOS, con¬
taining the mouse c-fos promoter (nucleotides -56 to
+72 relative to the transcription start site) [15] linked to
the CAT gene was used as the basis for reporter plasmid
construction. Synthetic double-stranded oligonucleo¬
tides corresponding to the rat VIP CRE (nucleotides -94
to -67) and the rat somatostatin CRE (nucleotides -37
to -45) (Fig. 1) were synthesised (Oswel DNA Services,
University of Edinburgh) to allow insertion into the
unique Sal I restriction site immediately upstream of the
c-fos promoter. All clones were confirmed by sequence
analysis using a primer corresponding to a sequence
within the c-fos promoter. The somatostatin CRE is
probably the best-characterised element of this type and
is known to be capable of mediating a response to fors-
kolin, when in the context of specific promoters [16,17].
Thus, it was used as a positive control with which to
compare the rat VIP CRE results.
Rat DRG cultures were prepared as described previ¬
ously [18] and maintained in Ham's F14 medium (Impe¬
rial Laboratories) containing 100 U/ml penicillin and 100
mg/ml streptomycin (Gibco), 4% Ultroser G serum sub¬
stitute (Gibco), 50 ng/ml mouse salivary gland NGF
(generous gift from Dr. J. Winter. Sandoz Institute.
London, UK). Prior to microinjection, media contained
cytosine-/?-D-arabinoside (10 /tM) to counteract prolifer¬
ation of non-neuronal cells. Plasmid constructs were
microinjected at 200 /tg/ml 1-4 days after plating. Micro¬
injection was carried out as described previously [19]
except that instead of glass coverslips, cultures were
GAT CGT GAC GTC AGG
CA CTG CAG TCC CTA
plated on shallow 10-mm diameter polystyrene wells at a
density of 4,000-10.000 neurons per well. Three hundred
and fifty neurons per well were injected with plasmid.
Following injections, neurons were left overnight in nor¬
mal medium before addition of medium containing K+
or forskolin. For depolarisation experiments, medium
containing 40 mM K+ was prepared as described previ¬
ously [7]. Forskolin (Sigma), stock solution dissolved in
ethanol at 10 mM was added at 1:1000 to yield a final
concentration of 10^tM. Cells were left in the presence of
stimuli for 72 h before extraction in lysis buffer (Boehrin-
ger-Mannheim) for 30 min at room temperature. Lysates
were assayed for CAT immunoreactivity using an en¬
zyme-linked immunosorbent assay kit calibrated with
purified CAT (Boehringer-Mannheim) at 3-200 pg per
assay well. Statistical analysis of CAT immunoreactivity
results were carried out using a 2-way analysis of
variance for all combinations of injected construct and
treatment of cells after injection. A post-hoc Student
Newm?n-Keuls test was used to detect significance of
individual comparisons. The critical value for signifi¬
cance of differences between group means was taken as
P< 0.05.
After injection of the control plasmid, FOS, into neo¬
natal rat DRG neurons, there was no significant increase
in CAT immunoreactivity over the low levels detected in
uninjected cultures under basal conditions, or in the
presence of forskolin or under depolarising conditions
alone. Under conditions of combined forskolin and de-
polarisation, however, significant concentrations of spe¬
cific CAT immunoreactivity could be detected (Fig. 2).
Injection of the plasmid containing the VIP CRE re¬
sulted in CAT expression significantly different from
those seen with FOS only under conditions of combined
forskolin and depolarisation, when CAT levels were ap¬
proximately 4-fold higher than those in cultures injected
with FOS (Fig. 2). Unlike the VIP CRE, injection of the
plasmid containing the somatostatin CRE resulted in sig¬
nificant levels of CAT expression under basal conditions.
SOMATOSTATIN CRE
TCG ACC ATG GGA TCA CCA CTG TGA CGT CTT TCA VIP CRE
GG TAC CCT AGT GGT GAC ACT GCA GAA AGT AGC T


































Fig. 2. EfTects of 10 ,uM forskolin and 40 mM K* on reporter gene
expression in neonatal rat DRG neurons. Each value is mean ±
standard error for at least 4 separate culture wells. As absolute levels of
CAT immunoreactivity varied between experiments, results were nor¬
malised against values obtained with an internal control (construct con¬
taining three copies of the VIP CRE stimulated with forskolin and KT).
Background = cultures that had received no injections.
This was not significantly altered by forskolin or depo-
larisation alone, but was increased to levels similar to
those seen with the VIP CRE construct under conditions
of combined forskolin and depolarisation (Fig. 2).
Injection of FOS into adult rat neurons produced
similar results to those seen in neonates: there was no
significant CAT under basal conditions but combined
depolarisation and forskolin treatment resulted in the
appearance of detectable CAT immunoreactivity. Re¬
sults obtained from adult rat cells injected with the VIP
CRE construct differed from those obtained in neonates,
however, in that CAT concentrations were not signifi¬
cantly different from those seen with the FOS plasmid
under basal or stimulated conditions (Fig. 3). Adult rat
neurons injected with the somatostatin CRE construct
did not express significant levels of CAT under basal
conditions but did express CAT at significantly higher
levels (approximately 1.6-fold) than FOS under condi¬
tions of combined depolarisation and forskolin treat¬
ment (Fig. 3).
If the absolute levels of expression of the FOS plasmid
were much higher in DRG neurons from adult rats than
in neonates, then this might obscure any effect of the VIP
CRE and hence lead to the apparently different result.
To test this, expression levels of the FOS plasmid were
compared as directly as possible using adult and neona¬
tal rat DRG cultures prepared, injected and assayed at
the same time (Table I). The results of this experiment
showed that absolute levels of FOS expression differed
by no more than 2-fold between neonatal and adult rat
neurons, indicating that the different results obtained
with the CRE-containing constructs are indeed due to a
change in CRE function.
Our results show that the rat VIP CRE is capable of
enhancing the response of the c-fos promoter to forskolin
and depolarisation in neonatal rat DRG neurons. This is
the first demonstration that this particular element can
act as a functional enhancer. No such effect was seen in
adult rat neurons showing that the ability of the CRE to
enhance synergistic responses to cAMP and depolarisa¬
tion declines as the neurons mature, just as the response
of endogenous VIP does. Because FOS itself exhibited a
synergistic response to combined depolarisation and
forskolin, it is not possible to say from our results
whether the effect of the VIP CRE on CAT expression in
neonatal rat neurons was due to a response on the part of
the CRE itself to cAMP and depolarisation or only an
enhancement of the FOS response. The cause of the FOS
response is unknown. This construct does not respond to
combined depolarisation and forskolin treatment in
transfected PC 12 cells even though associated CREs do
confer responsiveness to these stimuli (S.P. Dobson and
J.P. Quinn, unpublished data). Nonetheless, the magni¬
tude of the FOS response is virtually identical in neona¬



















Fig. 3. Effects of 10 /uM forskolin and 40 mM depolarisation on re¬
porter gene expression in adult rat DRG neurons. Each value is mean ±
standard error for at least four separate culture wells. Other details as
for Fig. 2.
ences seen with the VIP CRE construct can be attributed
to properties of the CRE. Our results therefore support
the view that the VIP CRE is likely to participate in regu¬
lating the endogenous VIP response to combined depo-
larisation and forskolin seen in neonatal rat neurons [7].
In both neonatal and adult rat neurons, our results
obtained with the somatostatin CRE were slightly but
significantly different from those obtained with the VIP
CRE. suggesting that different CREs can confer specific
patterns of gene expression. The rat VIP CRE identified
by Giladi et al. [8] (TGACGTCT) bears a 7/8 homology
with the somatostatin consensus CRE sequence
(TGACGTCA) [17]. However, it has been shown that
mutating the final adenosine nucleotide of the somato¬
statin CRE into a thymidine, as in the VIP CRE, can
affect its enhancer activity [16]. The different results ob¬
tained with the two CREs may therefore reflect this slight
sequence difference. On the other hand, the human VIP
CRE has been shown to contain two adjacent CRE-like
sequences, one identical to that in the rat and another
upstream of it, that are both required for full enhancer
activity [12]. Our rat VIP CRE oligonucleotides were de¬
signed to include not only the consensus CRE identified
by Giladi et al. [8] but also a second sequence
(TGGGATCA) upstream of it that has 5/8 homology
with the consensus CRE and whose position corresponds
approximately to the second element in the human VIP
gene. It is possible that this sequence also contributes to
the enhancer function of the CRE.
Although the lack of effect of the VIP CRE on CAT
expression in adult rat neurons corresponds to the ab¬
sence of synergistic response to cAMP and depolarisa-
tion by endogenous VIP in these neurons [7], the CRE
TABLE I
COMPARISON OF ABSOLUTE LEVELS OF CAT IMMUNO-
REACTIVITY (pg/WELL). BETWEEN ADULT AND NEONA¬
TAL RAT NEURONS, FOLLOWING MICROINJECTION WITH
FOS PLASMID
Adult and neonatal rats DRG neurons were plated out at similar densi¬
ties on alternate days and 350 neurons/culture were microinjected with
FOS plasmid. Following stimulation with combined 10 nM forskolin
and 40 mM K* for identical periods of time, extracts were assayed
simultaneously for CAT immunoreactivity. Each value is mean ±
standard error for four separate culture wells.
Neonatal rat Adult rat
neurons neurons
Uninjected basal conditions 3.83 ± 1.82 8.40 ± 0.79
Neurons injected with FOS basal 13.06 ±4.14 28.74 ± 5.26
conditions
Neurons injected with FOS 59.48 ± 18.20 109.86 ± 18.52
10//M forskolin + 40 mM K~
did not direct spontaneous expression as is seen for en¬
dogenous VIP. The idea that spontaneous VIP expres¬
sion in adult neurons and induced expression in neonates
might both be mediated through the CRE is therefore
not supported by the present results. However, it is still
possible that the CRE participates in regulating sponta¬
neous VIP expression in adults in association with other
regulatory elements. We are currently performing fur¬
ther experiments with regions of 5'-flanking DNA from
a rat VIP genomic clone [8] to investigate this.
Another problem with the interpretation of our results
is that endogenous VIP expression is seen in only ap¬
proximately 30% of DRG neurons in culture [7]. Since
our microinjection technique is not selective for specific
neuronal subpopulations [19] we would expect that the
majority of injected neurons in our experiments were not
expressing endogenous VIP. Since we have shown a dif¬
ference in CRE function in DRG neurons at different
stages of maturity, it is conceivable that its function also
differs in different subpopulations of DRG neurons.
Further studies involving localisation of reporter gene
and endogenous VIP expression will be needed to deter¬
mine whether this is so.
The mechanisms responsible for the synergistic re¬
sponse to cAMP and depolarisation and the reasons for
its disappearance in mature neurons are unknown. One
possibility lies in cAMP-sensitive Ca2+ channels whose
abundance in rat DRG neurons declines as the neurons
mature [20], However, the uniform response of the FOS
plasmid in neonatal and adult rat neurons argues against
this possibility and suggests that the different responses
mediated by the VIP CRE may reflect differences in the
cellular transcription factor proteins that bind to the
CRE. What these factors may be remains to be deter¬
mined. but the human VIP CRE has been shown to bind
Fos, Jun and CREB in vitro [13]. In this context it is of
interest that peripheral axotomy of DRG neurons has
been shown to lead to altered expression of Jun and
CREB [21-23] and further, that adult rat DRG neurons
spontaneously express Jun in culture (see Jenkins et al.
[23] and references therein). Taken together, these obser¬
vations suggest that interactions between these factors
and the CRE could play a role in regulating the VIP
response to nerve injury in vivo.
We are grateful to Dr. Janet Winter for supplying us
with NGF and to Norma Brearley for help with prepara¬
tion of the manuscript. S.P.D. is a Medical Research
Council student.
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